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The spread of the parasitic mite, Varroa destructor (and the RNA viruses that it transmits 
between honeybees) is closely linked to increased overwintering losses and declining 
honeybee health.  Deformed wing virus (DWV; Iflaviridae) a picorna-like single-stranded, 
positive-sense, RNA virus, is widespread in honeybees and usually present as a low level, 
asymptomatic infection.  However, the transmission of DWV by Varroa to developing pupae 
causes markedly elevated virus levels and characteristic developmental abnormalities. 
This work aims to further the understanding of DWV virulence and pathogenicity and reveal 
how this is linked to Varroa parasitism. Molecular techniques and a novel in vitro larval 
rearing system have been used to study how transmission route influences DWV 
accumulation and localisation in honeybee tissues.  Additionally, the impact of Varroa on 
DWV levels and diversity on both a colony and a landscape level have been investigated, 
testing the hypothesis that a single virulent strain has a selective advantage when transmitted 
by Varroa.  
The route of transmission does influence DWV infection and tissue location in developing 
honeybees, as shown by RNA-FISH.  Injection of a dose of 10-4ng of viral RNA was 
sufficient to produce a pronounced DWV infection in the majority of individuals, whereas 
300ng/larvae of DWV RNA needed to be mixed with larval food before any high viral load 
individuals were found.  I also present novel work in which the relative expression levels of 
key developmental genes from the Homeobox and Ecdysone families are examined in 
honeybee larvae challenged by injection with DWV.  In addition to this, a long-term study 
of viral diversity in the Ardnamurchan Peninsula, Scotland, illustrates how the viral 
landscape is affected by the introduction of the Varroa mite.  Varroa colonisation led to a 
shift from a mixed population of viruses, predominantly VDV-like or VDV/DWV 
recombinants, towards a mainly DWV-like virus population. 
 
 1 
Chapter 1. Introduction 
 
1.1 General Introduction 
Insect pollination of agricultural crops and wild plants provides a key ecosystem 
service, with up to 35% of global crop production (Klein, et al., 2007) and over 85% of 
wild flowering plants (Ollerton, et al., 2011) utilizing insect pollination services.  
Consequently, global threats to  pollinators (Potts, et al., 2010a) are of great concern to 
the scientific and agricultural communities and may pose a threat to human and 
environmental health.   
The European honey bee (Apis mellifera L.) is the world’s most economically 
important managed pollinator.  Honey bees are partially domesticated, and have been 
used by people for  honey production and pollination services for at least 7000 years 
(Bloch, et al., 2010; Oldroyd, 2012).  This association means that many members of the 
public  are aware of, and concerned by, threats faced by honey bees.  Globally, stocks 
of honey bees have increased by approximately 45% during the last half century,  
predominantly as a result of a rising demand for insect pollinated crops in Asia and 
South America (Aizen and Harder, 2009).  However, there is evidence indicating that 
we should be concerned about the continuing, long term viability of honey bee stocks, 
particularly with respect to increasing threats to honey bee health from parasites, 
pathogens and other natural enemies   (Potts et al 2010b).  In contrast to the rise in 
honey bee colony numbers at the global level, the numbers of managed honey bee 
colonies in western Europe fell  by 25% between 1985 and 2005 (Potts, et al., 2010b) 
and in North America it decreased by  59%  from 1959 to 2005 (Mazer, 2007).  These 
declines are associated with documented increases in overwinter colony losses linked 
to infectious diseases, and which have also occurred  in, Asia, Africa and South 
America (BBKA; vanEngelsdorp, et al., 2009; Goulson, et al., 2015; Chantawannakul, 
et al., 2016; Maggi, et al., 2016).  Rising overwinter losses can be offset to some extent 
by beekeepers splitting their colonies to make increase in the summer but this is 
unlikely to be sustainable in the long term, and already the rate of increase of honey 
 2 
bee stocks globally is not keeping pace with rising demand (Aizen & Harden, 2009).  
Regional declines in honeybee stocks, and failure to meet increasing demand for their 
services, could have wide ranging impacts, both for food production and the natural 
environment (Klein, et al., 2007; Potts, et al., 2010b).  
 
 
Figure 1.1. European declines in managed honey bee colonies (1985-2005) (A) and beekeepers (1985-2005) (B). 
Reproduced from (Potts, et al., 2010b).  (C) The three main drivers of honey bee loss, with red arrows representing 
direct pressures from these drivers, green arrows representing interactions between drivers and blue arrows 
representing interactions within the drivers, figure adapted from (Potts, et al., 2010a).  The focus of this work is the 
impact of pests and pathogens on honey bee health, but it is important to consider how these factors interact with the 












While there are a range of drivers affecting honey bee health (Potts et al., 2010a,b), the 
spread of the ectoparasitic mite Varroa destructor (and the RNA viruses that it carries 
and transmits between honey bees) is closely linked to the increase in overwintering 
losses and decline in honeybee health and appears to be a particularly important threat 
(Anderson and Trueman, 2000; Martin, 2001; Le Conte, et al., 2010).  Deformed Wing 
Virus (DWV) is the pathogen that has been shown to have the closest association with 
Varroa parasitism and honey bee colony losses, and knowledge of how this virus has 
capitalised on the global spread of the Varroa mite will be crucial if we are to develop 
effective mitigations and conserve honey bees into the future (Allen and Ball, 1996; 
Bowen-Walker, et al., 1999; Nordstrom, et al., 1999; Sumpter and Martin, 2004; 
Ribière, et al., 2008; de Miranda and Genersch, 2010)  
 
 
1.1 The Biology of the Honey Bee 
Honey bees (Hymenoptera, Apidae, subfamily Apinae, tribe Apini) are closely related to 
the orchid bees (tribe Euglossini), the bumble bees (tribe Bombini) and the stingless 
bees (tribe Meliponiane).  These tribes are  characterized by the presence of a pollen 
basket on the hind tibia and the exhibition of some degree of social behaviour (Winston, 
1987).  There are five extant species of  honey bees: the European (aka the common or 
western) honey bee Apis mellifera, the Asian honey bee Apis cerana, the giant honey 
bees Apis dorsata and Apis laboriosa, and the dwarf honey bee Apis florea.  The natural 
habitat of the western honey bee reaches from northern Europe down to the southern tip 
of Africa, and its range has been further extended into Asia, The Americas and 
Australasia through domestication and beekeeping (Winston, 1987).   
Apis mellifera is a eusocial insect, characterised by division of labour according to sex 
and age, and cooperative rearing of offspring.  A typical A. mellifera colony is made up 
of a multiple comb nest within a cavity (be that naturally occurring or man-made) and 
contains a single reproductive female (known as the queen), 20,000 to 60,000 non-
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reproductive females (or workers), 10,000 to 30,000 juvenile non-reproductive females 
(worker brood) and several hundred reproductive males (drones).  Typically, honey bee 
workers develop to adulthood in 21 days, with queens taking 16 days and drones taking 
24 days (Winston, 1987) (Fig 1.2 A).   
As eusocial insects, honey bees have developed a complex system of social 
organisation, defined by reproductive division of labour (with reproduction being the 
domain of the queen and drones, and all other tasks being carried out by female 
workers), the cooperative care of offspring and the presence of overlapping generations 
within the colony (Wislon, 1971; Schmid-Hempel, 1998).  Living in these large, 
complex societies improves honey bees’ ability to compete for resources against smaller 
groups or solitary individuals but is also associated with the rapid spread of pathogens 
due to close physical contact within crowded colonies (Schmid-Hempel, 1998; Hughes, 
et al., 2002; Holldobler and Wilson, 2008).  This means that honey bees invest heavily 
in pathogen defences, including inducible cellular and humoral immunity, the 
acquisition and secretion of antimicrobial compounds and group defences such as 
hygienic behaviour (Arathi, et al., 2000; Castella, et al., 2008; Fernandez-Marin, et al., 
2009; Wilson-Rich, et al., 2009).  The genetic diversity within a colony, created by 
multiple queen matings (polyandry) also plays a role in disease prevention (Boomsma; 
Tarpy, 2003; Seeley and Tarpy, 2007).   
Within honey bee colonies, as with all eusocial insect societies, the majority of tasks 
within the colony are performed by the functionally sterile adult female workers 
(Kolmes, 1986).  Workers are involved in the tasks of comb building and cleaning, 
tending to the developing brood, feeding and responding to the queen, colony 
ventilation, guarding the colony and foraging for pollen and nectar.  Worker task 
allocation is temporal, with the risky duties such as foraging being carried out by older 
individuals (Tofilski, 2002).  During the spring and summer, newly emerged bees or 
‘house’ bees perform housekeeping duties inside the colony such as nectar and pollen 
processing and brood care, and then transition to foraging duties at around 23 days post 
emergence (Winston, 1987).  In contrast, worker bees produced in the autumn are 
needed to ensure the survival of the colony during the winter whilst no brood is 
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produced and no foraging occurs, they remain inside the colony and can live for up to 6 
months (Winston, 1987).  The queen is responsible for egg laying, and only leaves the 
colony for mating flights or during swarming.  Drones are present during the early part 
of the season and their sole function is to mate with queens (Winston, 1987).   
 
Figure 1.2 (A) Developmental times for workers, drones and queens, figure adapted from Winston (1987).  (B) The 
honey bee worker, queen and drone.  The queen and worker are female and diploid. The drone is male and haploid.  




1.2 Varroa destructor – History, Taxonomy, Global Distribution and Biology 
Varroa mites (Acari: Varroidae) are highly specialized, obligate parasites of eusocial 
bees, first described by Oudemans in Java, Indonesia in 1904, feeding on the 
haemolymph of A. cerana (Anderson and Trueman, 2000). Varroa mites were able to 
expand their host range from their natural host,  A. cerana,  to A. mellifera, when the 
latter  began to be kept by beekeepers  in areas where A. cerana is endemic (Oldroyd, 
1999a).  Apis mellifera proved to be a far more susceptible host due to differences 








between the species in brood development and, with the assistance of modern, 
globalized beekeeping practices, Varroa has been  spread across most of the world.  It is 
thought that this host species jump marked the speciation of the originally described 
mite (known as Varroa jacobsoni) into two species – which are differentiated by genetic 
markers and by the ability to reproduce in A. mellifera  colonies  (Anderson and 
Trueman, 2000; Rosenkranz, et al., 2010).  The new species, able to successfully 
parasitize A. mellifera, was described by Anderson and Trueman in 2000 and is known 
as Varroa destructor.  In this text, the term Varroa refers to Varroa destructor. 
 
From its origins in Asia, V. destructor has been  spread across the majority of the globe 
as a result of the international trade in honey bees.  It is present on every continent 
where beekeeping takes place, with Australia being the only remaining large land mass 
that is Varroa free (Beverley, 2017).  Varroa mites were reported in A. mellifera 
colonies in Eastern Russia in 1952, China in 1959, Paraguay in 1971, Germany in 1977 
and the USA in 1987 (Rosenkranz, et al., 2010).  They were first recorded in the UK in 
1992 and, by 2005, were considered to be ubiquitous across England and Wales, and 
widespread across Northern Ireland and Scotland (NationalBeeUnit, 2010).   
 
Infestations by Varroa are considered to be one of the key causes of honey bee colony 
loss, particularly through overwintering losses (Potts et al., 2010b). Details of the 
biology of Varroa, and of its role as a vector of bee pathogenic viruses, particularly 




Figure 1.3.  Map of known Varroa destructor distribution, as published by the Invasive Species 
Compendium, www.cabi.org/isc. 
 
Varroa mites are obligate ectoparasites of honey bees and their life cycle takes place 
within the hive.  The mites demonstrate distinct sexual dimorphism and are 
haplodiploid, with the adult female having a reddish-brown, oval shaped body 1.1 to 
1.2mm in length and 1.5 to 1.6mm in width.  Male mites are smaller (approximately 
0.7mm in width and length) and very pale tan in colour  (Rosenkranz, et al., 2010).   
The female mite has two life phases – the phoretic phase, where it is attached to an adult 
bee and able to travel in this way between honey bee colonies, and the reproductive 
phase which takes place inside sealed drone or worker brood cells.  The reproduction 
cycle begins with a female entering a cell immediately prior to capping.  She then lays 
one unfertilised egg (which hatches into a male) and then several fertilised eggs which 
develop into females.  Mating between the hatched offspring occurs within the sealed 
cell, allowing several fertilised females to emerge along with the bee once it reaches 
adulthood.  Males and any immature female nymphs remain in the cell and die after the 
bee emerges (Oldroyd, 1999b; Rosenkranz, et al., 2010).  Details of the timing of these 
events are given in Fig 1.4.  Mites exhibit a preference for reproduction within honey 
bee drone brood, with an 8 to 10-fold higher infestation rate in male brood (Boot, et al., 
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1995; Rosenkranz, et al., 2010) and, because the capped stage of drone brood extends 
for two days further than that of worker brood, more mites go on to reach maturity.  In 
drone cells two to three viable female offspring are produced for each foundress mite, 
whereas in worker cells one or two female offspring reach maturity  (Schulz, 1984). 
However, drone production is seasonal, peaking in spring and early summer,  and once 
this period is over the Varroa load in worker brood increases (Rosenkranz and Renz, 
2003) 
 
Figure 1.4.  The reproductive life cycle of V. destructor on A. mellifera worker brood.  At 0h the mature female enters 
the cell. At 60h the male egg has been laid close to the top of the cell and the mother has opened a feeding hole on the 
developing pupae.  By 90h the male nymph has hatched and the first female egg has been laid.  A new daughter egg is 
laid every 30 hours.  Once the male and female offspring reach adulthood (starting at 220 hours post capping) they 
mate on the side of the cell.  At 300 hours the newly adult honey bee emerges, along with the mother mite and any 
mature, mated daughters.  The male and any immature females stay in the cell to die. Figure from (Oldroyd, 1999b). 
 
 
All life stages of the Varroa mite feed on honey bee haemolymph, either from the 
developing pupae in the reproductive phase, or from the adult bee during the phoretic 
stage.  It is through this feeding that the honey bee is damaged by Varroa.  The loss of 
haemolymph from the developing pupae is energetically costly, reducing the weight of 
the emerging worker bee by (on average) 7%, and by as much as 19% in drones 
(Dejong, et al., 1982; Duay, et al., 2003).  Worker bees which were exposed to Varroa 
feeding during their development have an altered physiology, life pattern (starting their 
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foraging stage earlier) and a significantly shorter life span (Dejong, et al., 1982; 
Amdam, et al., 2004).  Foraging behaviour and ability is also affected, with parasitized 
individuals exhibiting longer absences from the colony and a reduced return rate from 
foraging (Kralj and Fuchs, 2006; Kralj, et al., 2007).   
 
1.3 Varroa as a Vector of Honey Bee Pathogenic Viruses  
There is general consensus among honeybee researchers that Varroa destructor’s close 
association with honey bee viruses plays a significant part in explaining why their 
introduction to A. mellifera has proved so costly in terms of honeybee health (Sumpter 
and Martin, 2004; Shen, et al., 2005a; Shen, et al., 2005b; Genersch and Aubert, 2010; 
McMenamin and Genersch, 2015).  Varroa mites can transmit multiple viruses to their 
hosts, including deformed wing virus (DWV), Kashmir bee virus (KBV), acute bee 
paralysis virus (ABPV) and Israeli acute paralysis virus (IAPV) and these viruses, not 
the mites themselves, may be responsible for a significant proportion of the harm that 
occurs in bees when they are parasitized by Varroa (Bowen-Walker, et al., 1999; Cox-
Foster, et al., 2007; Carreck, et al., 2010).  Viruses transmitted by feeding mites may be 
able to pass directly into the developing pupae or adult bee’s haemolymph, thus 
bypassing the usual routes of transmission and therefore the honeybees’ existing 
defences (Shen, et al., 2005a).  
The introduction of Varroa to an area has been shown to have a dramatic impact on the 
viral landscape within honey bee colonies.  Prior to the introduction of Varroa mites, 
honey bee viruses were known to be present in the UK, but were often at very low titres 
– below the detection thresholds of the most commonly used techniques of the time 
(Bailey, et al., 1981).  Sampling of bees from recently Varroa infested UK colonies in 
Devon and Herefordshire between 1993 and 1997, revealed that three honey bee viruses 
were repeatedly found at higher levels in Varroa exposed bees compared  to their 
recorded occurrence (both in terms of virus titre per bee and virus prevalence within a 
colony) prior to Varroa introduction (Carreck, et al., 2010).  These viruses were DWV, 
cloudy wing virus (CWV) and slow paralysis virus (SPV).  The presence of one or more 
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of these viruses was also strongly associated with over winter colony loss.  There have 
been a number of wide-ranging honey bee disease monitoring projects, prompted by the 
international concern over the dramatic increase in honey bee colony losses over the last 
20 years.  The National Bee Unit (FERA, UK) have published the results of their 
comprehensive sampling and monitoring project, which gives an excellent picture of the 
viral prevalence in colonies in England and Wales after the introduction of the Varroa 
mite (sampling took place between 2007 and 2008).  As anticipated, weaker colonies 
were found to be more frequently associated with higher numbers of pathogens.  One 
key finding of the survey was that, of all of the pathogens tested for, DWV was the only 
one that could be reliably used as an indicator of colony strength, with colonies that had 
high levels of DWV being consistently more likely to have fewer combs of brood or 
bees (Budge, et al., 2015).  A similar project in Germany found that high levels of DWV 
and acute bee paralysis virus (ABPV) in the autumn, along with a heavy Varroa mite 
load, were significantly related to overwinter colony losses (Genersch, et al., 2010).  
DWV has also been implicated in the rise in colony losses in Greece (Bacandritsos, et 
al., 2010) and Switzerland (Dainat, et al., 2012b).  However the picture is less clear in 
the USA, where research has focused on ‘Colony Collapse Disorder’ (CCD), with DWV 
being amongst the set of pathogens that were found to be moderately higher in colonies 
that had suffered from CCD in one study (Cornman, et al., 2012), but not amongst the 
most significant predictors reported by van Engelsdorp, et al., (2009).   
The link between Varroa transmitted honey bee viruses and colony loss is intensified by 
the dynamics of brood rearing and Varroa load within the colony.  The workers reared 
in late summer and autumn are the overwinter bees, and they need to live for up to 6 
months during the winter period whilst no brood is reared (Winston, 1987).  During the 
time when these overwinter bees are being reared, drone brood production ceases and 
mite population continues to increase, leading to a substantial rise in the proportion of 
workers infested with Varroa mites (Martin, 1998; Rosenkranz and Renz, 2003).  A 
modelling approach has shown that this leads to reduced lifespan in these individuals 
caused by DWV infection, which impacts the age structure of the overwintering bee 




1.5 Deformed Wing Virus – Classification, Genetics and Structure  
Deformed wing virus (DWV; Iflaviridae) a picorna-like single-stranded, positive-sense, 
RNA virus, is one of many viruses infecting honeybees and one of the most heavily 
investigated due to its close association with Varroa mites and honey bee 
overwintering losses.   
 
The genus Iflavirus includes diverse RNA viruses of arthropods, which have 
icosahedral non-enveloped virus particles about 26 to 32 nm in diameter (Figure 1.5 A)  
(Chen, et al., 2012).  Iflavirus virions contain a single copy of linear positive-sense 8 to 
10 kb genomic RNA which possesses small genome-linked virus protein, Vpg, 
covalently linked to the 5’ terminus and poly(A) sequence at the 3’ terminus. Genomic 
RNAs of iflaviruses have extended 5’ untranslated region (5’UTR), reaching about 1 
kb, which acts as an internal ribosome entry signal, IRES.  The IRES is followed by a 
single open reading frame (ORF) coding for a large polyprotein, ranging in size from 
2800 to 3200 amino acids, with the structural proteins and the non-structural proteins 
encoded by the 5’- and 3’-parts of the ORF, respectively.  Iflavirus genomic RNA is 
infectious and serves as a template for the synthesis of viral polyprotein.  The genus 
name is derived from the name of its type species, Infectious flacherie virus, a 




Figure 1.5 (a) Transmission electron photograph of deformed wing virus (DWV) particles, bar 50 nm. (b) 
SDS PAGE of DWV virions showing three major structural proteins, VP1, VP2, and VP3. Lane M, 
molecular weight protein markers; lanes 1–4, dilutions of virus preparation. (c) Organization of DWV 
genomic RNA. The long box represents the single open reading frame with the conserved domains 
indicated. Vertical lines represent identified cleavage sites. Conserved domains are indicated as follows: 
boxes in the VP2 and VP1 proteins shown are picorna-like capsid drug-binding pocket domains, box in 
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VP3 is a CrPV capsid-protein-like domain, and dark boxes in the nonstructural part are picorna-like 2C 
helicase, 3C protease, and RNA-dependent RNA polymerase (RdRp) domains. (d) Phylogram of the 
recognized and putative members of the genus Iflavirus. Full-length polyprotein sequences of the iflavirus 
isolates listed in Table 1.1 were used. The tree was produced using the neighbour-joining method and 
evaluated with bootstrap analysis, 1000 replicates, percentage of bootstrap support if each branch is 
indicated. Branch length indicates evolutionary distance; scale bar shows 0.5 amino acid substitutions 
per site. Figure adapted from (Fannon and Ryabov, 2016) 
 
In recent years, more viruses with Iflavirus characteristics have been discovered in a 
variety of arthropod species mostly as a result of transcriptome sequencing (see table 1.1 
for details and references).  Despite high variation between the polyproteins of different 
iflaviruses, they share a number of common features.  The short N-terminal Leader 
protein (L) of unknown function, which is highly diverse between iflaviruses, precedes 
more conserved block of the structural proteins with three domains typical for the capsid 
proteins of icosahedral picornaviruses (VP1, VP3, VP3) (shown in Figure 1.5 B), and 
the smallest structural protein VP4, which are arranged in the order VP2-VP4-VP1-VP3 
in the polyprotein (Lanzi, et al., 2006).  The structural proteins are proteolytically 
processed by the 3C protease domain encoded by the non-structural block, and precise 
processing sites have been experimentally determined for several iflaviruses, including 
Deformed wing virus (Lanzi, et al., 2006) and Lymantria dispar iflavirus 1 (Carrillo-
Tripp, et al., 2014) (Figure 1.5 C).  The C-terminal half of the iflaviral polyprotein 
contains domains with the motifs typical for picornaviral 2C RNA helicase, a 
chymotrypsin-like 3C protease and 3D RNA-dependent RNA polymerase (Figure 1. 5 
C) (Koonin and Dolja, 1993).  No experimental data is available on the processing of the 
non-structural portion of iflavirus polyprotein, although it is suggested that processing of 
the non-structural proteins is facilitated by the 2C protease similar to that  of the 
picornavirus polyproteins. 
 
The genus Iflavirus covers a group of positive-sense ssRNA viruses in the family 
Iflaviridae, order Picornavirales.  Currently, only six species are recognized in the genus 
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Iflavirus according to the ICTV report published in 2012 (Chen, et al., 2012) (Table 
1.1).  At least 17 additional insect RNA viruses with fully sequenced genomes (or at 
least with fully sequenced protein coding regions) are putative members of  the genus 
according to their genome organization and to their being significantly different from 
other iflaviruses (nucleotide [nt] identity less than 90%) (Table 1.1). Among the 
evolutionarily close iflaviruses, similarity can very high; the nt and aa identity between 
closely related honey bee viruses DWV and Varroa destructor virus 1 (VDV-1) are as 
high as 84% and 95%, respectively; and lepidopteran Perina nuda virus (PnV) and 
Ectropis obliqua virus (EoV) have 82% nt and 87% aa identity. 
 
The phylogenetic tree shown in figure 1.5 (d) shows how DWV falls into a clade with 
two other characterised iflaviruses, Kakugo virus (KV) and Varroa destructor virus-1 
(VDV-1).  KV was first isolated from the brains of aggressive honey bees in Japan 
(Fujiyuki, et al., 2004) and it is so closely related to DWV that there is some 
disagreement as to whether the two are actually regional isolates of the same virus 
(Lanzi, et al., 2006) or two distinct species (Fujiyuki, et al., 2006).  However, unlike 
KV, DWV has never been associated with an increase in the aggressiveness of infected 
bees (Rortais, et al., 2006).  VDV-1 was first isolated from Varroa, taken from honey 
bee colonies in the Netherlands (Ongus, et al., 2004), and once identified, was found to 
be widely prevalent in honey bees, often co-occurring and recombining with DWV-like 
viruses (Moore, et al., 2011; Ryabov, et al., 2017).   
   
DWV, KV and VDV-1 exhibit 84% sequence homology, and can be considered as 
strains of the same virus (Ryabov, et al., 2014a).  The nucleotide differences between 
the three characterized viruses are mostly located at the 5’ end of the genome, chiefly in 
the 5’ UTR and the Lp region (Lanzi, et al., 2006; de Miranda and Genersch, 2010).  
The strains have been shown to recombine (Moore, et al., 2011), and can be seen as a 
viral quasispecies or variants of the same species complex.  The quasispecies hypothesis  
refers to an equilibrium in the process of mutation and natural selection, leading to a 
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genetically diverse population (Domingo, et al., 2012).  These diverse variants are 
clustered around one or more ‘master sequence’ genotypes, those of the highest fitness 
in a particular environment or niche (Domingo, et al., 2012).  The small genomes and 
high replication and mutation rates of RNA viruses contribute to their highly genetically 
diverse populations, and viral evolution is often explained in terms of quasispecies 
concepts   (Domingo and Holland, 1997; Holmes and Moya, 2002; Stich, et al., 2007). 
 
For this thesis,  DWV or DWV-like will be used to refer to all strains of the virus that 
are similar to the full length Deformed Wing Virus sequence, as is detailed in Lanzi et al 
(2006), RefSeq NC_004830.2 Accession Number AJ489744.  VDV-1 or VDV-like 
refers to viral sequence deemed to be similar to the Varroa Destructor Virus-1 sequence 
from (Ongus, et al., 2004), RefSeq NC_006494.1, Accession Number AY251269.  
Similarity is determined by BLAST alignment of sequenced samples and by strain 
specific PCR and qPCR (see details in Chapter Two). 
 
There has been a trend in recent publications to refer to DWV and KV type viral 
sequences as DWV type A, and VDV type viral sequences as DWV type B (McMahon, 
et al., 2016b; Mordecai, et al., 2016a; Mordecai, et al., 2016b).  This is an interesting 
development, as it serves to illustrate how these strains can be seen as members of the 
same species complex rather than as distinct taxa.  However, currently only two research 
groups have adopted this change in nomenclature, and  a consensus has not been 
reached yet from the research community about an agreed nomenclature.   For clarity, 
the original DWV/VDV-1 definitions will be used in this work in line with the  majority 
of published research.  
 
The three-dimensional structures of DWV have recently been determined by cryo-
electron microscopy and X-ray crystallography (Skubnik, et al., 2017).  The DWV 
virion contains a C-terminal extension of the capsid protein VP3, which forms a 
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globular domain containing a predicted receptor binding site on the virion surface.  
DWV’s active site is predicted to be flexible, adopting two conformations according to 
pH or ionic conditions, and it is hypothesized that this variable p domain may be 




Figure 1.6 Structures of the icosahedral asymmetric unit of DWV and its virions in alternative conformations, figure 
from (Skubnik, et al., 2017). (A) The icosahedral asymmetric unit of DWV in schematic representation, major capsid 
protein VP1 shown as blue, VP2 shown as green, and VP3 shown as red. The P domain (part of VP3) is magenta.  
The molecular surfaces of DWV virions were determined by cryo-electron microscopy (shown in B) and by X-ray 
crystallography (shown in C).  The virion surfaces have been colored to illustrate their distance from the midpoint of 












Table 1.1 Members of the Genus Iflavirus with Full-Length Genomic RNA Sequences 





Members of the genus Iflavirus recognized by the ICTV, 2012 report (Chen, et al., 2012) 
Infectious flacherie virus (IFV) NC_003781 Moths/Lepidoptera (Isawa, et al., 
1998) 
Perina nuda virus (PnV) NC_003113 Moths/Lepidoptera (Wu, et al., 2002) 
Ectropis obliqua virus (EoV) NC_005092 Moths/Lepidoptera (Wang, et al., 
2004) 






(Lanzi, et al., 2006) 
Deformed wing virus—Kakugo virus (KV) NC_005876 Honeybee/Hymenoptera (Fujiyuki, et al., 
2004) 
Varroa destructor virus 1— (VDV-1) NC_006494 Honeybee/Hymenoptera 
Mites/Arachnida 
(Ongus, et al., 
2004) 
Sacbrood virus— (SBV) NC_002066 Honeybee/Hymenoptera (Ghosh, et al., 
1999) 
Putative members of the genus Iflavirus 
Formica exsecta virus 2 (Fex2) KF500002 Ants/Hymenoptera (Johansson, et al., 
2015) 
Nilaparvata lugens honeydew virus 1 (NLHV-1) AB766259 Planthopper/Hemiptera (Murakami, et al., 
2013) 
Nilaparvata lugens honeydew virus 2 (NLHV-2) NC_021566 Planthopper/Hemiptera (Murakami, et al., 
2013) 
Nilaparvata lugens honeydew virus 3 (NLHV-3) NC_021567 Planthopper/Hemiptera (Murakami, et al., 
2013) 
Lymantria dispar iflavirus 1 (LdIV1 KJ629170 Moths/Lepidoptera (Carrillo-Tripp, et 
al., 2014) 
Antheraea pernyi iflavirus—LnApIV (ApIV) KF751885 Moths/Lepidoptera (Geng, et al., 2014) 
Heliconius erato iflavirus (HeIV) KJ679438 Butterflies/Lepidoptera (Smith, et al., 
2014) 
Slow bee paralysis virus (SBPV) NC_014137 Honeybees/Hymenoptera (de Miranda, et al., 
2010) 
Laodelphax striatella honeydew virus 1 (LSHV1) KF934491 Planthopper/Hemiptera  
Brevicoryne brassicae virus (BrBV) NC_009530 Aphids/Hemiptera (Ryabov, 2007) 
Dinocampus coccinellae paralysis virus— KF843822 Parasitoid 
wasp/Hymenoptera 
(Quebec, 2013) 
Spodoptera exigua iflavirus 1 (SeIV-1) NC_016405 Moths/Lepidoptera (Millan-Leiva, et 
al., 2012) 
Spodoptera exigua iflavirus 2 (SeIV-2) JN870848 Moths/Lepidoptera (Choi, et al., 2012) 
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Lygus lineolaris virus 1 (LyLV-1) JF720348 Plant bug/Hemiptera (Perera, et al., 
2012) 




1.6 Deformed Wing Virus – history, spread and global prevalence 
 
DWV was first named and characterised in Japan in 1982, when a virus was isolated 
from symptomatic honey bees in a colony infested with Varroa.  The bees had stunted 
abdomens and deformed wings, hence the name given to the virus (Ribière, et al., 
2008).    Wing deformities and reduced abdominal size began to be widely reported in 
honey bee colonies following the spread of Varroa destructor, and these symptoms 
were initially attributed to the feeding activities of the mite.  However, it became 
evident that not all Varroa exposed bees developed these symptoms, and that some 
individuals in heavily infested colonies had the deformities despite having no direct 
Varroa exposure (Koch and Ritter, 1991; Marcangeli, et al., 1992).  Further research 
revealed that experimental injection of DWV causes the characteristic symptoms in 
Varroa naïve bees (Moeckel, et al., 2011).  DWV is now known to be present in honey 
bee colonies globally, having been detected in bee samples from Europe, Africa and 
Asia (Allen and Ball, 1996) and in  North, South and Central America (Ellis and Munn, 
2005; Maggi, et al., 2016).  The picture is more complicated in Australasia, with DWV 
being present in New Zealand where Varroa has recently been introduced (Mondet, et 
al., 2014; Iwasaki, et al., 2015) but not in Australia which remains Varroa free 
(Roberts, et al., 2017).   
 
In the UK,  a virus later shown to be DWV was first identified in the early 1980’s, 
before the introduction of the Varroa mite, when examination of deformed 
(symptomatic) bees revealed high titres of an icosahedral single stranded RNA virus 
(Bailey, et al., 1981).  However, DWV was not seen as a major issue by beekeepers or 
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researchers and symptomatic outbreaks were very rare.  DWV was rarely present at 
levels high enough to be detectable by the techniques of the time.  The honey bee 
research community is currently undecided as to the prevalence of DWV in honey bee 
colonies prior to the introduction of Varroa.  Sensitive molecular techniques have 
revealed that low level, asymptomatic DWV infection can be detected in colonies from 
Varroa naive areas, such as those on Colonsay island (an island in the Inner Hebrides 
of Scotland, currently one of the few remaining Varroa free areas of Europe) and those 
in Northern Scandinavia, beyond the expansion front of Varroa (Yue and Genersch, 
2005; de Miranda and Fries, 2008; Ryabov, et al., 2014b).  However, samples from 
Australia (the last large land mass to remain free of the parasite) have been shown to be 
DWV free (Roberts, et al., 2017).  Whether the virus could have been introduced by 
beekeeping practices in to these European samples, or whether it was widely present in 
the area, forming a persistent, asymptomatic infection, the fact remains that in the 
absence of Varroa the virus is capable of establishing a covert, asymptomatic infection.  
 
DWV replication has also been identified in bumble bees (Bombus pascuorum and 
Bombus terrestris) and in a number of other ‘hive attendant’ arthropods, including the 
European earwig (Forficula auricularia) and the German cockroach (Blattella 
germanica) (Genersch, et al., 2006; Levitt, et al., 2013).  These species are not 
vulnerable to Varroa parasitism, so they are thought to become infected through direct 
association with honey bee colonies, and possible ingestion of contaminated food or 
pollen (Levitt, et al., 2013). 
 
1.7 Deformed Wing Virus – pathology and virulence. 
 
DWV is extremely widespread in A. mellifera colonies.  For example, it was found to 
be present in 95% of British apiaries in a survey conducted by the National Bee Unit 
(G. Budge, National Bee Unit, unpublished data).  In the absence of Varroa, DWV 
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infection usually persists at a very low level and does not result in visible symptoms or 
have any apparent negative impact on host fitness. However, for reasons that are still 
not fully understood, the transmission of DWV by Varroa to the developing pupae 
causes elevated virus levels and characteristic symptoms of atrophied wings, stunted 
abdominal development and cognitive/learning impairments (de Miranda and 
Genersch, 2010).  Bees with high levels of DWV also have significantly shortened 
lifespans (Dainat, et al., 2012a).  Varroa infestation and the subsequent increase in 
DWV levels and symptomatic individuals within a hive have severe implications for 
the ability of a colony to gather stores, nurse larvae and, ultimately, survive overwinter.  
Large scale sampling studies of honey bee colonies across the UK and Europe have 
repeatedly reported that DWV is the pathogen  most frequently associated with 
elevated Varroa loads, weakened colonies and increased overwintering losses and that 
high levels of DWV, particularly in the autumn when the colony is preparing for 
overwintering, is strongly correlated with colony loss (Highfield, et al., 2009; 
Berthoud, et al., 2010; Genersch, et al., 2010; Budge, et al., 2015)  
 
 
Figure 1.7 An adult worker bee suffering from DWV. Symptomatic DWV infected honey bees have 
deformed wings, stunted abdomen, impaired learning capacities, reduced foraging ability and reduced 




In work recently published by our research group, we have demonstrated that a single 
virulent hybrid form of DWV accumulates to high levels in pupae upon which mites 
have fed.  This recombinant virus is characterized as having DWV-like sequences for 
non-structural genes and VDV-1 like capsid protein genes (Ryabov, et al., 2014a).  In a 
significant proportion (approximately 70%) of pupae exposed to Varroa, the delivery 
of DWV directly into the hemolymph by the feeding mite results in the amplification of 
near clonal population of DWV-like virus to high levels (i.e. comparable to DWV 
levels found in symptomatic adult bees).  Any pupae in the hive that have been 
unexposed to Varroa, along with the remaining 30% of the exposed individuals, have 
very low (asymptomatic) levels of DWV like viruses with a much greater diversity in 
virus population (Ryabov, et al., 2014b).   This pattern – increase in the level of DWV 
with a corresponding decrease in viral sequence diversity upon exposure to Varroa – 
was recorded on a much larger scale in a study that looked at alterations in the DWV 




Figure 1.8 Phylogenetic analysis of the central region of DWV-like virus genome, figure from (Ryabov, et al., 2014b). 
Sequences derived from Varroa parasitized individual honeybee pupae with ‘high’ levels of DWV (determined by 
qPCR) are highlighted with arrows. All of these individuals had a near clonal population of DWV/VDV-1 





The research described above allows us to look at DWV-like viruses as a quasispecies, 
a rapidly evolving group of closely related RNA viruses (Domingo and Holland, 1997; 
Lauring and Andino, 2010).  DWV and VDV-1 can each be seen as the master variants, 
with inaccurate RNA replication and recombination leading to a swarm of variants.  
This theory is described in (Mordecai, et al., 2016a), who go on to look at the 
predominant virus present in an isolated apiary of bees that appear to be able to 
withstand long term high Varroa levels and the subsequent elevated DWV-like virus 
levels.  These bees were found to be infected with predominantly VDV-like viruses 
(named ‘DWV type B’ by Mordecai et al) and they suggest that a prior infection with 
the ‘non-lethal’ type B variant prevents the type A (full length DWV-like) viruses 
establishing and leading to colony death.  This interesting observation has not yet been 
recorded elsewhere, but it gives further weight to the theory that virus strain is closely 
linked to the route of transmission and virulence of DWV-like viruses.   
 
The complexity of the system (and need for further research) is highlighted by the 
recent publication (McMahon, et al., 2016b) in which, laboratory and field studies are 
used to demonstrate that an emerging DWV genotype (DWV-B, or VDV-like viruses) 
is more virulent than the established DWV genotype (DWV-A or DWV-like) and is 
widespread in the UK.  The paper also shows that colonies infected with DWV-B 
collapse sooner than colonies infected with DWV-A.  This result appears contradictory 
to the Mordecai paper, indicating that this complex system is not yet fully described by 






1.8 The Honey Bee Transcriptional Response to Varroa parasitism and to DWV 
infection. 
 
The honey bee response to DWV infection is not yet fully understood.   One of the 
main strands of research has focused on revealing more about the honey bee anti-viral 
response, and how this is modulated by DWV infection and by Varroa parasitism.  It is 
also hoped that investigation of the changes in gene expression during DWV infection 
may reveal more about the mechanisms by which the virus causes disease symptoms in 
honey bees.  Here, it is useful to look at the state of current knowledge in three 
fundamental areas; the honey bee immune response to Varroa parasitism, the honey 
bee immune response to DWV infection and the honey bee developmental response to 
DWV infection. 
 
1.8.1. The Honey Bee Immune Response to Varroa parasitism and to DWV 
infection. 
 
Our current knowledge of the immune defence pathways in honey bees is largely based 
on identification of honey bee orthologs to better known and characterized genes from 
mosquito and Drosophila (Weinstock, et al., 2006)  This use of comparative genomics 
has revealed new information about honey bee immune gene pathways, but it is 
important to note that eusocial Hymenoptera, including A. mellifera, diverged from the 
Diptera (which contains Drosophila and mosquitoes) over 300 million years ago 
(Dearden, et al., 2006; Evans, et al., 2006).  A comprehensive review of the insect 
immune pathways which have been revealed in honey bees is provided by (Brutscher, et 





Figure 1.9 Honey bee immune pathways, with the genes that have been implicated in antiviral responses 
highlighted in bold text.  The main immune pathways present in honey bees are; RNAi, Jak/Stat, 
Toll;NFkB, JNK, and MAPK. This figure has been adapted from (Brutscher, et al., 2015), a 
comprehensive review of antiviral defence mechanisms in honey bees. 
 
Many ectoparasites, especially ticks (Wikel and Bergman, 1997; Schoeler and Wikel, 
2001) immune-suppress their hosts to facilitate extended feeding, and these 
immunocompromised hosts then become more vulnerable to infectious diseases (Titus 
and Ribeiro, 1988; Schwan, et al., 1995; Edwards, et al., 1998).  This knowledge has 
prompted research into how Varroa parasitism affects honey bees, in an attempt to 
establish whether immune pathways are compromised in Varroa exposed individuals, 
potentially explaining the close association between Varroa mites and honey bee 
viruses, as parasitized bees would be more vulnerable to infection.  However, gene 
expression analysis of Varroa parasitized honey bees has produced contradictory results 
about the impact that Varroa feeding has on the immune response of its host.  The first 
study published on the topic reported that Varroa exposed, newly emerged, honey bees 
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had  reduced expression of genes encoding antimicrobial peptides (AMPs - abaecin, 
defensin, and hymenoptaecin) and immunity-related enzymes (phenol oxidase and 
lysozyme) compared to the expression levels in Varroa naïve bees when challenged 
with heat inactivated E.coli (Yang and Cox-Foster, 2005).  Similarly Gregory et al. 
(2005) found that bees that had been parasitized by Varroa  also had lower levels of 
AMP gene expression, although there was no evidence that these immunosuppressed 
bees were more vulnerable to infection, with no correlation between bacterial or viral 
infection and AMP expression level being established (Gregory, et al., 2005).  In 
contrast, subsequent publications reported that, although there were some subtle 
differences in gene expression between Varroa exposed and Varroa naïve bees in genes 
associated with neuronal development and metabolic activities, there was no difference 
in the expression of immune related genes between the two groups (Navajas, et al., 
2008; Kuster, et al., 2014).  Microarray analysis conducted by our research group 
(Ryabov, et al., 2014a) found some perturbation of immune related genes from the Toll 
pathway and significantly enhanced expression of the honeybee orthologue of Vago 
(GB10896), a secreted protein that is upregulated in mosquitos and  drosophila during 
the RNAi response to viral infections (Deddouche, et al., 2008; Paradkar, et al., 2012).  
However, the contrasts between the treatment groups did not reveal any immune 
pathways that were consistently up or down regulated, and the majority of the 
previously implicated AMPs appeared to be unaffected by Varroa parasitism.  
 
Comparative genomics indicates that honey bees possess the same putative antiviral 
defence pathways as Drosophila and mosquito, notably the Jak/STAT, Toll and Imd 
signalling pathways, RNA interference, endocytosis, as well as MAPK and melanisation 
reactions (Fig. 1.8). RNA interference (RNAi) is the main route of antiviral defence in 
both fruit flies and in mosquitos (Ding, 2010), and has therefore been of particular 
interest to researchers investigating how honey bees respond to viral infections.  RNAi 
is a sequence specific, post-transcriptional gene silencing mechanism that is elicited by 
dsRNA.  Laboratory and field experiments have shown that feeding bees with virus 
specific dsRNA, to trigger the RNAi response, provides some protection from IAPV and 
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DWV infections (Maori, et al., 2009; Hunter, et al., 2010; Desai, et al., 2012).  It has 
also been demonstrated that administration of non-specific dsRNA, regardless of 
sequence, can surpress experimental infections of Sindbis virus expressing enhanced 
green fluorescent protein (SINV-GFP) (Flenniken and Andino, 2013; Brutscher, et al., 
2017).  Experimental infection with SINV-GFP also revealed differential expression of 
genes involved in RNAi, Toll, Imd, and JAK-STAT pathways, and in vivo knockdown 
of dicer (RNAi pathway) and  cyclin dependent kinase (uncharacterized) lead to 
increased virus levels (Brutscher, et al., 2017).  
 
No consensus has yet been reached in the published literature on the role of the putative 
bee antiviral defence pathways in relation to parasitism by Varroa and its associated 
viruses. The Toll pathway component dorsal-1A was implicated in limiting DWV 
infections in honey bees (Nazzi, et al., 2012), with downregulation of dorsal-1A 
expression leading to increased DWV loads. However, the same study found no 
alteration in expression of components of the RNAi pathway in heavily Varroa infested, 
DWV infected bees. Similarly,  Ryabov et al. (2014) observed that some proposed 
components of the Toll signalling pathway were differentially expressed in response to 
Varroa parasitism, but the lack of expression of the AMPs that are the end products of 
these pathways suggested that Toll and Imd activation had not been triggered. 
Moreover, no significant changes in expression of genes associated with the RNAi 
response (such as Argonaute and Dicer) were observed in their analysis of Varroa 
exposed, DWV infected honey bees.  In contrast, in their research into the immune 
responses of Varroa exposed pupae, (Kuster, et al., 2014) found that expression of 
defensin,  apidaecin, abaecin, hymenoptaecin, PPOact, PGRPs, and relish increased 
with increasing DWV load, implying that the Imd and Toll pathways are central in the 
honey bee immune response to DWV infection.  
 
One concern faced by all of these publications, and a possible explanation for the 
inconsistencies in results, is that it is difficult to separate the effects of Varroa 
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parasitism (with its associated wounding, introduction of non-viral pathogens and 
possible immune suppression) from the effects of Varroa-mediated viral infections, 
since the majority of Varroa exposed bees also carry a high viral load (Gregorc, et al., 
2012).  To date, there has been little work published that separates the effect on honey 
bees of Varroa feeding on its own from the impact of Varroa-mediated DWV infection.  
The in vitro collection of Varroa saliva has allowed a preliminary biochemical 
characterization of the secretions, with 15 distinct proteins present in the saliva 
(Richards, et al., 2011).  The Varroa saliva was also shown to impair the function of 
Lacanobia oleracea (Lepidoptera, Noctuidae) haemocytes in culture, indicating that 
these salivary proteins may facilitate the suppression haemocyte-mediated wound 
healing (Richards, et al., 2011).  Another possible explanation for the diverse results 
found by different research groups could be that different life stages of honey bees were 
sampled, and the expression of immune related genes is predicted to be very transient 
and dependent on developmental stage (Zaobidna, et al., 2017).  Detailed analysis of the 
expression of 14 genes in the Toll pathway, including effector genes of AMPs, in 
response to Varroa exposure in larvae, prepupae and pupae, found that the immune 
response was most pronounced in larvae, with a significant increase in the expression of 
10 immune related genes, including defensin-1 and defensin-2, being observed in 
Varroa exposed bees, relative to non-infested individuals (Zaobidna, et al., 2017).   
 
The difficulty in distinguishing between the immune response to Varroa feeding and 
viral infections resulted in  the two being classed together in a recent meta-analysis of 
multiple transcriptome data sets (Doublet, et al., 2017).  The analysis found 167 genes 
that were consistently differentially expressed in response to Varroa/virus treatments 
(79 down-regulated and 88 up-regulated).  The transcriptional response to Varroa/virus 
treatments included in the analysis was distinguished by the differential expression of 
genes from the Toll (tube and def-2) and Imd pathways (iap2 and relish).  Doublet et al. 
note that they did not observe any differential expression in genes associated with the 
RNAi pathway, they suggest that this may be due to the transient nature of the RNAi 
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response, meaning that the expression of these genes may be missed in meta-analysis 
incorporating data from honey bees of different ages and times post infection.   
 
1.8.2. The Honey Bee Developmental Response to Varroa parasitism and to DWV 
infection. 
 
The mechanism by which Varroa and DWV cause disease symptoms in infected bees is 
not well understood (de Miranda and Genersch, 2010).  A ‘successful’ DWV infection 
has been shown to have a specific and predictable effect on a developing honey bee 
pupae, with bees injected with DWV going on to develop characteristic symptoms of 
atrophied wings, stunted abdominal development and cognitive/learning impairments 
(Yue, et al., 2007; de Miranda and Genersch, 2010; Moeckel, et al., 2011).  The 
transition from the bee pupa to the adult stage is a highly dynamic, programmed process 
that entails remodelling of tissues and growth of new organs. To date, nothing has been 
published about how this process is affected at the molecular level by Varroa parasitism 
and DWV infection, but a recent microarray analysis of gene expression in honey bee  
pupae, controlling tightly for age of pupae and parasite load, found differential 
expression of genes associated with morphogenesis, including a number of ecdysone 
response genes, known to be controlled by the ecdysone- ultraspiracle receptor complex 
in D. melanogaster (Gauhar, et al., 2009) and a strong effect of Varroa parasitism on the 
expression of honeybee homeobox genes (>70% of homeobox genes were differentially 
expressed in response to Varroa mite burden) (Chandler et al, unpublished data) 
 
Insect morphological development is governed by a suite of evolutionarily conserved 
homeodomain proteins, transcription factors and co-factors which regulate cell fate and 
cell type gene expression to determine insect segment morphology and system 
development. (Walldorf, et al., 2000; Ladam and Sagerstrom, 2014). The homeobox is 
a sequence of DNA coding for 60 amino acids that was originally discovered in the 
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genome of the fruit fly D. melanogaster, and has now been characterised in all three 
kingdoms of multi-cellular organisms.  Homeobox containing genes are translated into 
DNA binding proteins which are crucial in the regulation of gene expression in 
morphogenesis and cell differentiation (Mark, et al., 1997).  Very little is known about 
the functions of homeodomain containing genes in honey bees, but databases such as 
HomeoDB allow us to see the homologs from model organisms such as fruit files 
(Zhong, et al., 2008; Zhong and Holland, 2011).   
 
The microarray results reported above are intriguing as they are the first time that 
developmental genes have been found to be overrepresented in the differentially 
expressed gene set from Varroa exposed, DWV infected honey bees.  This disturbance 
in gene expression may help to explain the morphological deformities that occur in 
parasitized bee pupae, and they provide a platform for more detailed, mechanistic 
studies of the bee-virus-Varroa interaction.  If our observations are correct, they also 
raise questions of whether the alteration in host phenotype is: (i) beneficial to Varroa 
and / or DWV (and therefore subject to natural selection); (ii) a response of the bee to 
limit the damaging effects of parasitism (ditto); or (iii) is simply a side-effect of the 
infection process (Schmid-Hempel, 2011).  Further work is necessary to establish 
whether this disturbance in developmental gene pathways is a consistent response in 
genetically diverse honey bees, and to establish if the perturbation is due to Varroa 
parasitism or to DWV infection.   
 
1.9. Project outline, Hypothesis and Aims 
 
The spread of the parasitic mite, Varroa destructor (and the RNA viruses that it 
transmits between honeybees), is closely linked to increased overwintering losses and 
declining honeybee health.  Deformed wing virus (DWV) is widespread in honeybees 
and usually present as a low level, asymptomatic infection. However, the transmission 
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of DWV by Varroa to developing pupae causes markedly elevated levels of a near 
clonal virus population, leading to characteristic developmental abnormalities. At 
present, there are significant gaps in understanding about the pathology of Varroa-
mediated DWV infections, and this is preventing the development of new interventions 
to effectively mitigate the effects of DWV and Varroa on honey bee populations.  
 
The aim of this project is to generate new knowledge on the interactions between 
honeybees, Varroa and Deformed Wing Virus to underpin the development of improved 
management options for beekeepers. Three different research questions were addressed. 
 
 
1. How does DWV transmission route influence virus accumulation, localization and 
diversity? 
 
We know that the mode of DWV transmission plays a crucial in determining the 
outcome for infected honey bees.  Individuals infected via Varroa feeding are more 
likely to go on to have a high viral load than those infected orally or vertically (Yue, et 
al., 2007; Moeckel, et al., 2011).  We hypothesise that DWV is more infectious when 
transmitted by Varroa because it is injected directly into the haemolymph, bypassing he 
hosts immune defences and gaining access to a wider range of tissues.  We have tested 
this hypothesis through experimental infection of honey bees with DWV, followed by 




2. How does the spread of the Varroa mite alter the prevalence and population 
diversity of DWV like viruses? 
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It has been widely reported that the spread of the Varroa mite has coincided with the 
emergence of a highly virulent strain of DWV, which may have a selected advantage 
when transmitted by the mite (Martin, et al., 2012; Ryabov, et al., 2014a; McMahon, et 
al., 2016b; Mordecai, et al., 2016a).  However, there is currently disagreement in the 
published literature with regard to the exact genome of this virulent strain, with some 
groups pointing towards DWV-like viruses being more virulent and associated with 
Varroa parasitism (Mordecai, et al., 2016a; Brettell, et al., 2017), some identifying 
VDV-like strains (McMahon, et al., 2016a) and others pointing towards a recombinant 
VDV/DWV viral sequence (Ryabov, et al., 2014a).  Two repeated sampling 
experiments have been conducted to try and resolve these inconsistencies, looking at 
the change in DWV population at the forefront of the Varroa invasion in the UK, and 
attempting to track any changes in the predominant strain of the virus over a single 
season in a heavily Varroa infested honey bee colony. 
 
 
3. How are Varroa destructor and Deformed Wing Virus responsible for 
developmental abnormalities in honeybees. 
 
The mechanism by which Varroa and DWV causes disease in individual bees is not 
well understood (de Miranda & Genersch, 2010).  We propose that DWV infection 
during crucial stages of honey bee pupation and metamorphosis causes disturbances to 
the expression of developmental gene pathways, including ecdysone receptor signalling 
and homeobox developmental genes, leading to the characteristic DWV symptoms.  
This hypothesis is tested through comprehensive measuring of the expression of key 
developmental genes in honey bee pupae infected with DWV, both via Varroa feeding 




Chapter 2. Materials and Methods 
 
This chapter gives details of the main techniques and protocols used throughout the 
research chapters of this thesis.  Where alterations to standard techniques have been 
employed full particulars are given. Details specific to individual experiments (sample 






A number of honey bee (Apis mellifera) colonies were maintained for the duration of 
this project to provide insects for direct sampling and insect manipulation experiments.  
Details are provided here of the colonies used for sampling in the 2015, 2016 and 2017 
seasons.  The bees used for this work have not been genotyped, but they are thought to 
be a mixture of subspecies, as is common in non-commercial apiaries in the UK – with 
the most common subspecies being Apis mellifera mellifera (the European dark honey 
bee) and Apis mellifera lingustica (The Italian honey bee) (Lodesani and Costa, 2003; 
Carreck, 2008).  Where further detail on the heritage of individual colonies is known, it 
is given below. 
 
Colonies were all inspected weekly during the beekeeping season (April to September) 
to check colony health and to control for swarming.  At each inspection, the presence of 
the queen, the number of frames of brood and stores and the general health and 
temperament of the bees was recorded.  Varroa population monitoring was also carried 
out regularly (method described below).  If the colony was strong or looked to be 
preparing to swarm, a split was made using the Pagden method of swarm control, as 
described in (NationalBeeUnit, 2017).  All colonies were fed with Ambrosia fondant 
(manufacturer Nordzucker) during September to encourage them to build up stores for 






Two independent colonies were maintained at apiary A, on the University of Warwick 
campus, in Coventry.  Beebase Apiary co-ordinates SP293755.  The colonies were 
established on the site during 2014 and were first generation descendants of colonies 
imported from Colonsay, Scotland (subspecies Apis mellifera mellifera, 
http://www.snhbs.scot/colonsay/) hybridised with local honey bees. Varroa mite 
numbers and DWV levels were measured at the start of the season, one colony (Blue) 
underwent no Varroa control measures whilst the other colony (White) was treated with 












2016 and 2017 seasons 
Apiary coordinates SP270571 and SP267566 
 
2016 - After a site move, the beekeeping for 2016 and 2017 seasons took place at The 
University of Warwick, Wellesbourne site, with two separate apiaries on site. Site B, 
‘Townsend’ housed two well established experimental colonies (thought to be hybrid A. 
mellifera mellifera and A. mellifera lingustica subspecies) along with the surviving 
‘White’ colony from the 2015 season.  One colony on this site was lost to swarming 
during the season. 
Site C ‘Top’ was a newly established apiary containing four colonies, purchased as 5 
frame nuclei with overwintered Buckfast queens from BS Honeybees 
(https://www.bshoney bees.co.uk/) in May 2017.  Two of these colonies became well 
established and were used for sampling throughout the season, whilst two failed to 
thrive due to poorly mated queens and were therefore not used for any experimental 
work.  
 
2017 – Townsend apiary (B), two well established colonies made it through the winter 
and one was divided as swarm control early in the season.  These colonies were 
supplemented with a collected swarm from the Coventry area to give an apiary of 4 
colonies for the 2017 season. 
Apiary C began the season with just two of the Buckfast colonies from 2016.  In the 
spring 4 new 5 frame nuclei were purchased from Paynes Southdown Bee Farms (West 




Figure 2.2. The locations of experimental apiaries B and C on Wellesbourne campus, used for 
experiments in 2016 and 2017. 
 
2.1.1 Varroa population monitoring 
 
Varroa levels were regularly monitored across all colonies using the Natural Mite 
Mortality method, as described by the National Bee Unit: 
 
1) Attach a sheet of A3 paper, coated in petroleum jelly to trap falling mites, to the base 
board of the hive and insert under the open mesh floor. 
2) During summer collect colony debris for 7 days;  
3) During winter collect debris for two weeks;  
4) Count the total number of mites collected, divide this figure by the number of days 






5) Multiply the daily mite fall figure by one of the following. Winter i.e. November to 
February x400 Summer i.e. May to August x30 March, April, September and October 
x100 (These periods are approximate only) 
 (www.nationalbeeunit.com/downloadDocument.cfm?id=199) 
 
2.2 Isolation of virus particles from honey bees 
 
There is currently no functional reverse genetic system or infectious full-length clone 
available for DWV infection research. Therefore, virus particles must be purified from 
naturally infected honey bee tissue for use in injection and feeding experiments.  
DWV-like viruses can be purified from almost any honey bee tissue but the greatest 
yield comes from symptomatic (deformed wings, stunted abdomen) adult bees or 
heavily Varroa-infested pupae.  For the experiments described in this thesis, a virus 
preparation was generated from mite-exposed pupae, taken from a high Varroa colony 
on Wellesbourne Campus in May 2015.  The exact protocol used was developed in the 
lab and remains unpublished, so full details of the protocol are given here: 
 
1. Homogenize 5g of insect tissue, frozen or live, with 35 mL sodium phosphate 
buffer 100mM, pH 7.4 (NaP buffer) supplemented with 0.05% of Tween 20 
using a pestle and mortar.  
2. Centrifuge for 12 min in a high-speed centrifuge (22848 x g Relative Centrifugal 
Force (RCF), 4°C) 
3. Carefully remove and retain the supernatant, leaving the fat layer (top) and the 
un-homogenized tissue (bottom). 
4. Layer the cleared supernatant over a 20% sucrose cushion (2.5 mL, 20% sucrose 
in NaP buffer) in 30 mL ultracentrifuge tube, Beckman SW28 rotor.  Top up 
with the NaP buffer so that liquid reaches 0.5 cm from the top of the tube. 
5. Centrifuge at 28000 r.p.m (141000 x g RCF), 18°C, for 3h 30 min, pour off the 
supernatant and re-suspend the pellet in 2 mL of NaP buffer, leave overnight at 
4°C to ensure complete resuspension of the virus particles.  
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7. Set up a discontinuous caesium chloride (CsCl) density gradient in a 35 mL 
ultracentrifuge tube, Beckman SW28 rotor, by layering from the bottom 5 mL 
aliquots of CsCl with the following densities 1.6 g/cm3, 1.5 g/cm3, 1.4 g/cm3, 1.3 
g/cm3, and 1.2 g/cm3. The CsCl solutions are prepared using saturated CsCl (1.9 
g/cm3 in dH20) mixed with NaP buffer in varying proportions to achieve required 
density. Carefully layer the re-suspended sucrose cushion pellet containing the 
virus particles over the CsCl gradient after mixed with enough buffer to reach 
0.5 cm from the top of the tube. 
8. Centrifuge for 18 hr, 28000 r.p.m. (141000 x g RCF) at 4°C, Beckman SW28 
rotor. 
9. Carefully collect separate 1.5 ml fractions, starting from the top. 
10. Weigh each 1.5 mL fraction to determine density, collect fractions with density 
1.30 to 1.40 g/cm3, pool them together and dilute 5 to 10-fold with NaP buffer.   
11. Centrifuge the diluted fractions for 3hr, at 4°, 28,000rpm (141000 x g RCF), 
SW28 Beckman bucket rotor.  
12. Immediately remove supernatant and re-suspend the pellet with 200 µL 0.1 M  
  NaP buffer, pH 7.4. Note that pellet could be invisible. Store at -80°C. 
 
 
2.3  In vitro larval maintenance, for larval feeding experiments.  
 
In order to investigate the interaction between orally administered DWV and 
developing honey bees, a method that allows young (3 days from laying) larvae to be 
taken from a colony and fed and maintained in the lab was required. The technique is 
described in full in the COLOSS BEEBOOK (Crailsheim, et al., 2013) but details of 
the conditions used for the experiments described in this report are given here. 
 
2.3.1 Larval feeding protocol 
Three-day old honeybee larvae were used for larval maintenance experiments (from 
2015 White, low Varroa colony).  Correct larval age was ensured by placing the empty 
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brood frame into the center of the brood box 5 days prior to sampling, and then through 
careful checking of the size and appearance of each individual selected, using the 
COLOSS Beebook larval age standard images (Figure 2.1) (Human, et al., 2013).  The 
larvae were gently washed out of their frame with warm (30°C), sterile water. They 
were quickly and gently moved into 6 well plates (Falcon® 6 Well Clear Flat Bottom 
TC-Treated Multiwell Cell Culture Plate), 6 larvae per well, on top of sterile polyester 
disks (Anti static polyester lining fabric, Fabric UK. Disks 3cm diameter) and 300 µl 
warm larval diet (6 g D-(+)- glucose, 6 g D-(-)- fructose, 1 g Yeast Extract, 37 ml 
ddH2O, 50 g Royal Jelly (Wellbee-ing UK).  Larvae were maintained in an incubator 
(Thermo Scientific, BBD 6220 CO2 incubator, 33°C, 90% humidity) and each 
individual was fed approximately 50 µl warm (30°C, warmed in water bath) larval diet 
four times per day.  Larvae were transferred into clean 6 well plates each morning, and 
any dead individuals were counted and removed. Once the larvae reached pupation age, 
on day 5 of the feeding experiment, they were gently rolled on filter paper to remove 
any adherent food or waste products and placed into petri dishes containing clean filter 
paper. Pupae require no feeding and were allowed to develop at 33°C, 80% humidity 
(Thermo Scientific, BBD 6220 CO2 incubator). 
 
Figure 2.3 In vitro larval maintenance, for larval feeding experiments. Larvae were reared in flat well 
plates, on disks of anti static polyester lining fabric.  Maintained in an incubator at 33°C, 90% humidity 
and fed 50 µl warmed larval diet 4 times per day. 
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2.4.  Honeybee injection for in vitro administration of DWV. 
 
Individual pupae or newly emerged adult bees were injected with DWV directly into 
the haemolymph to mimic exposure to DWV through Varroa feeding.   
 
2.4.1 Pupae injections Protocol.  
 
A frame of capped brood was removed from the colony and brought quickly to the lab 
in an insulated carrier to prevent chilling. Brood cells were uncapped using forceps and 
individual pupae were gently removed and inspected for Varroa mites.  Once the 
desired number of Varroa free pupae of the appropriate age had been collected, they 
were injected using a 25 µl Hamilton syringe with a 26s gauge needle, along with a 
repeating dispenser to ensure that a 0.5 µl dose was administered with each injection 
(Hamilton Repeat Dispenser, model PB-600).  The syringe was held in a fixed position 
on staging (Prior, England), with the insect being brought towards the needle and 
penetrated in the side of the abdomen, between the developing tergites.  The needle was 
inserted parallel to the tergite, avoiding the gut and entering the into the haemocoel.  
Individuals were injected with either sterile phosphate-buffered saline (PBS) or DWV 
virus prep (Wellesbourne 2015 VP, from symptomatic DWV individuals) diluted to the 
desired concentration in PBS.  Injected pupae were placed into petri dishes containing 
filter paper and stored in a sterile, humidity controlled incubator (Thermo Scientific, 
BBD 6220 CO2 incubator) at 33°C, 80% humidity until sampling.   An inspection 12 
hrs after injection allowed any individuals damaged by handling or injection to be 




Figure 2.4. Honeybee injection for in vitro administration of DWV. 
 
 
2.4.2 Adult injections. 
 
Adult honey bee injections were all carried out using newly emerged, Varroa free 
individuals, collected from a single colony.  A frame of capped brood was removed 
from the colony, after checking that the majority of the brood was at the ‘pupal moult’ 
or ‘resting adult’ stage of development, 11 to 12 days post capping (see Figure 2.4).  
Individuals were allowed to emerge naturally in the lab, under observation, any with 
Varroa (on the bee or in the cell) were discarded, and all Varroa free bees were 
collected in disposable flight cages with a diet of 50% sucrose solution, as described in 
(Evans, et al., 2009).  The disposable flight cages or ‘bee-cups’ were made up of a 
disposable plastic half pint tumbler (Nisbets Catering Equipment) paired with a plastic 
Petri dish (84 mm diameter, Sarstedt) and a plastic scintillation vial (20 ml, Sarstedt).  
Bee-cups were constructed as per Evans, et al, 2009 (Figure 2.3). 
 
Once the desired number of Varroa free honey bees of the appropriate age had been 
collected, they were injected using a 25 µl Hamilton syringe with a 26s gauge needle, 
along with a repeating dispenser to ensure that a 0.5 µl dose was administered with 
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each injection.  Injections were always carried out within 12 hours of emergence, 
whilst the cuticle was soft and the bees were still unable to sting.  The syringe was held 
in a fixed position on staging (Prior, England), with the insect being brought towards 
the needle (held still by the wings) and penetrated in the side of the abdomen, between 
the cuticle segments (tergites), into the haemocoel.  Individuals were injected with 
either sterile phosphate-buffered saline (PBS) or DWV virus prep (Wellesbourne 2015 
VP, from symptomatic DWV individuals) diluted to the desired concentration in PBS.  
The injected bees were kept in treatment groups within disposable flight cages with a 
diet of 50% sucrose solution in a humidity controlled incubator (Thermo Scientific, 
BBD 6220 CO2 incubator) at 33°C, 80% humidity until sampling (Evans, et al., 2009). 
 
 
Figure 2.5 Disposable flight cage for injected adult honey bees, designed following instructions in 
(Evans, et al., 2009).  Injected bees were kept in treatment groups within disposable flight cages with a 
diet of 50% sucrose solution in a humidity controlled incubator (Thermo Scientific, BBD 6220 CO2 






Figure 2.6 Standardised larval and pupal ageing charts, as used in all experiments. This figure has been 




2.5. Sample processing for molecular analysis. 
 
2.5.1. Insect sampling 
 
Live insects to be sampled were flash frozen in liquid nitrogen and stored in individual 
1.5 ml sample tubes (Eppendorf) at -80°C.  For direct sampling of capped brood from 
colonies, brood frames (or excised sections) were returned to the laboratory in an 
insulated polystyrene container and then individual pupae were taken from cells, aged 




2.5.2. RNA Extraction and processing 
 
All equipment (pestle and mortar, Eppendorf tubes, spatula) was chilled in liquid 
nitrogen prior to use.  Frozen honey bee tissue was homogenized whilst submerged in 
liquid nitrogen. The powder was not allowed to thaw and was split into two chilled 1.5 
ml Eppendorf tubes – one for downstream RNA extraction, the other stored at -80°C.  
RNA extraction was carried out using TRI reagent (Sigma-Aldrich) according to the 
manufacturer’s protocol. Total RNA was re-suspended in 50 µl RNAse free water and 
stored at -80°C.  
 
2.5.3 RNA clean up 
 
RNA concentration was determined using a Nanodrop spectrophotometer. 10 µg of 
total RNA was then treated with DNAse I (NEB) according to manufacturer’s protocol 
to remove any contaminating genomic DNA.  Immediately after this reaction, the 
sample was further purified (and any DNAse enzyme removed) using the RNA 
GeneJET kit (Thermo Scientific) following the RNA clean up protocol. 
 
2.5.4. Reverse Transcription 
 
The clean RNA was then used immediately for reverse transcription, creating cDNA 
for PCR or qPCR analysis.  10 µl of DNAse I treated column-purified RNA was used 
in each reaction, along with random hexamer (N10) primer (100 µM), RNAse Out 
(Invitrogen) and SuperScript II (Invitrogen) according to manufacturer’s instructions.  







2.6. DNA analysis 
 
2.6.1 Nested PCR detection of DWV, VDV1 and their recombinants 
 
Identification of the strains of DWV-like viruses, in particular highly virulent VDV-1-
DWV recombinants, requires cloning and sequencing of cDNA fragments (Ryabov, et 
al., 2014).  The levels of DWV in asymptomatic bees may be not be sufficient for 
direct amplification of the cDNA fragments for further characterization.  Nested PCR, 
which includes amplification of a fragment of cDNA in two stages, first with a pair of 
“outer primers” and then with the pair of “inner primers” located within the re-
amplified region, allows amplification of low levels of template.  In respect to DWV 
and VDV-1 infection, a highly characteristic region suitable for identification of 
individual strains of DWV, VDV-1 and VDV-1-DWV recombinants is 1.3 kb 
fragments at the border between the structural genes (CP) and non structural (NS) gene 
blocks (corresponding to nucleotides 4926–6255 of the DWV genome; GenBank 
accession No. AJ489744).   The outer and inner primer sequences are shown in 
Appendix 1.  
 
Step One – using flanking primers “Nested-outer-universal-DWV-4700-For” and 
“Nested-outer--universal-DWV-6700-Rev”  
For a 50µl reaction volume: 
Component     Volume (µL) 
GoTaq Green Master Mix, 2X   25 
Forward primer (100 µM)   1 
Reverse primer  (100 µM)   1 
cDNA template (diluted 1:5 in dH20) 5 
dH20       18 
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The components were mixed in a PCR tube and placed into the thermal cycler for the 
following: 95°C, 2 minutes, 15 cycles (95°C, 30 sec - 52°C, 1min - 72°C, 2min), 95°C, 
hold. 
 
Step 2 – using DWV or VDV specific primer combinations. There are 4 possible inner 
primer combinations, allowing amplification of DWV, VDV-1 and VDV-1-DWV 
recombinants. For amplification of the non-recombinant DWV (“Nested-Inner-DWV-
4900-For” and “Nested-Inner-DWV-6500-Rev”); non-recombinant VDV-1 (“Nested-
Inner-VDV-4900-For” and “Nested-Inner-VDV-6300-Rev”), VDV-1 CP – DWV NS 
recombinants (“Nested-Inner-VDV-4900-For” and “Nested-Inner-DWV-6500-Rev”), 
and DWV CP – VDV-1 NS recombinants (“Nested-Inner-DWV-4900-For” and 
“Nested-Inner-VDV-4900-For”) though the DWV CP-VDV-1 NS recombinant has 
never been detected.  
5 µl of the ‘Step 1’ reaction served as the template for each of these ‘Step 2’ mixes: 
For a 50 µl reaction volume: 
 
Component     Volume (µL) 
GoTaq® Green Master Mix, 2X   25 
Upstream primer  (100 µM)   1 
Upstream primer (100 µM)   1 
Product from ‘Step 1’ at 95°C  5 
dH20       18 
 
The components were mixed in a PCR tube and placed into the thermal cycler for the 
following: 95°C, 2 min, 30 cycles (95°C, 30 sec - 52°C, 1min - 72°C, 2min), 72°C, 10 
min. 
 
The product of each ‘Step 2’ reaction was analysed by agarose gel electrophoresis (1% 
gel on TAE buffer, 100V for 30min, stain with ethidium bromide), to determine which 
strains of DWV–like viruses and which recombinants are present in the sample.  
Further information on virus identity for phylogenetic analysis can be obtained by 
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cloning these PCR products into a plasmid vector (e.g. pGemT- Easy, Promega) and 
sequencing the plasmid using the Sanger dideoxy method. 
 
2.6.2. Real-time PCR quantification of DWV 
 
Real time PCR (or qPCR) allows accurate and simple quantification of DWV-like 
viruses within individual bees.  With qPCR, fluorescent dyes are used to label PCR 
products during thermal cycling and the accumulation of fluorescent products is 
measured in real time.  In my work, I have used qPCR to quantify viral load in 
individual bees, normalized to a constitutively expressed housekeeping gene (actin).  I 
have also used this technique to give an indication of the prevalence of DWV capsid and 
polymerase sequences, with primers designed to anneal to a single reference strain of 
DWV or VDV-1 from GenBank (DWW-PA AY292384.1, VDV-1 KC786222.1) 
(Appendix 1) 
 
For a 20 µl reaction volume mix: 
Component     Volume (µL) 
Brilliant III QPCR Master Mix, Low ROX 5 
dH20      3.8 
Forward Primer (100 µM)   0.1 
Reverse Primer  (100 µM)   0.1 
cDNA template    1 
 
Reaction conditions: 95°C – 3 min,  50 cycles (95°C – 10 sec, 60°C – 30 sec).  All 
qPCR carried out using a Roche Lightcycler 480 machine. 
For absolute quantification of viral copy number, serial dilutions of known amounts of 
template were included on the qPCR plate and their ct scores used to plot a standard 
curve.  The ct scores of the individual samples were then transformed using the equation 
of the standard curve to give the concentration per well, which was then converted to 




2.7. Localisation of DWV in honey bees using Stellaris probes (RNA-FISH) and 
confocal microscopy 
 
Individual honey bee samples were experimentally exposed to DWV and then fixed, 
embedded in paraffin, sectioned and hybridized with RNA-FISH probes to VDV-like 
capsid RNA to show the localization of DWV/VDV-like viruses within the tissue. 
 
2.7.1 Stellaris-RNA FISH 
 
Custom Stellaris® RNA FISH Probes were designed against the published capsid 
sequence for VDV (GenBank: AY251269.2) by utilizing the Stellaris® RNA FISH 
Probe Designer (Biosearch Technologies, Inc., Petaluma, CA) available online at 
www.biosearchtech. com/stellarisdesigner.  The sectioned honey bee tissue was 
hybridized with the VDV Stellaris FISH Probe set labelled with CAL Fluor® Red 590 
(Biosearch Technologies, Inc.), following the manufacturer’s instructions available 





2.7.2 Probe Design 
 
The Stellaris probes cannot distinguish between sequences with high levels of 
homology, so in silico testing was carried out to determine the best sequence upon 
which to base the probe design in order to give either a). the ability to accurately 
distinguish between VDV-like and DWV-like sequences or -  if the technology was 





Sequence homology in the capsid region of the two most distantly related DWV-like 
sequences on Genbank (determined by clustal alignment) is 84%.  These capsid 
sequences are not distinct enough to be differentiated by Stellaris probes, according to 
the manufacturer’s literature, so I now needed to determine whether a probe set designed 
to detect one capsid sequence would successfully detect all DWV-like viruses. 
 
A probe set was designed to anneal to the VDV-like capsid sequences, as this is the 
most prevalent in local bees and the predominant strain found in the virus prep used for 
all experimental infection assays.  For the designed probe set, a BLAST search was 
conducted.  As expected, the probes were all a 100% annealing match to the VDV-like 
capsid sequence for which they were designed (accession number KJ437447.1), when 
aligned to a DWV-like capsid (accession number KX580899.1)   80% (40/50 probes) 
were a 100% identity match for the template sequence, with the remaining 20% (10/50) 
having just one mis matched base.  It is recommended by the manufacturer that at least 4 
mismatches are required to prevent a probe binding to a non-target sequence, and that a 
probe set of 25+ is sufficient to give full on target annealing.  Change this: Therefore it 
was concluded that the probe set designed would be likely to detect both VDV-like and 




2.7.3 Processing of experimentally infected honey bees for RNA-FISH 
 
All tissue fixed in Kahle's solution and then stored at 4°C until use. 
Mix: 
17 ml  Ethanol EtOH, 
6 ml  Formalin H2C(OH)2, 
28 ml  RNAse free water ddH2O, 






Individual bees/pupae were divided into 3 sections – head, thorax and abdomen and 
placed into a histology cassette for dehydration.  Larvae were left whole up until the 4th 
instar, with older larvae and propupae being cut into two pieces (head and body). 
 
Dehydration of tissue 
 
Slow dehydration for long periods on ethanol series ranging from 15% to 100%, diluted 
in DEPC treated distilled water (ddH2O). Cold ethanol solutions with gentle shaking (at 
4°C) of samples during all the time of dehydration process, with 2 hours in each 
ethanol solution. The dehydration and embedding protocols are described in (Silva-
Zacarin, et al., 2012). 
 
The series of ethanol solutions were as follows: 
15%, 30%, 50%, 70%, 80% (overnight at 4°C), 85%, 90%, 100%, 100% (overnight at 
4°C). 
 
Paraffin embedding method  
 
After fixation and dehydration, samples were gently transferred into small glass 
containers. Histoclear II (National Diagnostics (Luchtel, et al., 1998)) was used for 
clearing the tissue in place of the Xylene recommended by (Silva-Zacarin, et al., 2012) 
as it is nontoxic.  Samples were placed into a solution containing 50% Histoclear 
II:50% ethanol for 1 hour, with occasional shaking at room temperature. 
This solution was subsequently replaced by a 75% Histoclear II:25% ethanol solution 
and incubated for 1 hour. 
This solution was then replaced with 100% Histoclear II three times for at least 1 hour 
each at room temperature, in order to remove completely the ethanol from all tissues.   
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Paraplast X-TRA (Sigma-Aldrich) chips were added gradually in the glass containers 
containing the samples and finally placed in a heat block at 60°C for 2 hours.  Molten 
Paraplast X-TRA was then replaced three times for at least 8 hours each time to obtain 
optimal infiltration of paraffin into the whole larvae.  Note: samples can stay few days 
in Paraplast before polymerization.  
 
The embedding moulds containing molten Paraplast X-TRA were placed on a hot plate 
(50°C) and the larvae were oriented in these moulds with warmed tweezers. After 
Paraplast X-TRA polymerization, paraffin blocks were stored at 4°C until use.  
 
 
Sectioning embedded material  
 
The paraffin-embedded tissues were attached to the back of the histology cassette and 
the edges shaped with a razor blade to form a pyramid.  Ribbons of 8 µm thickness 
were generated using a microtome and placed on ddH2O coated slides (Adhesion 
slides, SuperFrost® Plus, VWR) with the ribbon shiny side toward the water surface.  
Excess water was removed and slides were incubated overnight at 35°C to promote an 
optimal tissue adhesion to the slide. Slides were then stored in dry boxes at 4°C until 
use.  
 
Deparaffinisation of formalin-fixed paraffin embedded tissue sections 
 
Briefly, the Paraplast X-TRA embedding medium was removed from the slides through 
immersion in Histoclear II.  The slides were then immersed in 100% EtOH for 20 mins, 
95% EtOH for 10 mins and then 70% EtOH for at least 1 hour to re-hydrate and 
permeabilise the tissue sections.  Immediately prior to hybridization, slides were 
removed from the ethanol and placed into RNAse free PBS (5 min), followed by 20 
mins in PBS with proteinase K (10 µg/ml) at 37°C.  Finally, slides were equilibrated in 




Hybridisation of tissue 
 
The Stellaris-FISH probe is supplied as a dried stock.  Initial dilution was in TE buffer 
to 12.5 µM concentration, with the diluted probe solution being stored at -20°C.  This 
was then further diluted to a working solution of 2.5 µM in TE buffer (this 
concentration was selected after initial testing of the probe set at different dilutions – 
1:10, 1:2.5, 1:5, 1:10 – as per manufacturers instructions).  2 µl of the ‘working 
solution’ of the probe was added to 100µl of hybridization buffer (see below) per slide, 
this mix was pipetted over the slides and then covered with a clean cover slip and 
incubated over night at 37°C in a humidified chamber.  Finally, the slides were 
immersed in wash buffer for 30 min, dried and mounted in ProLong Diamond AntiFade 




1 g Dextran Sulfate 
1 ml 20x Saline-Sodium Citrate (SSC) buffer 
1 ml deionized formamide 




5 ml 20x SSC buffer 
5 ml deionized formamide 
+ Nuclease free water to 50 ml final volume. 
 
2.8 Confocal Microscopy 
 
All imaging took place using the Zeiss 880 confocal microscope, (Imaging suite, 
University of Warwick).  Samples that were known to have either high or low levels of 
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DWV were prepared and used to set the parameters for laser illumination levels and 
objectives.  For all images, tile scans of 5x5 images with the 25x objective were 
recorded, to allow for a 1500 µm square section of tissue to be analysed per image.  
Filters were set for one channel (to detect DAPI) at 410 nm to 566 nm with the 651 nm 
excitation laser at 2%, and a second channel (to detect the Stellaris probe, labelled CAL 
Fluor® Red 590, hybridised to DWV) between 585nm and 733nm, excitation from 
laser at 405 nm, 3.5%.  Gain and offset settings were optimised for the control slides 
and remained unchanged for all images. 
 
Slides had been prepared with the insects pre-dissected – with larvae and propupae 
divided into ‘head’ and ‘body’ segments and pupae and adults divided into ‘head’, 
‘thorax’ and ‘abdomen’.  Identification of tissue types within segments was carried out 
in reference to (Stell, 2012).  For each time point, three individual insects were 
examined per treatment, with at least three images of each body segment being 
quantified per individual.  To avoid the introduction of researcher bias into the 
selection of imaging sites, all slides were examined ‘blind’ with the treatment type 
obscured until after the images had been processed and quantified. 
 
2.8.1. Image processing 
 
All images were processed using Fiji (Schindelin, et al., 2012), an image processing 
package of the open platform, public domain, Java based imaging program developed 
by the National Institutes of Health  (Schindelin, et al., 2015).  To quantify the levels of 
fluorescence for both DWV (CAL Fluor® Red 590, Stellaris Probe) and for DAPI (the 
nuclear stain 4’, 6-diamidino-2-phenylindole, fluorescence at 461 nm when bound to 
double stranded DNA within cells (Kubista, et al., 1987)) images were converted to 
RGB colour and then quantified using the Colour Pixel Counter plugin (author Ben 
Pichette).  The number of red pixels per image (DWV) was normalised to the number 








All data analyses were performed using SPSS version 24 (SPSS, Inc., Chicago IL).   
 
Where both deltaCt and calculated viral copy numbers are shown, the viral copy 
numbers are used for statistical analysis. 
 
Statistical tests were selected according to the data set, further details are given in the 




Chapter 3. Principals of DWV Infection. Investigation of how 
DWV transmission route influences virus accumulation and 
localization. 
 
3.1. Introduction  
 
In this chapter, a range of experiments are described that simulate physical transmission 
of deformed wing virus into adult, larval and pupal honeybees. Both oral transmission to 
larvae, and Varroa mediated transmission to pupae and adults were studied. The latter 
was done by injection of a DWV preparation into bees maintained under controlled 
environment conditions in the laboratory.  
 
DWV was first found and characterised in the UK in the 1980’s, before the introduction 
of the Varroa mite (Bailey, et al., 1981) when examination of deformed (symptomatic) 
bees revealed high titres of an icosahedral single stranded RNA virus.  However, DWV 
was not seen as a major issue by beekeepers or researchers and symptomatic outbreaks 
were very rare (Allen and Ball, 1996).  DWV was rarely present at levels high enough to 
be detectable by the techniques of the time.  The honey bee research community is 
currently undecided as to the prevalence of DWV in honey bee colonies prior to the 
introduction of Varroa (de Miranda and Genersch, 2010).  Sensitive molecular 
techniques including qPCR and Illumina sequencing have revealed that low level, 
asymptomatic DWV infection can be detected in colonies from Varroa naive areas, such 
as those on Colonsay island (an island in the Inner Hebrides of Scotland, currently one 
of the few remaining Varroa free areas of Europe) and those in Northern Scandinavia, 
beyond the expansion front of Varroa (Yue and Genersch, 2005; de Miranda and Fries, 
2008; Ryabov, et al., 2014b).  However, samples from Australia (the last large land 
mass to remain free of the parasite) have been shown to be DWV free (Roberts, et al., 
2017).  Whether the virus could have been introduced by beekeeping practices into these 
European samples, or whether it was widely present within wild bee populations in the 
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area, forming a persistent, asymptomatic infection, the fact remains that in the absence 
of Varroa the virus is capable of establishing a covert, asymptomatic infection.  
 
DWV replication has also been detected in bumble bees (both Bombus pascuorum and 
Bombus terrestris) and in a number of other arthropods that are associated with honey 
bee hives, including the European earwig (Forficula auricularia) and the German 
cockroach (Blattella germanica) (Genersch, et al., 2006; Levitt, et al., 2013).  These 
species are not vulnerable to Varroa parasitism, so they are thought to become infected 
through direct association with honey bee colonies, and possible ingestion of 
contaminated food or pollen.   
 
Upon the introduction of Varroa to the UK, the prevalence of apparent, symptomatic 
infections by certain viruses (DWV, cloudy wing virus (CWV) and slow paralysis virus 
(SPV)) increased markedly (Martin, et al., 2010; Martin, et al., 2013).  A comprehensive 
sampling and monitoring project, conducted by the UK National Bee Unit has given a 
reliable picture of the ‘post Varroa’ viral landscape in honey bees in England and 
Wales.  As anticipated, weaker colonies were found to be more frequently associated 
with higher numbers of pathogens.  One key finding of the survey was that, of all of the 
pathogens tested for, DWV was the only one that could be reliably used as an indicator 
of colony strength, with colonies that had high levels of DWV being consistently more 
likely to have fewer combs of brood or bees (Budge, et al., 2015).  A similar project in 
Germany found that high levels of DWV and acute bee paralysis virus (ABPV) in the 
autumn, along with a heavy Varroa mite load, were significantly related to overwinter 
colony losses (Genersch, et al., 2010).  DWV has also been implicated in the rise in 
colony losses in Greece (Bacandritsos, et al., 2010) and Switzerland (Dainat, et al., 
2012b).  However the picture is less clear in the USA, where research has focused on 
‘Colony Collapse Disorder’ (CCD), with DWV being amongst the set of pathogens that 
were found to be moderately higher in colonies that had suffered from CCD in one study 
(Cornman, et al., 2012), but not amongst the most significant predictors reported by 
(vanEngelsdorp, et al., 2009).   
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In the absence of Varroa, transmission of honey bee viruses including DWV occurs 
through two separate pathways: either vertical or horizontal (Fig 3.1).  Vertical 
transmission is the transfer of an infection between generations, from parent to 
offspring.  Vertical transmission of DWV has been experimentally shown between 
drones and queens during mating and between queens and eggs (Yue, et al., 2007; de 
Miranda and Fries, 2008; de Miranda and Genersch, 2010).  This DWV transmission 
route results in persistent, covert, asymptomatic infections and is in line with a general 
hypothesis that vertical pathogen transmission leads to the selection of less virulent 
strains, that allow the infected individual to survive to adulthood (Ewald, 1983; Fries 
and Camazine, 2001). Horizontal transmission occurs between members of the same 
generation (in honey bees, this occurs between members of the worker caste and drones 
within a colony  (Chen, et al., 2006a)) (Fig 3.1).  Horizontal transmission of DWV has 
been shown to occur via food given to larvae and transferred between adults and results 
in covert infections (Yue and Genersch, 2005; Gisder, et al., 2009).  DWV has also been 
shown to be present in the midgut of asymptomatic individuals (Fievet, et al., 2006) and 
in the faeces of adult honey bees (Chen, et al., 2006b).   
 
The vertical and horizontal routes of infection offer some explanation as to how DWV is 
maintained in honey bee populations consistently and at low levels in the absence of 
Varroa without undergoing the periodic, host density-dependent epizootics that are 
common in other viral pathogens.  However, the introduction of Varroa mites to A. 
mellifera dramatically changed the population dynamics of DWV.  Two hypotheses 
have been put forward to explain the increase in the prevalence of symptomatic 
infections by DWV associated with the introduction of Varroa.  The first hypothesis is 
that Varroa parasitism of developing pupae has an immunosuppressive effect, which 
allows viral infections vectored by the mite to progress unchecked in naïve honeybee 
hosts.  Some other species of ectoparasites have been shown to suppress the immune 
response of the host and it has been proposed that this is an adaptation that facilitates 
parasite reproduction or feeding and also benefits the transmission of pathogens (Zhao, 
et al., 2009; Herniou, et al., 2013).  For example, the tick Ixodes scapularis is a vector 
of pathogens including Lyme disease in the Eastern United States.  In order to secure a 
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blood meal from their mammalian hosts, the ticks must feed for several days.  They 
have been shown to counter the immune responses of their hosts to facilitate this 
feeding, and this is achieved through salivary proteins which inhibit T-cells, B-cells, the 
complement systems and the coagulation system (Schuijt, et al., 2011).  It has also been 
shown that the host response to Borrelia burgdorferi (the spirochete that causes Lyme 
disease) differs depending on how the disease is transmitted – by the tick or 
experimentally via a needle.  This is due to both the tick suppression of the host immune 
response, and due to the modification of the Osp-A surface protein on the spirochete 
during tick feeding.  The presence Osp-A is necessary to induce the host development of 
antibodies to the spirochete (Schwan, et al., 1995; Wikel, 1999). 
 
 
In some examples, mutualistic symbiosis between vectors and the pathogens they 
transmit is highly co-evolved, for example in the case of  parasitoid brachonid and 
ichnemenoid wasps, where polydnaviruses are integrated into the parasitoid genome, 
allowing the wasps to produce and use functional modified virus particles containing 
fragmented dsDNA genomes which encode virulence genes (Zhao, et al., 2009).  These 
virions are utilised by  the parasitoids to evade or suppress the immune systems of their 
lepidopteran hosts, injecting them alongside their eggs to prevent encapsulation by 
haemocytes (Federici and Bigot, 2003; Herniou, et al., 2013).  In contrast, the 
interaction between Varroa, DWV and A. mellifera is relatively recent in evolutionary 
terms (Locke et al 2012), and hence it is premature to speculate as to whether there is a 
mutualistic interaction in A. mellifera hosts.  There is some evidence from laboratory 
experiments that the saliva injected by Varroa into honey bees has an 
immunosuppressive effect on the host, explaining the increased virulence of DWV when 
it is associated with Varroa (Yang and Cox-Foster, 2005; Rosenkranz, et al., 2006; 
Dainat, et al., 2012a; Nazzi, et al., 2012; Francis, et al., 2013) although this finding has 
been disputed by Kuster et al. (2014), who found no evidence for immunosuppression in 
Varroa parasitized bees (Kuster, et al., 2014), while an in vitro study of the effects of 
Varroa infestation on developing worker bees showed increased expression of several 
immune genes (Gregorc, et al., 2012).  To date, there has been little work published that 
separates the effect on honey bees of Varroa feeding on its own from the impact of 
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Varroa-mediated DWV infection due to the ubiquitous association of DWV with 
Varroa mites.  The in vitro collection of Varroa saliva has allowed a preliminary 
biochemical characterization of the secretions, with 15 distinct proteins present in the 
saliva.  The Varroa saliva was also shown to impair the function of Lacanobia oleracea 
haemocytes in culture, indicating that these salivary proteins may facilitate the 
suppression of haemocyte-mediated wound healing (Richards, et al., 2011). 
  
A second explanation for the increased virulence of DWV when associated with Varroa 
mites, is that the feeding mite has opened up a new route of transmission for DWV by 
injecting it directly into the honey bee haemocoel, allowing the virus access to a wider 
range of tissues than it would otherwise have through infection per os, and bypassing 
co-evolved host defences. 
 
Alternatively, there could be some filtering or preferential selection of certain DWV 
sequences or strains when transmission is via Varroa mites (Ryabov, et al., 2014; 
Gisder, et al., 2018), and these selected strains could in turn be more pathogenic when 
injected into the honey bee during Varroa feeding.  There is more focus on the selection 
of virulent strains in Chapter 4 of this work.  
  
 
Figure 3.1 Defining the different possible transmission routes for honey bee viruses. Adapted from de 
Miranda et al. (2011) and COLOSS BEEBOOK Vol 1. 
sexual
Varroa















Horizontal	transmission	 (direct	to	 haemolymph	by	Varroa feeding)
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It has been shown that symptomatic, Varroa exposed individuals have DWV present in 
total RNA extracted from their heads, as do individuals experimentally injected with 
DWV to mimic Varroa feeding (Yue and Genersch, 2005; Iqbal and Mueller, 2007), this 
infection of the brain is absent in vertically or orally exposed individuals.  Experimental 
injection of DWV into bees has been shown to cause subtle learning deficits in adult 
bees and ‘classical’ DWV symptoms (deformed wings, stunted abdomen) in individuals 
that were injected as pupae (Moeckel, et al., 2011).  
 
It is clear from the literature that the route through which an individual honey bee is 
exposed to DWV is crucial in determining if a symptomatic infection will develop.  
There is also persuasive evidence that different tissue types are infected in asymptomatic 
and symptomatic infections. However, there is little detailed knowledge on the pattern 
of tissue infection following oral or Varroa mediated infection, or on the time course of 
infection following controlled dose experimental infection. 
 
In this chapter, a series of experiments were conducted using larval feeding or injection 
techniques to reveal more about how the mode of transmission affects the pathogenicity 
of the virus and how this is linked to virus localisation and pupal development.  The 
viral outcomes (determined by qPCR, calculating DWV copy number per individual) as 
a result of oral exposure (larval) or injection (pupae, adults) of DWV virus prep were 
established.  This ‘dose response’ information was followed by time course 
experiments, where a group of individuals were administered a single dose of virus and 
then sequentially sampled in order to reveal more about the time course of infection.  A 
subset of individuals was collected from each sampling point and fixed to allow 








Figure 3.2 Sampling times for feeding and injection experiments. Time of exposure to DWV shown by orange arrows, 






















Techniques for larval rearing, pupal injection and adult injection experiments were 
described in Chapter 2 of this thesis, sections 2.3, 2.4.and 2.5, and the DWV virus 
preparation method is given in section 2.2. The experiments were conducted as follows: 
 
3.2.1 Characterisation of DWV virus preparation  
 
All experiments in this chapter were conducted using a virus preparation (VP) from 
symptomatic honey bees (Wellesbourne 2015 VP).  Before it could be used to infect 
bees, PCR and qPCR tests were carried out on the VP cDNA to give an indication of the 
strain of DWV present and check that no other honey bee viruses were present.   
 
Virus prep was ‘cleaned up’ using the GeneJet RNA Purification kit (Thermo Scientific. 
RNA clean up protocol) and then used as a template for reverse transcription, to give 
cDNA.  This cDNA was then used as a template for PCR reactions with primers to 
amplify Sacbrood Virus (SBV), Acute Bee Paralysis Virus (ABPV), Israeli Acute Bee 
Paralysis Virus (IABPV) and Chronic Bee Paralysis Virus (CBPV) and Deformed Wing 
Virus (DWV).  A qPCR run was carried out with DWV strain specific primers following 
the protocol in Chapter 2 (Section 2.6.2.). A full list of primers can be found in 
Appendix 1 of this work.  
 
 
3.2.2 - Quantification of DWV in honey bee pupae following inoculation via larval 
food  
 
This involved giving a single dose of DWV VP to young honey bee larvae (5 d old from 
egg laying.)  This experiment recreated direct horizontal transmission of DWV within a 
colony, specifically the transfer of the virus from nurse bees to developing larvae during 
feeding, the primary route via which DWV is thought to persist in a colony in the 
absence of Varroa mites.  Dose ranges and sampling times were established during 
preliminary experiments.   
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3.2.2.1. Dose Response - Quantification of DWV in honey bee pupae following 
inoculation via larval food 
 
The basic in vitro larval maintenance protocol is given in Chapter 2 (2.3.1).  This 
protocol was modified by mixing a dose of DWV into the larval food given on day one 
of the assay.  The doses given were as follows: 5.56 x 1013 DWV copies/larvae, 5.56 x 
1011 DWV copies/larvae, 5.56 x 1010 DWV copies/larvae, 5.56 x 109 ng DWV 
copies/larvae, 5.56 x 107 ng DWV copies/larvae and 5.56 x 105 DWV copies/larvae, 
plus a control dose containing no DWV.  Sampling took place at the purple eye stage of 
pupal development, 10 days after DWV exposure.  The experiment was repeated on two 
separate dates, and in each replicate 12 individuals treated at each dose.  Sampling, 
RNA extraction and qPCR analysis were carried out as in Chapter 2, sections 2.5 and 
2.6.2. 
 
3.2.2.2. Time to Response - Quantification of DWV in honey bee pupae following 
inoculation via larval food.  
 
The basic in vitro larval maintenance protocol is given in Chapter 2 (2.3.1).  This 
protocol was modified by mixing a dose of DWV into the larval food given on day one 
of the assay.  The doses given were as follows: 5.56 x 1013 DWV copies/larvae or a 
control dose (DWV free food).  Sampling took place at set times throughout the 
experiment, at 24 h, 72 h, 96 h, 144 h, 168 h and 240 h post DWV exposure.  The 
experiment was repeated on two separate dates, and in each replicate 40 individuals 
were treated at each dose.  Sampling, RNA extraction and qPCR analysis were carried 
out as in Chapter 2, sections 2.5 and 2.6.2. 
 
3.2.3. Quantification of DWV in honey bee pupae following inoculation via 
injection 
 
These experiments involved using a Hamilton syringe to administer a single dose of 
DWV VP to honey bee pupae at the ‘white eye’ stage of development to mimic the 
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direct transfer of the virus to honey bee haemolymph during Varroa feeding.  As 
described in Chapter 1, Varroa mites reproduce within capped cells in honey bee 
colonies, feeding upon developing pupae.  Varroa feeding has actually been 
documented to start within 5 hours of the cell being capped, whilst the inhabitant bee is 
still at the propupal stage of development (Kanbar and Engels, 2003; Rosenkranz, et al., 
2006).  However, preliminary experiments established that it was not possible to 
successfully inject propupae due to the pliability of the cuticle and lack of internal 
structure, which cause leaking of haemolymph and death following injection.  Injection 
immediately following pupation, at the white eye stage of development, was found to be 
more reliable.  This is the stage of development at which the mother mite would make 
the final feeding perforation in the second abdominal segment - immediately prior to 
sclerotisation of the pupal cuticle – which is then used by the mother mite and her 
offspring throughout the pupal stage (Kanbar and Engels, 2003).  Dose ranges and 
sampling times were established during preliminary experiments.   
 
3.2.3.1 - Dose Response - Quantification of DWV in honey bee pupae following 
inoculation via injection. 
 
White eye pupae, day 12 to 13 from laying (4 days post capping) were injected with a 
single dose of DWV VP, doses ranged from 1.85 x 102 viral copies per individual, to 
1.85 x 108 viral copies per individual.  A single injection was given into the pupal 
haemocoel on day one of the experiment, as described in Chapter 2, section 2.4.1.  
Sampling took place 4 days post injection, at the purple eye stage of development. The 
experiment was repeated on two separate dates, with 6 individual bees per treatment in 
each replicate.  Sampling, RNA extraction and qPCR analysis were carried out as in 
Chapter 2, sections 2.5 and 2.6.2. 
 




White eye pupae, day 12 to 13 from laying (4 days post capping) were injected with a 
single dose of DWV VP, 1.85 x 106 viral copies (n=50), or with a control injection 
(n=25).  A single injection was given into the pupal haemocoel on day one of the 
experiment, as described in Chapter 2, section 2.4.1.  The injected pupae were left to 
develop to adulthood in the incubator (12 days) and then scored as having either normal 
or deformed wings, and normal or stunted abdomen. 
 
 
3.2.3.3. Time to Response - Quantification of DWV in honey bee pupae following 
inoculation via injection  
 
White eye pupae, day 12 to 13 from laying (4 days post capping) were injected with a 
single dose of DWV VP, 1.85 x 106 viral copies, or with a control injection.  A single 
injection was given into the pupal haemocoel on day one of the experiment, as described 
in Chapter 2, section 2.4.1.  Sampling took place at planned time points throughout the 
experiment, at 0 h, 10 h, 23 h, 33 h, 48 h, 58 h, 72 h, 80 h, 96 h and 105 h post DWV 
exposure.  The experiment was repeated on two separate dates, with 60 individual bees 
per treatment in each replicate.  Sampling, RNA extraction and qPCR analysis were 
carried out as in Chapter 2, sections 2.5 and 2.6.2. 
 
 
3.2.4. Quantification of DWV in honey bee adults following inoculation via 
injection  
 
These experiments involved using a Hamilton syringe to administer a single dose of 
DWV VP to newly emerged worker bees to reveal more about the effect of phoretic 
Varroa mites feeding on adult bees (Genersch, et al., 2005; Piou, et al., 2016).  Newly 
emerged individuals were used despite Varroa mites documented preference for nurse 
bees over newly emerged individuals or foragers (Xie, et al., 2016).  This was because it 
was necessary to watch the bees emerge from the frame to ensure that they were Varroa 
free prior to injection.  An additional advantage is that newly emerged bees are unable to 
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sting, meaning that they could be injected without immobilising via chilling or CO2 
anaesthesia, which have been shown to cause premature aging and reduced lifespan of 
worker honey bees (Human, et al., 2013).  Dose ranges and sampling times were 
established during preliminary experiments.   
 
3.2.4.1 - Dose Response - Quantification of DWV in honey bee adults following 
inoculation via injection 
 
Newly emerged adult worker bees were injected with a single dose of DWV VP, doses 
ranged from 1.85 x 102 viral copies per individual, to 1.85 x 108 viral copies per 
individual.  A single injection was given into the abdomen day one of the experiment, as 
described in Chapter 2, section 2.5.  Sampling took place 4 days post injection. The 
experiment was repeated on two separate dates, with 6 individual bees per treatment in 
each replicate.  Sampling, RNA extraction and qPCR analysis were carried out as in 
Chapter 2, sections 2.5 and 2.6.2. 
 
 
3.2.4.2. Time to Response - Quantification of DWV in honey bee adults following 
inoculation via injection  
 
Newly emerged adult worker bees were injected with a single dose of DWV VP, 1.85 x 
106 viral copies or with a control injection.  A single injection was given into the pupal 
haemocoel on day one of the experiment, as described in Chapter 2, section 2.5.  
Sampling took place regularly throughout the experiment, at 0 h, 10 h, 23 h, 33 h, 48 h, 
58 h, 72 h, 80 h, 96 h and 105 h post DWV exposure.  The experiment was repeated on 
two separate dates, with 60 individual bees per treatment in each replicate.  Sampling, 





3.2.5 Localisation of DWV in honey bees using Stellaris probes (RNA-FISH) and 
confocal microscopy 
 
Samples for RNA-FISH were produced by conducting exact repeats of the ‘Time to 
Response’ experiments detailed above in sections 3.2.2.2. and 3.2.3.2. to allow 
visualisation of the time course of infection in honey bees exposed to DWV via food or 
injection.  Samples were fixed and processed as is described in Chapter 2, section 2.8.3. 



























3.3.1 Characterisation of Virus Preparation used for Horizontal Transmission of 
DWV Experiments – Oral exposure and direct injection 
 
All experiments in this chapter were conducted using a virus preparation (VP) from 
symptomatic honey bees (Wellesbourne 2015 VP).  Before it could be used to infect 
bees, PCR and qPCR tests were carried out on the VP cDNA to give an indication of the 
strain of DWV present and check that no other honey bee viruses were present.  PCR 
results showed that the VP was positive for DWV, but free of Sacbrood (SBV), Acute 
Bee Paralysis Virus (ABPV), Israeli Acute Bee Paralysis Virus (IABPV) and Chronic 
Bee Paralysis Virus (CBPV) (Figure 3.3, A).   
 
Figure 3.3. PCR analysis of virus prep cDNA. Prep is positive for DWV but Sacbrood virus (SBV), Acute 
Bee Paralysis Virus (ABPV), Israeli Acute Bee Paralysis Virus (IABPV) and Chronic Bee Paralysis Virus 
(CBPV) are absent. 500bp ladder. B – Strain specific qPCR of VP cDNA, indicating that both 
recombinant VDV/DWV type virus and full length VDV-1 type virus are present in VP2015. Cp bars 



























The VP cDNA was then examined using DWV strain specific qPCR to give an 
indication of the predominant strain of DWV or VDV in the prep.  This gives a picture 
of the relative abundance of DWV-like or VDV-1-like structural (Cp) and non-structural 
(Pol) sequences within the sample.  The results indicate that there are high levels of 
DWV-like polymerase and VDV-1 like capsid sequences present in the VP, with VDV-
1 like polymerase sequences also represented, although at lower levels.  This result is in 
line with our previous findings that a virulent DWV/VDV-1 recombinant strain of the 
virus dominates the viral population in our local, Varroa exposed, honey bee colonies 





3.3.2 Larval feeding experiments 
 
3.3.2.1 Dose Response - Quantification of DWV in honey bee pupae following 
inoculation via larval food 
 
 
In order to learn more about how DWV infects honey bees and how this infection 
process is influenced by the mode of transmission of the virus, dose response curves 
were first established from the virus preparation (Wellesbourne 2015 VP) for the two 
routes of transmission – oral or direct injection.  It has been established in the literature 
that symptomatic individuals typically have a viral load of over 109 copies of DWV per 
individual, and that the infection is typically bimodal, with a clear distinction between 
‘infected’ individuals with viral loads of around 109 or above, and asymptomatic 
individuals with significantly lower viral loads (Zioni, et al., 2011; Ryabov, et al., 
2014a).   
 
Oral exposure of honey bee larvae to DWV VP, via a single dose at 5 days from laying 
in larval feeding experiments, resulted in a bimodal distribution in observed DWV 
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levels in the experimental insects, when sampled at purple eye pupal stage (12 days post 
virus exposure).  Individuals given a ‘low’ dose of the VP (5.56 x 105 DWV 
copies/larvae to 5.56 x 1011 DWV copies/larvae) had DWV levels indistinguishable 
from the control bees.  However, larvae given a very high dose of DWV (5.56x1013 
DWV copies/larvae) went on to have elevated DWV levels, in line with those observed 
in symptomatic adult honey bees (Figure 3.4).  There was a statistically significant 
difference between the treatment groups as determined by one-way ANOVA (F(4,20) = 
11.271, p < 0.05). A Tukey post hoc test revealed that only the 5.56 x 1013 DWV 
copies/larvae treatment was significantly different from the other treatments and the 








Figure 3.4. Dose response curves for oral exposure of DWV. Doses given to larvae from a single colony 
at 5 days post laying. Sampling at ‘purple eye’ larval stage, 10 days post virus exposure. A. Delta Ct for 
Universal DWV primers, normalised to Actin. B. DWV copy number. * denotes treatment groups shown to 





3.3.2.2. Time to Response - Quantification of DWV in honey bee pupae following 
inoculation via larval food 
 
As described above, honey bee larvae are able to be exposed to relatively high doses of 
DWV without succumbing to infection.  In order to have any ‘high virus’ outcome 




















































DWV copies/larvae must be given early in larval development.  Lower doses or later 
exposure resulted in individuals with low levels of DWV infection, similar to those 
found in control (non DWV exposed) bees.   
 
In order to learn more about how this high dose of DWV is able to overcome the host 
defences and cause symptomatic infections, experiments were conducted in which 
larvae were given a single, infectious dose of DWV (5.56 x 1013 DWV copies/larvae) 
and then samples were collected at regular time points throughout the larval stage and 
pupation.  The results of this experiment are shown in figure 3.5.  DWV levels were 
similar for control and treatment groups for the first 4 days of sampling, however at 6 
days post viral inoculation the samples from the virus exposed group had higher levels 
of DWV than those fed a DWV free diet.  A two-way ANOVA was conducted that 
examined the effect of treatment (DWV or Control) and time on viral outcome.  There 
was a statistically significant interaction between the effects treatment and sampling 
time on the level of DWV at sampling, F (5, 63) = 14.215, p <0.005. 
 
Post hoc analysis (Tukey HSD) reveals that there is no difference between the DWV 
levels in the control and in the treatment groups until 6 days post infection.  This is the 
point at which the propupae is undergoing metamorphosis prior to the fifth moult where 
the pupal form is revealed (Stell, 2012).  During honey bee development, the first 
physiological change to the larvae following its final meal and the capping of the cell for 
pupation, is the opening of the midgut, hindgut and malpighian tubules to allow waste to 
pass from the larval stomach and be evacuated into the bottom of the cell.  The empty 
intestines then undergo extensive remodelling during pupation.  It is possible that, if 
DWV is present during this process it may be able to access tissues that had previously 
been protected by the physical barrier of the larval midgut walls, leading to the elevated 


































































Mean	Copy	Number	 (DWV) Mean	Copy	Number	 (Control)
A	
B	
Figure 3.5. Time to Response - Quantification of DWV in honey bee pupae following inoculation via larval 
food. Single dose of 5.56 x 1013 DWV copies/larvae, given on day one of assay.  Sampling at set time points 
during larval and pupal development. A. Delta Ct for Universal DWV primers, normalised to Actin. B. DWV 
copy number. 
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3.3.3. Quantification of DWV in honey bee pupae following inoculation via 
injection 
 
3.3.3.1 Dose Response - Quantification of DWV in honey bee pupae following 
inoculation via injection 
 
 
Figure 3.6 White eye pupae, day 12 to 13 from laying (4 days post capping) were injected with a single 
dose of DWV VP, doses ranged from 1.85 x102 viral copies per individual, to 1.85 x 108 viral copies per 
individual. Sampling took place 4 days after inoculation. Results of two replicates shown. Results of Rep 1 
are shown in Ai (delta Ct) and Aii (calculated DWV Copy Number per bee).  Results of Rep2 are shown in 
Bi (delta Ct) and Bii (calculated DWV Copy Number per bee).  Brackets show treatments found to give 
significantly different viral outcomes to the control injected pupae. 
 
Batches of white eye pupae, day 12 to 13 from laying (4 days post capping) were 











































































































per individual, to 1.85 x 108 viral copies per individual.  All individuals were sampled 4 
days post injection, at the purple eye stage of development.  Results of two replicate 
experiments are shown in figure 3.6.  Injection of a dose of 1.85 x 107 viral copies was 
sufficient to produce a pronounced DWV infection in the majority of individuals (92% 
of n=12). However, the viral outcomes were more variable for doses between 1.85 x 106 
viral copies and 1.85 x 107 viral copies per pupae.  When a dose of 1.85 x 106 viral 
copies was given, 9/13 individuals (69%) were infected, and a dose of 1.85 x 105 viral 
copies viral copies resulted in an infection rate of 1/13 (8%).  This result suggests that, 
for our VP, a dose of 1.85 x 107 viral copies per individual was  sufficient to produce a 
symptomatic infection, but that there was some variation in susceptibility between 
individuals from the same colony.  There was a significant effect of DWV dose on the 
viral load of injected individuals in both replicates, as determined by one way ANOVA, 
for rep 1 (F(6,28)=14.28, p<0.05) and rep 2 (F(6,49)=73.95, p<0.05).  Post hoc analysis 
(Tukey HSD) revealed that, for both replicates, there were two distinct categories for 
viral outcome, with the doses of 1.85 x 107 viral copies per individual and greater 




3.3.3.2.  Establishing that ‘high DWV’ individuals go on to become symptomatic 
adults 
 
In all of the above dose response experiments, the dose of DWV administered was not 
high enough to cause increased mortality in any of the treatment groups.  The 
destructive nature of the sampling meant that, although we can state that DWV levels 
are in line with either asymptomatic or symptomatic individuals sampled from colonies, 
we cannot be sure that the ‘infected’ individual samples at ‘purple eye’ stage would 
have gone on to become symptomatic adults.  To address this a repeat of the pupal 
injection experiment was conducted, with individuals given either a control injection or 
a dose of 1.85 x 106 viral copies per individual.  This dose gave an infection rate, 
determined by qPCR at purple eye stage, of 69%.  The injected pupae were left to 
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develop to adulthood in the incubator and then scored as having either normal or 
deformed wings, and normal or stunted abdomen.  The adult bees in the DWV treatment 
group (n=50) were assessed as having deformed wings in 86% of individuals, and 
stunted abdomen in 72% of individuals.  In contrast, the control injected group (n=25) 
exhibited wing deformities in 25% of cases and had no individuals (0%) with stunted 
abdomens.  Independent t-tests show that the treatment and control groups differed 
significantly in terms of rate of deformity for both wings (t-value is -13.15435. The p-
value is < 0.0005) and abdomen (t-value is -7.91021. The p-value is < 0.0005).   
 
 
Figure 3.7. Honey bees injected with an infectious dose of DWV (1.85 x 106 viral copies) at white eye 
pupal stage and then left to develop in a humidity controlled incubator (33C, 90% humidity) to adulthood. 
Scored for wing deformity and stunted abdomen to allow assessment of symptom outcomes for DWV 
injected bees. 
 
3.3.3.3. Time to Response - Quantification of DWV in honey bee pupae following 
inoculation via injection  
 
Injection of DWV VP into ‘white eye’ pupae can be used to simulate DWV exposure 






























infection is far lower when administered by direct injection than when administered 
orally. An experiment was done in which individual ‘white eye’ pupae from a single 
colony were given a single infectious dose of DWV (1.85 x 106 viral copies per 
individual) by injection, and then samples taken at regular intervals to reveal more about 




Figure 3.8. DWV injection into 'white eye' pupae. Dose of 1.85 x 106 viral copies per individual followed 
by sequential sampling up to purple eye stage.  Results of two replicates shown. Results of Rep 1 are 
shown in Ai (delta Ct) and Aii (calculated DWV Copy Number per bee).  Results of Rep2 are shown in Bi 
(delta Ct) and Bii (calculated DWV Copy Number per bee).  Brackets show treatments found to give 
significantly different viral outcomes to the control injected pupae. 
  
 
A two-way ANOVA was conducted that examined the effect of treatment (DWV or 
Control) and time on viral outcome.  There was a statistically significant interaction 
between the effects treatment and sampling time on the level of DWV at sampling – 
Replicate 1, F (9, 84) = 7.875, p <0.005. Replicate 2, F (7, 72) = 11.985, p <0.005.  In 






































































































sampling point, where the means for the DWV and Control differed significantly (t 
(6)=-3.72, p <0.05).  A similar pattern was observed in replicate 2, but here the means of 
the treatment groups did not differ significantly until the 38 h sampling point (t 
(5)=3.08, p <0.05).  This time period (24 to 38 hrs) was noticeably shorter than the time 




3.3.5 Localisation of DWV in honey bees using Stellaris probes (RNA-FISH) and 
confocal microscopy 
 
Stellaris FISH (fluorescence in situ hybridization) is a RNA visualisation technique that 
permits detection, localisation, and quantification of individual RNA molecules within 
fixed, sectioned tissue using fluorescent microscopy.  Stellaris FISH Probes are 
designed and produced as a set of multiple oligonucleotides with different sequences 
each with a fluorescent label that collectively bind along the same target transcript to 
produce a punctate signal. 
 
The Stellaris probes cannot distinguish between RNA with high sequence homology, as 
discussed in chapter 2, so the probe set used was designed to detect both VDV-like and 
DWV-like capsid sequences.  
 
This technique was used to reveal more about the time course of DWV infection 
discussed earlier in this chapter.   A comparison of the localisation of the virus following 
experimental transmission, either via injection to mimic Varroa feeding or oral exposure 







3.3.3.1 Oral route of DWV exposure  
 





Figure 3.9 A. Sampling schedule for experiment. B. Fluorescence levels (normalised to DAPI levels to 
control for tissue density) for larvae fed a single dose of DWV (5.56 x 1013 viral copies per pupae, d5 post 
laying) and larvae fed on a virus free diet.  Fluorescence measurements taken for different body segments 
- head, thorax and abdomen – from three individual insects per time point, per treatment group. 
 
A two-way ANOVA was conducted that examined the effect of treatment (DWV 
feeding at 5 days post laying) and time from feeding on normalised fluorescence levels. 
There was a statistically significant interaction between the effects of treatment and 
































































20.147, p < 0.0005.  Post hoc testing (Tukey HSD) reveals that the treatment groups 
were not significantly different at the 24 h to 168 h sampling points, by the end of the 
experiment at 240 h the virus positive treatment group differed significantly from the 
control for all three body segments (p < 0.0005). 
 
A closer examination of the confocal images revealed  more about the progression of 
DWV infection in orally exposed honey bee larvae.  Both the confocal images (fig 3.10) 
and the quantification of fluorescence (fig 3.9) show that levels of DWV in all body 
parts remain low for both treatment groups until after 168 h post DWV inoculation.  At 
this point the larvae that were fed a high dose of DWV begin to show elevated levels of 
fluorescence in all body parts, indicating that DWV infection is progressing throughout 
the body.  This time point corresponds with the transition from larvae to pupae.  During 
this time period (0 to 3 days post capping) the honey bees are undergoing extensive 
metamorphosis, known as the propupal stage with the pupae developing within the 
larval skin.  At 4 days post capping the bees undergo the fifth moult, when the external 
features of the adult honey bee become visible, although the majority of the internal 






































































































































































































































































































































































Figure 3.10 Confocal images of samples from larval feeding experiments, larvae fed a single dose of DWV (5.56 x 
1013 viral copies per pupae, d5 post laying) and larvae fed on a virus free diet (Control).  All slides hybridised with 
Stellaris RNA FISH probes designed to bind to DWV/VDV capsid sequences, set labelled with CAL Fluor® Red 590, 
and imaged at fixed laser settings on a Zeis 880 confocal microscope, 25x objective, 5x5 tile scan.  Quantification of 
fluorescence was carried out using the Colour Pixel Counter plugin in Fiji (Schindelin, et al., 2012), with red 








































































3.3.3.2 Injection route of DWV exposure  
 
Time course of infection experiments were also conducted for the direct injection route 
of DWV exposure, with these samples also being used for confocal imaging with 
Stellaris RNA FISH showing DWV localisation in developing pupal tissue.  
 
 
Figure 3.11 Fluorescence levels (normalised to DAPI levels to control for tissue density) for pupae injected with a 
single dose of DWV (1.85 x 106 viral copies per individual, white eye stage) and control pupae injected with PBS.  
Fluorescence measurements taken for different body segments - head, thorax and abdomen – from three individual 
insects per time point, per treatment group. 
 
 
A two-way ANOVA was conducted that examined the effect of treatment (DWV 
injection at 3 days post capping) and time from injection on normalised fluorescence 
levels. There was a statistically significant interaction between the effects of treatment 
and sampling time on normalised fluorescence levels in the confocal images, F (7, 254) 
= 84.898, p < 0.0005.  Post hoc testing (Tukey HSD) reveals that the treatment groups 
were not significantly different at the 0h to 33h sampling points, but from 48h after 
injection to the end of the sampling period, the virus positive treatment group differed 









































































































































































































































































































































































































































































































































































Figure 3.12 Confocal images of samples pupal injection experiments.  Pupae injected with a single dose of DWV 
(1.85 x 106 viral copies per individual, d5 post laying) and larvae fed on a virus free diet (Control).  All slides 
hybridised with Stellaris RNA FISH probes designed to bind to DWV/VDV capsid sequences, set labelled with CAL 
Fluor® Red 590, and imaged at fixed laser settings on a Zeis 880 confocal microscope, 25x objective, 5x5 tile scan.  
Quantification of fluorescence was carried out using the Colour Pixel Counter plugin in Fiji (Schindelin, et al., 
2012), with red fluorescence (DWV) being normalised to blue (DAPI) to control for tissue density 
 
 
A closer examination of the confocal images reveals more about the progression of 
DWV infection in injected honey bee pupae.  The early sampling points (0h to 33h) 
show very low levels of fluorescence in both the control and DWV injected pupae.  
From 48h post injection onwards the levels of fluorescence are significantly greater in 
the DWV injected pupae than in those from the control group.  A One-way ANOVA 
reveals that, at 48h post injection, there was a significant effect of body segment upon 
level of fluorescence in DWV injected pupae (F(2, 22)=9.576, p=0.001).  Post hoc 
analysis reveals that fluorescence in the head (including the eye) differs from that in the 
thorax and abdomen.  It appears that in injected pupae, DWV infection progresses 
fastest in the brain and eye tissue.  However, by the next sampling point (58h) the 
infection appears to have progressed to a similar level in all of the body segments, with 
no difference in the measured fluorescence in the head, thorax and abdomen 


















In honey bees unexposed to Varroa parasitism, DWV forms a low level, asymptomatic 
infection and is transmitted vertically from drones and queens, and orally between 
workers (Yue, et al., 2006; de Miranda and Fries, 2008; Moeckel, et al., 2011).  DWV 
has been shown to reach higher levels and cause physical deformities and cognitive 
difficulties  in honey bees when it is administered directly to the hemolymph of 
developing pupae, either via Varroa feeding (Gisder, et al., 2009) or via experimental 
injection (Moeckel, et al., 2011).   
 
Until now, no work had been conducted that directly compared the dose of DWV 
required to cause a symptomatic or ‘high virus outcome’ infection in honey bees when 
administered either orally or via injection at the crucial larval and pupal stages of 
development.  Here we have tested the hypothesis that DWV is more likely to cause a 
symptomatic infection when injected directly into the pupal hemolymph (mimicking 
Varroa feeding) than when it is dispensed orally to the developing larvae (mimicking 
oral transmission in brood food within the colony), as it gains access to a wider range of 
tissues in which to replicate and consequently is infectious at a far lower dose.   
 
As described above, DWV infection can be seen as bimodal, with honey bees either 
exhibiting a low level asymptomatic infection or a high level symptomatic infection, 
with a clear distinction between ‘infected’ individuals with viral loads of around 109 or 
above, and asymptomatic individuals with significantly lower viral loads (Zioni, et al., 
2011; Ryabov, et al., 2014a).  Due to the destructive nature of the sampling required for 
this work we were unable to establish whether the individuals in these experiments 
would have gone on to exhibit DWV symptoms.  However, I believe that there is 
enough evidence, both in the literature (Moeckel, et al., 2011; Zioni, et al., 2011; 
Ryabov, et al., 2014a) and in section 3.3.3.2.  of this chapter that we can confidently 
state that pupae with a viral load of greater that 108 copies of DWV are likely to go on to 
be symptomatic adult honey bees. 
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As expected, the oral dose of DWV required for a symptomatic infection when 
administered to in vitro reared honey bee larvae is dramatically higher than that required 
when the same DWV virus prep is inoculated directly into the pupal hemolymph.  
Injection of a dose of 1.85 x 107 viral copies was sufficient to produce a pronounced 
DWV infection in the majority of individuals, whereas 5.56 x 1013 viral copies/larvae 
was required to be mixed with larval food before any high viral load individuals were 
found.  This dose of DWV is greater than the number of DWV genome equivalents that 
would be found within an entire symptomatic DWV infected honey bee.  Whilst DWV 
has been detected in the brood food that workers feed to the developing larvae using 
RT-PCR (Yue and Genersch, 2005) the level of virus present has not yet been 
quantified.  Still, it seems fair to assume that the quantity of DWV particles in this brood 
food would be significantly lower than the number present in an entire honey bee.  This 
finding explains why, in Varroa naïve colonies, symptomatic DWV infected honey bees 
are rarely (if ever) present.  However, brood food passed from nurse bees to larvae is not 
the only route of oral DWV transmission within a colony, workers exhibiting hygienic 
behaviour remove and cannibalize dead or diseased brood (Evans and Spivak, 2010; 
Moeckel, et al., 2011) and any worker bee consuming a DWV infected pupae would 
receive a large dose of DWV, potentially as high as the 5.56 x 1013 viral copy threshold 
required for symptomatic infections in larvae.  This infection route becomes more likely 
as the Varroa numbers in a colony increase, with any worker bees that avoided Varroa 
parasitism during their development (and were therefore unlikely to have a symptomatic 
DWV infection upon emergence) becoming infected through their hygienic duties as 
nurse bees.  Up to 100% of sampled workers in a collapsing, late season colony can 
have high level DWV infections (see Chapter 4, figure 4.8) in spite of not having visible 
DWV associated deformities.  This consumption of heavily DWV infected brood could 
shorten the lifespan and reduce the foraging ability of these late season bees (Dainat, et 
al., 2012a; Benaets, et al., 2017). 
 
The experiments described above also reveal more about the time course of DWV 
infection in honey bees exposed to infectious doses of DWV, either orally as larvae or 
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via injection as pupae.   This time period required for bees given an infectious dose of 
DWV via injection to have a DWV infection detectable for qPCR (24 to 38 hrs) was 
noticeably shorter than the time taken for DWV infections to become established in 
orally exposed bees (6 days/144 hours).  With both modes of transmission, the transition 
from low to high DWV load comes at the same time as the virus becomes detectable in 
the brain and developing compound eye, plus the muscle tissue in the developing thorax 
and the epithelial tissues of the mid and hind gut (Stell, 2012).  In injected pupae, there 
is no physical barrier between the virus and the vulnerable tissues, and infection 
progresses quickly, detectable by qPCR 24 to 38 h after inoculation.  However, in orally 
exposed individuals, the gut may form an effective barrier to infection (DeGrandi-
Hoffman and Chen, 2015), and in the feeding experiments in this chapter DWV 
infection was not able to progress, even with a very high oral dose of DWV, until the 
larval gut tissue was broken down following pupation (Stell, 2012).   
 
It has been shown by other research groups that a symptomatic DWV infection can be 
characterized by the presence of DWV in the head tissue of the adult bee (Moeckel, et 
al., 2011) but the RNA-FISH imaging experiment described in this chapter reveals more 
about where DWV localises in a honey bee pupae during the early stages of an infection.  
48 h after injection with an infectious does of DWV the virus particles are seen to be 
accumulating in the developing compound eye, the layer of cells surrounding the brain 
tissue, the salivary glands and mouth parts and in the epithelial cells of the mid and hind 
gut.  It appears that these tissues are most vulnerable to DWV infection once the virus 
has been injected or escaped from the digestive tract.  By the 58 h post injection 
sampling point, the virus particles are also shown to be present within the brain tissue 
and in the muscle tissue of the thorax.  As the infection progresses through the 72 h and 
96 h sampling points the levels of fluorescence throughout the honey bee tissue increase 
dramatically, until there appears to be little tissue selectivity for virus replication, with 
all body parts becoming heavily infected.   As described above, the orally administered 
virus takes longer to establish an infection, but once the breakthrough has occurred the 
progression of infection and tissues affected appear to be the same as in injected 




A pupal injection experiment was carried out to check that individuals given the dose of 
DWV virus prep that caused high viral load (as shown by qPCR) actually went on to 
develop the characteristic DWV symptoms of deformed wings and stunted abdomen 
(Results section, 3.3.3.2).   The proportion of DWV injected bees recorded as having a 
stunted abdomen was very close to the one predicted by the earlier qPCR results (72% 
observed, 69% predicted), with no control injected bees exhibiting a stunted abdomen, 
allowing us to be confident that the sampled individuals with high viral loads would 
have gone on to be symptomatic adults.  However, the rate of deformed wings was 
higher than expected, (86% observed, 69% predicted) and 24% of the control group also 
showed some wing deformities.  It has been shown that chilling of brood can lead to the 
emergence of individuals with wing deformities in both honey bees (Wang, et al., 2016) 
and in Apis cerana cerana (Zhou, et al., 2011).  It is possible, that despite efforts to keep 
pupae warm during collection and injections, that the slight cooling that occurs whilst 
handling the white eye pupae could lead to wing deformities.  It is therefore necessary to 
look for both deformed wings and a stunted abdomen when categorising an individual as 











Chapter 4. How does the spread of the Varroa mite alter the 
prevalence and population diversity of DWV-like viruses? 
 
 
4.1  Introduction 
 
 
RNA viruses characteristically exhibit high levels of genetic variation, a trait that is 
thought to enable them to respond to the changes in host immune defences as part of the 
host-pathogen coevolutionary ‘arms race’ (Obbard and Dudas, 2014).  The high mutation 
rates, rearrangement by genetic recombination, short replication times and high 
replication yields exhibited by RNA viruses result in them existing  as dynamic mutant 
‘swarms’, known as viral quasispecies (Domingo and Holland, 1997).  This genetic 
variation is created and maintained within infected cells (Del Portillo, et al., 2011; Leitch 
and McLauchlan, 2013) and organisms during viral infections and outbreaks (Domingo, 
et al., 2012; Gire, et al., 2014).  It has been proposed that existing as diverse quasispecies 
allows these pathogens to quickly overcome the challenges of a new environmental niche, 
such as the colonisation of a new host species, through the selection of the most fit 
distributions for the new environment (Domingo, et al., 2012) RNA viral populations have 
also been shown to persist as a number of related master variants, each with a ‘swarm’ of 
randomly generated mutants and it is this model that has been applied to explain the 
diversity seen in honey bee viruses such as DWV and IAPV (Palacios, et al., 2008; 
Mordecai, et al., 2016b). 
 
As described in Chapter 1 of this thesis, DWV is a single-stranded, positive-sense, picorna 
like virus which is very prevalent in honey bee colonies globally (Lanzi, et al., 2006).  
DWV is closely related to VDV-1 and KV (Fujiyuki, et al., 2004; Ongus, et al., 2004).  
The strains have been shown to recombine (Moore, et al., 2011), and are considered to 
form a viral quasispecies, or variants of the same species complex.  It has been suggested 
that it may be this genetic diversity which has allowed DWV-like viruses to capitalise on 
the global spread of the Varroa mite, transitioning from a comparatively benign, generally 
asymptomatic infection to a major honey bee pathogen.   This theory has been supported 
by recent research which shows a shift in the predominant strain of the virus when bees 
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have been exposed to Varroa parasitism, both on a broad landscape level upon the 
introduction of Varroa to Hawaii (Martin, et al., 2012) and at the level of individual honey 
bees (Ryabov, et al., 2014).   
 
Work published by our research group indicates that a virulent recombinant form of DWV 
is able to replicate to high levels when it is injected directly into honey bee haemolymph, 
either by Varroa feeding or by experimental injection.  It is this recombinant strain of the 
disease (with VDV-like capsid sequences and DWV-like non-structural regions) which 
was found to be present as a near clonal population in bees with high virus levels, both 
Varroa exposed pupae and symptomatic adults.  In contrast, Varroa naïve, low virus 
individuals were found to have a very diverse population of DWV-like viruses (Ryabov, 
et al., 2014).   
 
This narrowing in viral diversity in bees parasitized by Varroa mites was effectively 
shown on a larger scale by Martin et al. (2012) in their work with Hawaiian honey bees.  
The introduction of the mite to the islands significantly increased the prevalence of DWV, 
and this increase in viral prevalence was accompanied by a severe reduction in the 
diversity of DWV-like viruses, leading to a single predominant viral strain.  Although the 
techniques used in the Hawaii study did not allow the identification of the strain that was 
able to capitalise on the introduction of Varroa, this work along with the study conducted 
on our Warwickshire bees (Ryabov, et al., 2014) has triggered a lot of interest in the honey 
bee research community in how the spread of the Varroa mite alters the prevalence and 
population diversity of DWV-like viruses (McMahon, et al., 2016; Mordecai, et al., 
2016a; Mordecai, et al., 2016b; Brettell, et al., 2017). 
 
Subsequent published work has established that Varroa mites do have an impact on the 
strains and diversity of DWV-like viruses within a honey bee colony, but there is not yet 
an agreement on the identity of a single ‘virulent strain’ or ‘master variant’ of DWV 
(Table 4.1).  This suggests that the picture is more complex, and a number of hypotheses 
have been proposed to explain the results found by different research groups. 
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In their work looking at the DWV population in an apiary of isolated honey bees near 
Swindon, Wiltshire UK that appear to be able to tolerate high Varroa loads without colony 
losses (Mordecai, et al., 2016a) found that DWV-like viruses were present at high levels 
but did not appear to cause any of the ill effects usually associated with Varroa transmitted 
DWV.  They reported that this particular apiary was dominated by VDV-like viruses 
(termed DWV type B by the paper) and that DWV-like or recombinant strains were 
absent.  It was suggested that a phenomenon called superinfection-exclusion, in which a 
pre-existing viral infection is able to prevent a closely related virus forming a secondary 
infection (Folimonova, 2012), may explain how bees in this apiary are able to survive.  
This would mean that VDV (or DWV type B) is an avirulent strain of the virus and that 
bees infected with this strain are protected from the more harmful of virulent forms of the 
virus (DWV-like strains/DWV type A).  Mordecai, et al., (2016b) have also identified 
another ‘master variant’ of DWV, through Illumina sequencing and phylogenetic analysis 
of honey bee samples from an apiary in Devon, UK, and have named this variant DWV 
type C.  The two colonies sampled for this paper contained a mixture of DWV type A 
(DWV-like) and type C, with very low levels of DWV type B (or VDV-1), while one of 
the colonies – which subsequently died out over winter – contained a higher proportion 
of DWV type C.  Mordecai et al. (2016b) concluded that this could indicate that DWV 
type C is a virulent variant, and that the low levels of VDV-1 in the colonies mean that 
they are not benefiting from the protection of superinfection exclusion observed in other 
bees from the same study.  The authors do allow that direct manipulation experiments, 
such as those conducted by (Ryabov, et al., 2014) would be needed to determine whether 
the DWV type C strain is particularly virulent. 
 
A follow up study to the Martin et al. (2012) study  in Hawaii described above (Brettell, 
et al., 2017) used next generation sequencing to compare the DWV genomes in six 
Hawaiian samples (three colonies, each containing a single deformed bee and 30 
asymptomatic bees) in an attempt to determine which variant is responsible for wing 
deformities in infected bees.  DWV-like (type A) viruses dominated in all samples, with 
one exception – a mixed virus population found in asymptomatic bees from one colony 
with a slight leaning towards VDV-like viruses (DWV type B).  DWV-type C was only 
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found in one asymptomatic sample, alongside DWV type A.  The paper concludes that is 
no single DWV strain associated with wing deformity; but that many variants have the 
potential to cause symptoms in honey bees.  
 
The results reported in another recent UK study (McMahon, et al., 2016) appear to 
contradict the conclusions drawn by Mordecai et al.  (2016 b). This work involved the 
experimental injection of DWV-like virus extracts into adult honey bees and to observe 
the impact on mortality.  The field-derived virus strains used for inoculation were 
categorised as either DWV-like (Type A) or VDV-like (Type B) or an experimentally 
created mixture of the two (A and B).  Illumina sequencing was used to ascertain the 
predominant viral sequence in the inocula.  Injection with all strains of the virus 
significantly reduced honey bee lifespan in comparison with the control group, and bees 
exposed to VDV-like viruses (type B) or a mixed injection had their median survival rates 
reduced still further than those injected with DWV (type A).  Analysis of the sampled 
bees also found extensive evidence for recombination between DWV and VDV-1 (types 
A and B), but no evidence of DWV type C (the strain that was suggested to be virulent by 
Mordecai et al. (2016 b)).  McMahon et al. (2016) went on to analyse samples from a 
field survey of honey bee foragers at 25 sites across the UK.  They found no significant 
difference between the prevalence of DWV and VDV-1, but some differences in the 
spatial distribution of the two, with DWV being more uniformly spread across the UK 
and VDV more commonly found in samples from the South East of the country.  It was 
also found that the percentage of sampled bees infected with both DWV and VDV-1 was 
greater than would be predicted by chance. 
 
The fact that these studies have reached different conclusions is an indication that we 
don’t yet fully understand how and why the introduction of Varroa mites has transformed 
the population of DWV-like viruses within honey bee colonies.  Some of the 
inconsistencies may be explained by differences in methodology – experimental 
manipulation vs environmental sampling, pooled samples vs individual honey bees, 
sampling at different life stages (pupae vs newly emerged adults vs foragers) or 
geographic location see table 4.1.  It is also difficult to draw firm conclusions from small 
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sample sizes and single apiary experiments, but the current cost of NGS is prohibitive so 







Table 4.1 Summary of current research into DWV/VDV-1 virulent strains. 















































A change is viral 
diversity is shown, but 
no claim as to the 
dominant strain before 
or after Varroa 
infestation. 
















Suggest that VDV-1 is 
avirulent and forms a 
protective infection. 































The one firm conclusion that we can draw is that further research is required to reveal 
how the interaction between honey bees, Varroa and DWV is changing the viral 
landscape.  It seems likely that there is a certain element of the viral genome that confers 
a selective advantage when the disease is transmitted by Varroa, as this would create a 
strong selection pressure leading to the large shifts in predominant viral stain that have 
repeatedly been observed upon the introduction of Varroa mites - either to a Varroa naïve 
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area or individual bee.  However, as until very recently a reverse genetic system for DWV 
had proved elusive, researchers have been working with DWV preparations extracted 
from environmental samples (see table 4.1).  These virus preps can be sequenced and 
categorized as DWV-like or VDV-like, but there has been no way to create a ‘pure’ 
preparation of a single strain, and no way to manipulate and combine viral coding regions 
to test their effect on the virulence of the virus.  An infectious clone of DWV has just been 
published (Lamp, et al., 2016) and it is hoped that this will allow accurate, repeatable 
manipulation of the virus, shedding light on any elements of the DWV genome that confer 
virulence to the virus when it is injected into the honey bee hemolymph. 
 
However, there is clearly still much to be gained by informed collection and analysis of 
environmental honey bee samples.  The inconsistencies in the currently published work 
are intriguing and, undoubtedly, further analysis of how the DWV-like virus population 
is influenced by Varroa transmission will help to clear up and explain these contradictions 
and inform future molecular investigation of the viral genome.   
 
In this chapter I describe the impact of Varroa parasitisation on the population of DWV-
like viruses, both in a single apiary in Warwickshire, and on a larger scale, in an area at 
the forefront of Varroa expansion in the UK.  The aim of this work is to track any changes 
in the level of DWV, and in the most prevalent strain of the virus, as the Varroa mites 
become established in the area. 
 
A collaboration with Science and Advice for Scottish Agriculture (SASA) and beekeepers 
from the Ardnamurchan Peninsula, an area at the active infestation expansion front for 
Varroa in the UK has allowed a longitudinal study of the DWV-like viruses present in 
apiaries in the area.  Ardnamurchan is a 50-square-mile peninsula in the area of Lochaber, 
in the Western Highlands of Scotland.  It is noted for its remoteness, with the only access 
to most of the peninsula being one single track road.   There is no beekeeping on the 
majority of the peninsula but there are some apiaries closer to the hamlets of Acharacle 
and Strontian, on the eastern or mainland end of the headland.  Varroa mites were first 
found in the UK on 4th April 1992 in Devon, and spread fairly quickly from the south 
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coast throughout England and Wales as the high density of apiaries made it very difficult 
to prevent phoretic mites being carried between colonies.  Varroa mites were first reported 
in Southern Scotland in the mid 2000’s (Grey, et al., 2008) but the spread of the parasite 
throughout the remote and sparsely populated North and West of the country has been 
slow, as is shown by the map published by SASA in 2012 following a national survey 
(Figure 4.1).  The first Varroa mites were reported in Ardnamurchan in 2013 (Fiona 
Highet (SASA) and Kate Atchley (local beekeeper), personal correspondence).  The 
spread of the mites since that point has been very slow due to beekeepers treating 
intensively and selling or removing affected colonies, so there are still some apiaries in 
the area that appear to be Varroa free.  For the research presented in this thesis,  samples 
of honey bee brood collected from a number of apiaries in the area at the end of the 2014, 
2015 and 2016 beekeeping seasons have been examined using strain specific qPCR 
quantification of the levels of DWV-like and VDV-like capsid and polymerase sequences 
in individual honey bee pupae.  This allowed us to build up a picture of the levels of DWV 




Figure 4.1 This map shows the areas of reported presence and assumed absence of Varroa destructor in 
Scottish honeybees in 2012.  The map has been adapted from (Sunderland, et al., 2013).  The Ardnamurchan 
Peninsula is circled in red, and had no reported incidence of Varroa mites in 2012. 
 
 
I also conducted a year long study in a local apiary (maintained on the University of 
Warwick campus (Gibbet Hill), Coventry UK), sampling regularly in order to quantify 
whether the level and strain of DWV-like viruses changed within a colony if the Varroa 
mite population was allowed to grow unchecked.  This is of interest because many 
beekeepers do not treat their colonies for Varroa until the end of the beekeeping season, 
when the Varroa levels are regularly very high, meaning that winter bees are often 
infected with high levels of DWV (Martin, 2001; Martin, et al., 2010; Locke, et al., 2017).  
If a virulent strain of DWV has accumulated within the colony during the season, late 
treatment for Varroa would mean that the overwintering bees would be infected with this 
more harmful strain, with the possible consequence of shortening their lifespans and 
therefore making overwinter colony loss more likely.  If the colony is strong enough to 




by these overwinter bees is likely to be passed to the new brood and therefore persist 
within the colony.   
 
Throughout the 2015 season two adjacent colonies in the Gibbet Hill apiary were managed 
to give very different Varroa populations – with one (‘White’ Colony) being intensively 
treated with vaporised oxalic acid and thymol to keep mite numbers low, and the other 
(‘Blue’ colony) was untreated, allowing mites to accumulate to high levels.  Samples of 
adult bees and brood were taken throughout the season and Varroa levels were closely 
monitored. 
 
The aim of this chapter was to reveal more about how transmission of DWV by Varroa 
impacts the mixture of DWV-like strains present within honey bees, both in Varroa naïve 






















4.2.1 Analysis of predominant strain of DWV in the Ardnamurchan Peninsula, an 
area at the forefront of Varroa expansion in the UK. 
 
4.2.1.1 Ardnamurchan Peninsula Sampling 
 
Brood samples were collected in mid-September by Fiona Highet (SASA) and the 
collaborating beekeepers.  They were collected as excised sections of capped brood, flash 
frozen and then stored at -80°C until processing.  Individual pupae were removed from 
the comb whilst still frozen on dry ice and each cell was thoroughly checked for Varroa 
mites.  RNA extraction and clean up was carried out according to the methods in Chapter 
2 of this thesis (Section 2.6).   
 
4.2.1.2 Ardnamurchan Peninsula – Analysis of DWV levels and predominant strain.   
 
Total RNA was analysed for 8 individual pupae, per colony, per year.  Levels of DWV 
and predominant strains were identified using qPCR (as in Chapter 2, Section 2.6.2).  
Results were confirmed using nested PCR detection of DWV, VDV1 and their 
recombinants (as in Chapter 2, Section 2.6.1) and cloning and sequencing of the PCR 
products.  Two colonies were selected for this confirmation cloning, Baker2-2015 
(Varroa free) and SB2-2015 (High Varroa). 27 clones from each colony were sequenced 
(9 clones from each of three individual pupae), and the sequences were assessed as being 
either DWV-like, VDV-like or recombinants by BLAST search results and Clustal 
alignment (Altschul, et al., 1990; Thompson, et al., 1997; Goujon, et al., 2010).   
 
Samples were also analysed using a ‘High Resolution Melt’ (HRM) technique, as 
described in (Martin, et al., 2012) and in (Mordecai, et al., 2016a).  High resolution melt 
analysis is a novel, post-PCR analysis technique, allowing the identification of variation 
in nucleic acid amplicons.  It relies on the detection of small differences in PCR melting 
curves, generated by differences in the length, GC content and heterozygosity of the 
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amplicons (Cousins, et al., 2012).   Unfortunately, the HRM assay did not distinguish 
between the strains of virus present in the samples.  This is regrettable, as HRM analysis 
would have provided an excellent visual representation and numerical quantification of 
the diversity of DWV-like viruses in the samples (as in Martin et al. (2012) supplementary 
information 
http://science.sciencemag.org/content/sci/suppl/2012/06/07/336.6086.1304.DC1/Martin.
SM.pdf ).  However, our qPCR assay has been shown to reliably identify the predominant 
viral strain in a sample, giving the same outcome as Illumina sequencing and Sanger 
sequencing of cloned amplicons in our work published in (Ryabov, et al., 2014).  Further 
analysis of the HRM assay and strain specific qPCR results is provided in the discussion 










Table 4.2 Details of samples collected from the Ardnamurchan Peninsula 2014 to 2016.  Samples shaded in red were 
known to have Varroa mites in the colony at the time of sampling. Those in grey were thought to be Varroa free, having 















4.2.2 Single Apiary Experiment, analysis of the change in predominant strain of 
DWV in a single colony as Varroa infestation takes hold 
 
4.2.2.1 Single Apiary Experiment -  Beekeeping and Sampling 
 
Two colonies were selected from a single apiary - located on the University of Warwick 
campus – in the spring of 2015.  Both colonies had been created from a split of a single, 
strong colony during the summer of 2014 and had been treated to reduce Varroa numbers 
using Apiguard (thymol, Vita Bee Health, UK) in September 2014, according to 
manufacturer’s instructions. 
 
Samples of adult bees and of capped pupae were taken at the start of the 2015 season 
(20/4/2015) and then one colony (hereafter named ‘Treated’ or T) was treated with 
vaporised oxalic acid (Api-Bioxal) (using a Sublimox vapouriser, Icko Apiculture, Italy. 
Details of treatment outlined here https://theapiarist.org/sublimox/) to remove phoretic 
Varroa mites (Maggi, et al., 2017; Papezikova, et al., 2017). Treatments took place on 
the 20th, 25th and 30th April 2015 and then again on 1st, 5th and 10th June. The oxalic acid 
does not remove any mites within capped cells so 3 repeat treatments were carried out 
each time to kill any recently emerged Varroa.  At the end of the season Apiguard was 
applied to the T colony.  The other colony (hereafter named ‘Untreated’ or U) did not 
receive any Varroa treatments in the 2015 season. 
 
Samples of adult bees were taken monthly during the early summer (April, May, June) 
and then every two weeks throughout July to November as the Varroa numbers began to 
increase in colony U.  At each sampling point, a three day Varroa drop was collected and 
counted, and this figure was used to calculate the Varroa load for each colony.  Varroa 
load was calculated using the Natural Mite Mortality method outlined by The National 




Samples were stored at -80 °C until processing. RNA was extracted and cleaned up 
according to the methods in Chapter 2 (2.5) of this thesis.  
 
4.2.2.2 Single Apiary Experiment -  Analysis of DWV levels and predominant strain.   
 
Total RNA was analysed for 10 adult bees per sampling point.  Levels of DWV and 
predominant strains were identified using qPCR (as in Chapter 2, Section 2.7.2).  Results 
were confirmed using nested PCR detection of DWV, VDV1 and their recombinants (as 


























4.3.1. Analysis of predominant strain of DWV in the Ardnamurchan Peninsula, an 
area at the forefront of Varroa expansion in the UK 
 
4.3.1.1. DWV levels and strain in sampled bees 
 
Samples were categorised according to a). year of sample collection (figure 4.3 A) or b). 
number of years of known Varroa infestation for the sampled apiary, with the year of 
collection being disregarded (figure 4.3 B).  Total DWV copy number was determined for 
each sampled individual using qPCR.  This allowed us to build an accurate picture of the 




Figure 4.3. A DWV copy number per bee pupae, as measured by qPCR, from individual bees samples at different apiary 
sites in the Ardnamurchan Peninsula during the natural colonisation of Varroa mites along the Peninsula from 2014 
to 2016. Samples were categorised according to whether they came from apiaries with or without Varroa. Apiaries with 
Varroa were further categorised according to the number of years since the infestation first occurred.  Hashed bars 










































































































































































There was no statistically significant difference in DWV copy number/pupae for samples 
collected in 2014, 2015 and 2016, as determined by one-way ANOVA (F(2,161) = 0.855, 
p=0.427).  We had hypothesised that DWV levels would increase in the sampling period, 
as Varroa mites became more established in the Ardnamurchan Peninsula (as was 
observed in Hawaii after the introduction of Varroa (Martin, et al., 2012)), however this 
was not the case.  
 
The detailed information provided by the Ardnamurchan beekeepers on the presence or 
absence of Varroa in each sampled apiary allows us to also look at DWV levels as a 
product of the number of years for which Varroa have been present in the apiary, rather 
than solely separating samples by the year in which they were collected.  Hence we can 
categorise samples as being ‘Varroa Free’, ‘1st Year of Varroa Infestation’, ‘2nd Year of 
Varroa Infestation’ or ‘3rd Year of Varroa Infestation’ (Figure 4.3, B). There was a 
statistically significant difference in DWV copy number/pupae for samples collected in 
the 1st, 2nd and 3rd year of Varroa infestation and samples from Varroa free apiaries, as 
determined by one-way ANOVA (F (3,190) = 2.686, p=0.048).  Post hoc analysis (Tukey 
HSD) reveals that samples from year of Varroa infestation 3 have a significantly different 
load of DWV virus, when compared to the samples from Varroa naïve apiaries, or from 










Figure 4.4 Strain specific qPCR results for sampled colonies in 2014, 2015 and 2016.  Results displayed as mean delta Ct scores, normalised to honey bee actin 
levels per sample.  For each sampling year, results are separated to show relative levels of DWV-like (pale grey) and VDV-like (dark grey) capsid/structural 
sequences, and non structural sequences.  Colonies sampled each year are arranged from left to right along the x axis according to the length of time that they 
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Figure 4.5 DWV and VDV-like capsid (A) and non-structural (B) sequences, mean delta Ct scores for 
number of years of known Varroa infestation for the sampled apiary 
 
 
Strain specific qPCR can be used to identify relative levels of DWV-like and VDV-like 
capsid (structural) and polymerase-coding regions (non-structural).  This method does not 
give exact quantification of the strains present in a sample – but it does give an excellent 
































Levels of DWV-like or VDV-like capsid and polymerase sequences were determined for 
8 pupae per colony, sampled in the September of 3 sequential years (2014 to 2016) (Fig 
4.4).  In 2014 all of the colonies sampled from the Ardnamurchan area appear to have a 
similar, low level virus infection, with predominantly VDV-like capsid coding regions 
and DWV-like polymerase coding regions.  The colonies sampled in 2014 were either 
Varroa free (B3, B4, B1, K2) or had been exposed to Varroa parasitism for 2 years (M1, 
M2, SB1, SB2), however, Varroa numbers were very low as the beekeepers had been 
treating intensively to prevent the mites becoming established in the area.  The picture is 
different by September 2015, with one of the colonies sampled (SB2) having notably 
higher Varroa levels (personal correspondence, Fiona Highet SASA and Kate Atchley 
(local beekeeper), having been infested with the mites for 3 seasons.  All other apiaries 
sampled continued to have predominantly VDV-like capsid coding regions and DWV-
like polymerase coding regions, but samples from SB2 had significantly higher levels of 
DWV-like polymerase sequences, a notable shift from the same apiary in the previous 
year (t(15)=2.455, p=0.22) and from the other Ardnamurchan apiaries in 2015 
(t(55)=7.874, p<0.001).  In the non-structural coding region, the picture for the colony 
SB2 was also notably different to the other sampled colonies, with a greater difference 
between the levels of DWV-like and VDV-like polymerase coding regions in samples 
from SB2, indicating an increase in the levels of DWV-like non-coding regions of the 
virus.  The heavily infected colony SB2 was then lost during the winter of 2015/16.  In 
2016 we again see fairly uniform levels of DWV-like and VDV-like viruses in all apiaries, 
with the exception of D2, where Varroa had been present for 3 years and were becoming 
established.  Again, there appears to be a shift in the predominant capsid coding region 
present in the apiary, with more DWV-like than VDV-like sequences present. There also 
appears to be an increase in the DWV-like polymerase coding regions.  This pattern is 
similar to that observed in the most heavily Varroa infected colony from the previous 
year. 
 
The picture is clearer when we look at the mean delta ct results for the Ardnamurchan 
samples as a product of the number of years for which Varroa have been present in the 
apiary, rather than solely separating samples by the year in which they were collected (Fig 
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4.5).  In Varroa free apiaries, and those in their 1st and second years of infestation VDV-
like capsid sequences dominate – in Varroa free apiaries VDV-like capsid sequences are 
significantly higher than DWV-like ones (t(96)=12.244, p<0.001), and the same is true in 
apiaries in which Varroa have been reported for one season (t(43)=9.485, p<0.001), and 
two seasons (t(102)=9.418, p<0.001).  In apiaries for which Varroa have been present for 
three seasons the opposite is true, with DWV-like capsid sequences dominating 
(t(40)=4.557, p<0.001).  For the non-structural coding region DWV-like and VDV-like 
strains are present at very similar levels in Varroa free, year one and year two apiaries, 
but in apiaries where Varroa have been present for 3 years DWV-like sequences dominate 
(t(42)=7.929, p<0.001).   
 
4.3.1.1.2. Sequencing of cloned PCR fragments from DWV central region, validation 
of qPCR  
 
Nested PCR of the central region of DWV was conducted for samples from 
Ardnamurchan from 2015 to allow validation of the strain specific qPCR results.  Two 
colonies were selected for this procedure – Baker2 (Varroa free) and SB1 (Varroa 
positive), with 9 clones being sequenced from 3 pupae from each colony.  The FASTA 
sequences are included in the appendix (Appendix 2).  The numbers and proportions of 
DWV-like, VDV-like and VDV/DWV-like recombinant clones from each colony are 





Figure 4.6 Proportions of DWV-like, VDV-like and VDV/DVW-like sequences from a nested PCR of the 
central region of the virus.  Two colonies were selected for this confirmation cloning, Baker2-2015 
(Varroa free) and SB2-2015 (High Varroa). 27 clones from each colony were sequenced (9 clones from 
each of three individual pupae), and the sequences were assessed as being either DWV-like, VDV-like or 
recombinants by BLAST search results and CLUSTAL alignment. 
 
 
The cloned and sequenced PCR products show a similar picture to the qPCR results.  
Sequencing of the central region of the virus - through regions corresponding to positions 
4926 to 6255 of the DWV genome (GenBank Accession Number AJ489744), where 
recombination has been shown to occur (Ryabov, et al., 2014) - allows us to build up a 
picture of the strains of the virus that are most prevalent within a colony.  In the Varroa 
free colony (Baker2), there is an even split between VDV-like viruses and recombinant 
strains, with VDV-like structural regions and DWV-like non-structural regions.  In the 
Varroa infected colony, SB2, the picture is different, with the majority of amplified, 
cloned viral sequences being DWV-like and a smaller proportion of recombinant strains.  
The fact that the sequenced clones from these two colonies show a similar distribution of 
viral strains to those predicted by the strain specific qPCR assay validates the results of 
the qPCR assay, giving further evidence for a shift in the predominant DWV-like viral 
strain as Varroa become established in a colony.  
 
 
















Previous studies have identified a narrowing in the diversity of DWV-like viruses that 
accompanies this shift in the predominant viral stain (Martin, et al., 2012; Ryabov, et al., 
2014).  To achieve an accurate picture of the diversity of viruses within an individual or 
population deeper, next generation sequencing (NGS) is necessary. The techniques I have 
used in this work allow us to confidently analyse the proportions of the main viral strains 
at certain known points in the viral genome (qPCR), or to take a snapshot of the viruses 
present within a sample, working on the assumption that the most prevalent viral strains 
will be the most commonly represented in the amplified, cloned and sequenced PCR 
products.  Alignment of the thousands of sequence fragments generated by Illumina NGS 
to reference sequences is the most commonly used technique to allow a confident 
assessment of viral diversity in a sample, but unfortunately this process is expensive and 
therefore remains beyond the scope of this PhD project.  Some research groups have used 
a ‘high resolution melt’ technique to visualise and quantify the diversity of DWV like 
viruses in samples (Martin, et al., 2012; Mordecai, et al., 2016a), however neither the 
published protocol or one conducted with modified primers was able to reliably detect 
any change in viral diversity in the samples from Ardnamurchan.  Results of work done 




4.3.2 Single Apiary Experiment, analysis of the change in predominant strain of 
DWV in a single colony as Varroa infestation takes hold  
 
The sampling of the two experimental colonies maintained at the University of Warwick 
revealed significantly different trends in Varroa mite population levels, as shown in figure 




Figure 4.7 Varroa mite numbers in the two experimental colonies for the sampling season 2015.  Mite 
numbers were calculated using Natural Mite Mortality method outlined by The National Bee Unit. Figure 
A shows the mean daily mite drop numbers for each sampling period.  Figure B shows the calculated 
estimate for the total mites per colony at each sampling point. 
 
The levels of Varroa remain low in both colonies throughout the spring and early summer, 
with the mite drops consistently staying at fewer than 10 mites per day in the April to July 
sampling periods.  From August onwards, the Varroa numbers in the untreated (U) colony 
begin to rise dramatically, whilst in the treated (T) colony they remain at fewer than 10 
mites/day.  This is reflected in the calculated estimates for numbers of mites per colony, 














































were estimated to be 460 total mites in mid-August, raising rapidly to 4967 by late 
September and up to 7300 by the final sampling point in November. 
 
Samples of bees were collected throughout the season, with the aim of revealing how this 
unchecked Varroa infestation in U altered the level and population of DWV within the 
colony.  For clarity, we will compare the DWV levels and predominant strains from bees 
collected at the start (20.4.15 – hereafter ‘early’) and end (5.11.15 – hereafter ‘late’) of 




Figure 4.8 DWV levels in adult honey bees from both experimental colonies at the start and end of the 
sampling season. A. Log10 DWV genome equivalents per individual, B, Mean DWV genome equivalents 
per sampling group.  As hypothesised, the levels of DWV increase dramatically in the U colony whilst 



























































































As found by other research groups (Martin, et al., 2010; Francis, et al., 2013; Locke, et 
al., 2017), the unchecked expansion in the Varroa population within a honey bee colony 
was reflected in the levels of DWV infection in the adult foraging bees.  The untreated 
(U) colony in this study showed a 30 fold increase in the mean DWV genome number per 
adult sampled from the start to the end of the season, whereas the DWV levels in the 
treated (T) colony remained unchanged (Figure 4.8).   
 
When the mean DWV levels are plotted for all of the sampling points across the season 
(Figure 4.9 B), it appears that the increase in mean DWV level in adult bees follows a 
similar pattern to that observed in the estimated Varroa infestation numbers.  The large 
increase in the estimated Varroa population in colony U in mid September (sampling 
point 21.9.15) was followed by a corresponding increase in the mean DWV level per adult 




Figure 4.9 A Mean DWV genome equivalents per adult honey bee throughout the sampling season. DWV copy number 
per adult honey bee remains relatively low (at sub clinical levels (Locke, et al., 2017) in both colonies until September, 
where the levels in the U colony increase dramatically, whilst the levels in the T colony remain low. Genome equivalents 
shown using a Log10 scale. B. DWV copy number shown on the left axis without the Log10 conversion, Varroa 
population on the right axis.   The large jump in Varroa population in mid-September is followed by a corresponding 













































































The trends in Varroa population and DWV levels within the experimental colonies 
followed those described in the literature (Martin, et al., 2010; Francis, et al., 2013; Locke, 
et al., 2017), although there were two individuals with ‘high’ DWV levels in the first 
sample collected from the U colony (figure 4.8 A).  These individuals may have been 
overwintered workers, resuming foraging duties following the renewal of brood rearing 
in the late winter/early spring ((Seeley and Visscher, 1985; Döke, et al., 2015).  The fact 
that 20% of adult workers have high levels of DWV so early in the season may indicate 
that the colony suffered from a heavy Varroa infestation and corresponding high viral 
load in the season before the experiment (Locke, et al., 2017). 
 
Having established that that the lack of Varroa control treatments in colony U lead to a 
sharp rise in the DWV levels within the colony, it was then possible to test the 
predominant viral stain within the colony at the beginning and end of the experiment.  
This was intended to provide more information on whether high levels of Varroa mediated 














Figure 4.10  Strain specific qPCR results for early (hashed bars) and late (black bars) season samples from 
colony U (A) and colony T (B).  Universal Polymerase primers (UniPol) detect the same dramatic increase 
in DWV levels shown in figures 4.8 and 4.9.  Strain specific primers show that there was a corresponding 
increase in VDV type capsid sequences (VDV Cp), and in VDV and DWV type polymerase sequences (VDV 





Figure 4.10 (A) shows the results of the strain specific qPCR on early season and late 
season honey bees from colony U.  The DWV virus present at low levels at the start of 
the season had predominantly VDV like capsid sequences and VDV like or DWV like 
polymerase sequences.  The samples collected at the end of the season had higher levels 
of virus, but the proportions of DVW and VDV like sequences remained the same.  This 
would indicate that, whilst Varroa infestation had a large effect on the levels of DWV, it 
did not significantly alter the mixture of strains of virus within this colony.  In the treated 
colony (T) the pattern was very similar to the one shown in the untreated bees (Figure 
4.10 B), qPCR revealed the mix of DWV-like and VDV-like capsid and polymerase 
sequences to be the very similar to those found in the untreated colony at both the start 























4.4.1. Analysis of predominant strain of DWV in the Ardnamurchan Peninsula, an 
area at the forefront of Varroa expansion in the UK 
 
The analysis of the honey bee pupae samples collected from the isolated Peninsula of 
Ardnamurchan over a three-year period gives a valuable insight into how the introduction 
of Varroa changes the virus population within an area.  DWV levels remained low 
throughout the sampling period, a testament to the success of the Ardnamurchan 
beekeepers intensive Varroa monitoring and treatment regime.  However, in spite of this 
intensive work, the mites were able to become more established in two of the experimental 
apiaries (in each case in the third year of their presence) and in bees from these colonies 
we saw a marked alteration in the predominant strain of DWV.  In the Ardnamurchan 
samples we observed a shift from a mixed population of VDV-like and recombinant (with 
VDV-like structural regions and DWV-like capsid sequences) viruses in the Varroa free 
and ‘early stage’ Varroa exposed colonies, towards a predominantly DWV-like virus 
population in the colonies with a more established Varroa infestation.   
 
Our previous work (Ryabov, et al., 2014) describes a shift in the predominate DWV strain, 
alongside a narrowing in the viral diversity when Varroa naïve bees are introduced to an 
infested, high DWV colony.  In the 2014 experiment, Scottish bees (in this case from 
Colonsay rather than Ardnamurchan, but shown to have a similar low level, mixed DWV 
infection) were introduced to a Warwickshire colony with an established Varroa 
infestation.  The individuals exposed to the Warwickshire Varroa mostly went on to show 
high levels of a recombinant strain of DWV/VDV, a strain which dominates the local 
area, and we concluded that this strain has a selective advantage when transmitted by 
Varroa.  However, in the Ardnamurchan samples the full length DWV-like viruses 
dominate within colonies where virus transmission has become predominately Varroa 
mediated, as opposed to the oral and vertical transmission that maintains the low level 




The shift from the mixed virus population to a principally DWV-like population upon the 
introduction of Varroa to Ardnamurchan mirrors that reported in Hawaii (Martin, et al., 
2012; Brettell, et al., 2017).  The experiment described in this chapter emulates the Hawaii 
study in that it looks at changes in the DWV like viruses in the first few years after Varroa 
introduction.  In both experiments DWV-like viruses dominate within a few years, even 
though in Hawaii very little Varroa control was attempted in the sampled colonies 
(resulting in a rapid increase in DWV titres within the honey bee population) and in 
Ardnamurchan DWV levels remained low due to intensive Varroa control.   
 
I believe that there are two potential explanations for the results of this Ardnamurchan 
study when considered alongside the mixed conclusions drawn within the published 
literature with regard to virulent or avirulent strains of DWV.  Firstly, it is possible that, 
instead of a single virulent strain of the virus having a selective advantage when 
transmitted by Varroa (i.e. either a full length DWV like sequence, or a specific 
DWV/VDV recombinant) there is a more specific, shorter, section of the viral genome 
that confers this selective advantage.  This crucial genetic element could be contained 
within DWV-like, VDV-like and recombinant strains of the virus, and be present at low 
levels in the mixed population due to recombination and natural variation.  The strain 
which goes on to dominate following Varroa introduction is dependent on the strains 
present within the bees prior to the arrival of the mite, or alternatively, the strains carried 
by Varroa into an area.  Alternatively, it could be that DWV-like strains dominate within 
colonies where Varroa have recently become established (as in Ardnamurchan and 
Hawaii) but that this is not a final, stable, population and sampling in subsequent years 
could reveal different ‘dominant’ strains. 
 
To test these theories, it will be necessary to sequence the dominant strain of DWV in all 
the areas where Varroa mites have become established.  Alignment of these global full 
length DWV sequences would allow identification of any conserved elements of the 
genome, potential candidates for conferring this selective advantage.  A reverse genetic 
system, which is now possible following the identification and publication of an infectious 
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full length DWV clone (Lamp, et al., 2016), would allow testing of viral clones containing 
these candidate sequences.  Identification of the virulent strains of DWV, or of the element 
of the DWV genome that confers a selective advantage during Varroa transmission, 
would shed more light on why the DWV/Varroa combination has proved so deleterious 
to honey bee health worldwide.  It may also provide potential targets for developing anti-
viral treatments. 
 
4.4.2 Single Apiary Experiment, analysis of the change in predominant strain of 
DWV in a single colony as Varroa infestation takes hold 
 
Whilst the unchecked expansion of the Varroa population lead to a dramatic increase in 
the DWV levels within the experimental colony, the comparative ratios of DWV-like viral 
strains present did not appear to change.   
 
Previous studies have established that the most prevalent strain of DWV-like within 
Varroa exposed bees in our experimental apiaries in Warwickshire is a VDV/DWV 
recombinant (Moore, et al., 2011; Ryabov, et al., 2014).  Our qPCR results for the bees 
sampled throughout the 2015 season appear to show that this VDV/DWV recombinant 
strain predominates within the colony, both at the start and end of the season, irrespective 
of colony Varroa numbers and DWV titres within the sampled bees.  
 
 
The presence of ‘high’ DWV bees in the early season sample, in spite of the low Varroa 
numbers at that point in the season, is a strong indication that the overwinter bees had 
high levels of DWV as a result of Varroa infestation in the previous season (Locke, et al., 
2017).  This suggests that any alteration on the DWV population due to high Varroa load 
had already occurred within this colony, and the dominant strain persists overwinter, even 
after Varroa treatment has taken place.  The results of this experiment reveal that the 
strain of DWV present within a Varroa infested apiary remains stable throughout the 
season and, apparently, across a number of seasons.  Unfortunately, it was not possible to 
analyse samples from the same colony from subsequent seasons as the high viral load and 
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4.3.3 Techniques for determining DWV strain or diversity within honey bee samples 
 
The techniques used to give a picture of DWV strains within honey bee samples within 
this chapter – strain specific qPCR and central region cloning and sequencing - only give 
‘snapshots’ of the DWV-like viruses present rather than a complete picture of all of the 
DVW like viruses in a sample.  Next generation RNA-sequencing is required to reveal 
the full extent of all of the DWV RNA sequences present, and this technique has been 
used successfully by other papers in the literature (Ryabov, et al., 2014; Wood, et al., 
2014; Mordecai, et al., 2016a; Mordecai, et al., 2016b).  However, this technique is 
expensive and to analyse the many individual samples that have been collected and tested 
for the experiments outlined in this chapter was unfortunately not financially possible.   
 
The requirement for an affordable, reliable assay for DWV strain or diversity has been 
addressed by both our and other research groups, and two methods have been outlined in 
the published literature  (Martin, et al., 2012; Ryabov, et al., 2014; Kevill, et al., 2017) – 
these are the qPCR followed by validation through central region cloning methods 
outlined in this chapter and the high resolution melt technique (HRM) first used by Martin 
et al., (2012) in the Hawaii study.  I attempted to use the HRM technique using both the 
published oligos and alternative ones designed to anneal to the ‘local’ Warwickshire strain 
of DWV.  Unfortunately, I was unable to produce reliable results using the assay, possibly 
due to the very low levels of virus in the Ardnamurchan samples or due to the lack of 
genetic variability in the Warwickshire single apiary experiment. 
 
However, the strain specific qPCR assay used in this chapter has been shown to reliably 
reveal the proportions of DWV-like or VDV-like capsid sequences within a sample, with 
the qPCR results being validated by Illumina RNA-sequencing in the 2014 Ryabov et al. 
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paper.  A similar assay, although with an additional set of oligos to allow the 
quantification of three DWV variants, has been published by Kevill, et al. (2017), and 
again the results of the assay are validated by next-generation sequence data.  I feel that 
the methods outlined in this chapter represent a reliable, affordable way to analyse DWV 
genotype mixtures and predominant strains within honey bee samples. 
 
 129 
Chapter 5 - Varroa destructor, Deformed Wing Virus, and 





Overt DWV infections are characterized by visible disease symptoms (deformed wings, 
bloated and shortened abdomen, discolouring) and are associated within honeybee 
colonies with Varroa feeding, leading to elevated DWV levels within developing pupae. 
Laboratory infection assays have shown that symptomatic bees result from DWV 
injection in the absence of Varroa, suggesting that DWV is the causative agent of the 
deformed-wing syndrome (Moeckel, et al., 2011). 
 
The mechanism by which Varroa and DWV causes disease in individual bees is not well 
understood (de Miranda & Genersch, 2010). A priori, a “successful” infection involves 
failure of the bee immune system to prevent proliferation of the virus, alongside an effect 
of the virus and / or Varroa on the physical development of the bee pupa.  The transition 
from the bee pupa to the adult stage is a highly dynamic, genetically programmed process 
that entails remodelling of tissues and growth of new organs (Soares, et al., 2013; Belles 
and Santos, 2014; Vleurinck, et al., 2016).  It is possible that DWV infection of honeybee 
larvae, prepupae and pupae disturbs  development to the adult through effects on the 
expression of  genes associated with developmental processes.  This is known to happen 
in other systems: for example, infection with the baculovirus Lymantria dispar nuclear 
polyhedrosis virus affects the development of its insect hosts Lymantria dispar (the gypsy 
moth) and Spodoptera frugiperda (the fall armyworm) by altering the levels of 
ecdysteroid, the insect moulting hormone, in the haemolymph of infected individuals 
(Burand and Park, 1992; Park, et al., 1993; Park, et al., 1996).  Ecdysteroid is well studied 
as a moulting hormone in insects, and it has been established to play a critical role in the 




Exposure to pathogens, including DWV, has been shown to induce wide scale 
transcriptome changes in the host honeybee (Ryabov, et al., 2014; Doublet, et al., 2017), 
however the published works on this subject have produced conflicting results – for 
example Ryabov et al. (2014) reported that Varroa-exposed, DWV infected pupae had 
951 significantly differentially expressed (DE) genes (approximately 9% of the honeybee 
genome) when contrasted with control individuals.  Gene ontology analysis of these DE 
genes did not reveal any coordinated response to the pathogen load, with no significantly 
over represented gene ontology biological process terms.  This suggested that unchecked 
DWV replication lead to dysregulation of the usual transcriptional pattern within 
honeybee cells or mRNA stability, as has been previously reported in picornavirus 
infection of mammalian cells (Grinde, et al., 2007; Doukas and Sarnow, 2011; Rozovics, 
et al., 2012).  However, Doubet et al., (2017) performed a meta analysis of multiple 
transcriptome analysis experiments and revealed that the transcriptional response to 
Varroa/virus infection was characterised by the DE of genes from two immune pathways 
– Imd (iap2 and rel genes) and Toll pathways (tube and def-2 genes).  Notably, neither of 
the studies mentioned above have detected any DE of genes associated with honeybee 
development.  It is possible that fluctuations in the expression of developmental genes or 
hormonal receptors are occurring but not being detected due to the methodologies of the 
studies in the current literature.  Ecdysone receptors (Mello, et al., 2014) and homeobox 
developmental genes (Walldorf, et al., 2000a) have been shown to have transient 
expression in developing honeybees, tightly linked to developmental stage.  As a 
consequence of this, any experimental design involving pooled samples or only sampling 
at a single developmental stage or time point may not detect any perturbation to the 
expression pattern of developmental genes.   
 
 
The results of a recent microarray analysis of Varroa-parasitised bee pupae collected from 
a naturally infested colony maintained at Rothamsted Research UK may reveal more 
about how elevated DWV infection in honeybee pupae causes developmental 
abnormalities (D. Chandler, unpublished data).  Insect morphological development is 
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governed by a suite of evolutionarily conserved homeodomain proteins, transcription 
factors and co factors which regulate cell fate and cell type gene expression to determine 
insect segment morphology and system development. (Ladam and Sagerstrom, 2014; 
Walldorf, et al., 2000). The microarray data indicated that Varroa parasitism (and 
therefore viral load, as DWV infection was shown to be inextricably linked to Varroa 
parasitism in the sampled bees) had a strong effect on the expression of these homeobox 
genes, with 70% differentially expressed in response to Varroa mite burden.  This is a 
novel result, which has not been observed by other research groups; the work described 
in this thesis further explores this phenomena, revealing more about how universal and 
reliable this disturbance of developmental gene expression in response to DWV infection 
and Varroa feeding is in honeybee pupae. 
 
5.1.2 Insect developmental genes 
 
Holometabolous insects, such as honey bees, undergo complete metamorphosis during 
their development, transitioning through egg, larval, pupal and adult life stages (Truman 
and Riddiford, 2002; Kayukawa, et al., 2017).  This complex process is governed by a 
pattern of gene expression which has been most extensively studied in the model 
organism, Drosophila melanogaster (Arbeitman, et al., 2002).  The majority of published 
work focuses on D. melanogaster embryogenesis, with less focus on the pupal to adult 
metamorphosis that appears to be affected by DWV infection in honey bees.  
 
The major morphological transitions that occur during larval-to-adult insect 
metamorphosis are initiated by changes in the titre of the hormone 20-hydroxyecdysone 
(20-HE). This operates through an ecdysone receptor protein complex (ECR-C) formed 
with the ecdysone receptor (ECR) and its heterodimeric partner ultraspiracle (USP) 
(Barchuk, et al., 2008; Gauhar, et al., 2009).  The ECR-C modulates the expression of a 
group of 20-HE responding genes that encode transcription factors (Gauhar, et al., 2009) 
as well as controlling the length of the pupal development period (Barchuk, et al., 2008).  
Insect morphological development is also regulated by a suite of evolutionary conserved 
homeodomain proteins: these transcription factors, in combination with cofactors, 
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regulate cell fate and cell-type gene expression to determine insect segment morphology 
and the development of appendages, organs, the nervous system and the neuroendocrine 
systems (Hayashi and Scott, 1990; Ladam and Sagerstrom, 2014).  Most of the research 
on insect homeobox gene function has focused on embryonic development (mainly in 
Drosophila) (Deng, et al., 2012) but it has been shown recently that they also have critical 
developmental functions during larval-to-adult metamorphosis (Deng, et al., 2012).  The 
ecdysone and homeodomain protein signalling pathways co-regulate morphological 
development (Soares, et al., 2013), although the precise details of this interaction are not 
well understood. 
 
As mentioned above, insect homeobox (or Hox) gene functions have been studied most 
extensively in Drosophila; however honey bee homologs of known Drosophila 
homeobox-containing genes have been identified (Walldorf, et al., 1989; Zhong, et al., 
2008; Zhong and Holland, 2011) and their expression patterns described (Walldorf, et al., 
2000b).  Similarly, the role of juvenile hormone (JH) and the mechanism of action of 
ecdysteroids in insects were initially studied in D. melanogaster molting and 
metamorphosis (Belles and Santos, 2014).  These ecdysteroids have now been shown to 
be crucial in caste determination in eusocial insects, such as the  bumblebee Bombus 
terrestris (Geva, et al., 2005) and in the honey bee (Hartfelder and Engels, 1998), playing 
a role in the regulation of differential morphogenesis alongside JH (Mello, et al., 2014).   
 
In order to establish how these crucial developmental pathways are disturbed by Varroa 
feeding and DWV infection, a series of natural and experimental infection experiments 
were carried out.  The results reveal more about how DWV affects developing honey bee 
pupae, possibly pointing towards an explanation for the symptoms associated with DWV 
infection.  Interestingly, we also show unexpected between-colony variation in the 
developmental response to DWV, a result which may shed light on why previous studies 




The aim of this work was to test the hypothesis that DWV infection during crucial stages 
of honey bee pupation and metamorphosis causes disturbances to the expression of 
developmental gene pathways, including ecdysone receptor signalling and homeobox 
developmental genes, leading to the characteristic DWV symptoms.  This hypothesis is 
tested through comprehensive measuring of the expression of key developmental genes 
in honey bee pupae infected with DWV, both via Varroa feeding and experimental 


























5.2 Materials and Methods 
 
5.2.1 Analysis of developmental gene expression in naturally Varroa infested honey 
bee pupae 
 
To further explore the observational microarray profiling results described in the 
introduction to this chapter, a sample of honey bee pupae were collected from an 
independent apiary in a different part of the UK to establish if the disturbance to the Hox 
genes was detectable in an independent sample.   
 
Worker honey bee pupae were collected from a single, heavily Varroa-infested Apis 
mellifera colony (Colony ID FRANK79) from an apiary maintained by the National Bee 
Unit, the Animal and Plant Health Agency (APHA), Sand Hutton, York.   The colony was 
recorded as having a naturally mated queen, and was thought to represent a genetic 
mixture of European subspecies.  Pupae were removed from two frames of capped brood 
during a single day of sampling (1/9/2016).  The age of each pupa was determined using 
the standardised larval and pupal ageing chart (Methods Chapter, Figure 2.4) and the 
number of adult and juvenile Varroa mites in the cell with each pupae was also recorded.  
The bees were then flash frozen in liquid nitrogen prior to storage at minus 80 °C.  A total 
of 150 individual pupae were collected and categorized, the age and Varroa load 
distribution of pupae is shown in Figure 5.1. 
 
RNA extraction and clean up was carried out according to the methods in Chapter 2 of 








 Pupal age (days post capping) 
 0 1 2 3 4 5 6 7 8 12 
Varroa free 1 10 4 3 11 12 9 15 5 5 
Varroa in Cell 0 6 0 4 11 13 9 24 5 2 
 
 
Figure 5.1. Sample numbers and age/Varroa distribution in sample from National Bee Unit, The Animal and Plant 
Health Agency (APHA), Sand Hutton, York. 
 
DWV copy number was determined for each individual pupae using qPCR (as in Chapter 
2, Section 2.7.2).  This allowed each individual to be categorized by age (in days post 
capping) and as having ‘high’ or ‘low’ DWV levels.  (As discussed in Chapter 3 of this 
work, it has been established in the literature that symptomatic individuals typically have 
a viral load of over 109 copies of DWV per individual, and that the infection is typically 
bimodal, with a clear distinction between ‘infected’ individuals with viral loads of around 
109 or above, and asymptomatic individuals with significantly lower viral loads (Zioni, et 
al., 2011; Ryabov, et al., 2014).  This allowed us to categorise any pupae with a load of 
over 109 viral copies as being ‘high virus’.) 
 
Once we had information on the age, Varroa load and DWV levels of each sampled pupae, 
a subset of individuals was chosen for further analysis.  Due to the age distribution of 
samples, they were split into 6 age classes; Pre-pupae (with individuals up to 3 days post 
capping), 4 days post capping, 5 days post capping, 6 days post capping, 7 days post 
capping and 8+ days post capping.  For each age class, 6 to 9 Varroa free and 6 to 9 
Varroa exposed individuals were selected for this further analysis.  The objective of this 





















expression, either in the Hox genes or genes from the ecdysone receptor pathway.  Primer 
sets were designed to anneal to regions of the following genes: 
 







BeeBase ID Function in insects 
(according to Flybase) 




Expression is focused in limb 
primordia. Dll specifies limb 
location (distal) versus body 
wall (proximal). 
 





Nuclear transcription factor, 
involved in in antennal 
development, proximal limb 
and wing patterning and the 
development of the 
undifferentiated eye field. 
 




Expressed in dorsal median 
cells, and the development of 
the insect nervous system 







Component of the bithorax 
complex, controlling the fate 
of developing embryonic 
segments 
 




Controls the differentiation of 
developing motor neurons and 
the projection of axons to 
ventral body wall muscles. 
 





Involved in the patterning of 
the wing disk and in the 
development of muscle, 


















Binds to the hormone 20-
Hydroxyecdysone during 
insect development leading to 
a major activation cascade of 
genes involved in molting, 



















Binds to the hormone 20-
Hydroxyecdysone during 
insect development leading to 
a major activation cascade of 
genes involved in molting, 















Involved in insulin binding, 
protein binding and hormonal 
control of development. 
Invooved in the response to 
20-hydroxyecdysone 
 
 Crooked legs 
 







 Zinc finger transcription 
factor induced by 20-
hydroxyecdysone at the onset 
of metamorphosis. Involved 




Genes were selected because of a). level of up or down regulation in original microarray 
experiment, and b). the function or time of expression in drosophila. 
 
Primer sets were designed to anneal to and amplify reverse transcribed mRNA sequences 
for the selected genes.  These primers were tested in qPCR conditions for single product 
melt curves, and the amplicons were run on a gel and then sent for sequencing to check 
that the oligos were annealing only to the desired cDNA transcripts.  Once that it had been 
established that the primer sets were working as required, qPCR was carried out on the 
selected honey bee samples, as described in Methods chapter (2.6.2.) A full list of primers 
can be found in the appendix of this work. 
  
5.2.2 Analysis of developmental gene expression in experimentally DWV injected 
honey bee pupae 
 
The expression of developmental genes in honey bees is known to be transient and tightly 
linked to developmental stage (Walldorf, et al., 2000b; Mello, et al., 2014). In order to 
accurately quantify changes in the expression patterns of these genes in response to DWV 
infection, an experimental system was designed which allowed controlled dose 
applications of the virus in age-matched pupae.   
 
A set of white eyed pupae (4 days post capping, Figure 2.4) from a low Varroa colony 
maintained at the apiary at the Warwick Crop Centre, Wellesbourne, were collected on 
19.7.2016 and injected as described in section 2.4.1.  A dose of DWV that had previously 
been established to lead to full infection in the majority of treated individuals was selected, 
each pupae was injected with 1x10-5ng viral RNA.  Control pupae (from the same colony, 
collected on the same day, all of the same developmental stage) were injected with PBS 
alone.   Six individual pupae were sampled for each treatment (DWV injected or sham 
injected) at the following time points: 
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1 hours post injection (h.p.i), 10 h.p.i, 24 h.p.i, 33 h.p.i, 48 h.p.i, 58 h.p.i, 72 h.p.i, 80 h.p.i, 
96 h.p.i and 105 h.p.i.  (see Figure 5.2) 
 
Samples collected were flash frozen in liquid nitrogen and stored at -80°C.  RNA was 
extracted and processed, and qPCR carried out as described in section 2.6 of this work.  
 
The full experiment was then repeated on 8.5.2017 with individuals from a different honey 
bee colony from the same apiary to allow us to compare the responses in genetically 
distinct bees.  The sampling times for the second injection experiment were as follows: 
 
1 hours post injection (h.p.i), 10 h.p.i, 24 h.p.i, 33 h.p.i, 48 h.p.i, 58 h.p.i, 72 h.p.i, 80 h.p.i.  
(see Figure 5.2) 
 
These experiments are referred to as ‘Experiment 1’ and ‘Experiment 2’ in Results section 
5.3.2 
 
Figure 5.2.  Sampling points for analysis of developmental gene expression in experimentally DWV 
injected honey bee pupae shown in relation to days post capping and developmental stage of pupae. 
Experiment 1, all sampling points collected. Experiment 2, modified sampling following analysis of 






























5.2.3 Multi colony injection experiment  
 
In order to further investigate the different patterns in developmental gene expression 
observed in genetically distinct honey bee colonies, a large scale injection experiment was 
carried out.  Samples of Varroa naïve, white eye pupae (4 days post capping, Figure 2.4) 
were collected from 6 honey bee colonies on the Wellesbourne site on 17.7.2016.  Two 
of the colonies sampled (T1 and T2) were located in the Townsend apiary (Methods 
Chapter 2.1) purchased as nucleus colonies, of Buckfast type bees (Österlund, 1983) in 
the season prior to sampling.  The other sampled colonies were located on the Reservoir 
Site, three (R1, R2 and R3) were well established experimental colonies which had been 
on the site for a number of years and had been allowed to re-queen naturally when required 
through swarming, colony division (swarm control) and supersedure.  The final sampled 
colony (RS1) was also located on the reservoir apiary, and was a recently collected swarm 
of bees from the Coventry area (approximately 15 miles from the apiary).  Consequently, 
little was known about the history of these bees but the colony had become established 
and the queen was laying well. 
 
A sample of brood was collected from each colony on a single day, and 40 age matched, 
Varroa naive, white eye pupae were extracted per colony.  Each individual was then 
injected with either a single infectious dose of DWV (1x10-5ng DWV RNA) or with the 
equal volume of PBS.  The injected insects were then stored in petri dishes in a humidity 
controlled incubator (33°C, 90% humidity).  Injected pupae were collected and flash 
frozen in liquid nitrogen at 24 h (10 individuals per colony) and 96 h post inoculation (10 
individuals per colony).   
 
After sample collection, RNA was extracted and processed, and qPCR carried out as 





5.3.1 Analysis of developmental gene expression in naturally Varroa infested honey 
bee pupae 
 
In order to further investigate how developmental gene expression differs in honey bee 
pupae exposed to Varroa mites and DWV virus, when compared to normal gene 
expression in Varroa naïve pupae, an analysis was done of naturally infested honey bees 
sampled from a colony maintained by the National Bee Unit, APHA,  Sand Hutton, York.     
The age matched pupae were tested for DWV levels (fig 5.2) and then a comparative 
analysis of the expression levels of a number of Hox and EcR pathway genes in the two 







Figure 5.3. DWV levels in two treatment groups of naturally Varroa exposed honey bee pupae sampled from a colony 
maintained by the National Bee Unit, York UK. Points represent the mean value from 6 – 9 individual bees. Each bee 
was aged using a standardised larval and pupal ageing chart. The ‘young’ age category refers to pre-pupae (with 
individuals up to 3 days post capping), while ‘old’ refers to  8+ days post capping.  qPCR results shown as deltaCt 
numbers (A) and as calculated DWV copy numbers per individual pupae (B). Error bars are standard error of the 




As expected, the DWV levels in the Varroa exposed pupae were higher than those found 
in the Varroa naïve individuals (by 4 days post capping (Day4) the difference was 
significant t(15)=5.319, p<0.001.)  The increase in virus titre is greatest between the 
‘young’ pupae and those sampled at 4 days post capping.  This rapid accumulation of 
DWV genomes within the first 48h of exposure via Varroa feeding is similar to the pattern 
of DWV infection described in experimentally inoculated bees described in Chapter 3 of 


































undergoing extensive metamorphosis, known as the propupal stage with the pupae 
developing within the larval skin.  At 4 days post capping the bees undergo the fifth moult, 
when the external features of the adult honey bee become visible, although the majority 
of the internal organs are yet to form (Stell, 2012).  It is during this period of honey bee 
development that the accumulation of DWV appears to be at its peak in Varroa exposed 
bees.  
 
These samples were then used for further qPCR experiments to establish any disturbances 
to the normal expression levels of Hox genes (Figure 5.4). 
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Figure 5.4. qPCR results, revealing the pattern of gene expression of 6 Hox genes in two treatment groups of naturally 
Varroa exposed honey bee pupae sampled from a colony maintained by the National Bee Unit, York UK. Points 
represent the mean value from 6 – 9 individual bees. Each bee was aged using a standardised larval and pupal ageing 
chart. The ‘young’ age category refers to pre-pupae (with individuals up to 3 days post capping), while ‘old’ refers to  
8+ days post capping.  qPCR results shown as deltaCt numbers: A. Distalless (Dll). B. Extradenticle (Ext). C. Buttonless 
(Btn). D. Abdominal A (AbdA). E. ExtraExtra (ExEx). F. Drop1 (Dr1).  Mean expression levels, normalized to actin 
(Delta Ct) are shown for Varroa exposed (high DWV) pupae (solid line) or control (Varroa naïve, low DWV) pupae 















































































The control lines in Figure 5.4 show the natural fluctuations in expression for the selected 
Hox gene during the delicate process of honey bee pupation and metamorphosis.  There 
are subtle but significant differences at certain sampling ages between the control group 
and the Varroa exposed, virus infected individuals; 
 
• For distalless (Dll) (Figure 5.4 A) there was no significant difference in the 
expression levels in control bees and DWV infected bees, with the exception of 
pupae sampled at 5 days post capping.  In these individuals, the expression of Dll 
was detected as being significantly higher in the control group (t(15)=2.442, 
p=0.027).   
• Expression levels of extradenticle (Ext) (Figure 5.4 B) showed significant 
differences from the control group in DWV infected bees at 6 days post capping 
(t(13)=2.432, p=0.03).   
• In the sampled bees, expression levels of buttonless (Btn) (Figure 5.4 C) were not 
significantly different between the treatment groups, with the exception of 
individuals sampled at 7 days post capping, where Varroa exposed pupae had 
significantly lower levels of Btn (t(16)=2.911, p=0.01).   
• AbdominalA (AbdA) (Figure 5.4 D) expression levels again followed a similar 
pattern in control and DWV/Varroa exposed pupae, but in individuals sampled at 
days 5 (t(16)=2.482, p=0.025) and 6 (t(11)=3.245, p=0.008) post capping, there 
was a significant difference in the measured levels of AbdA in the Varroa exposed 
pupae in comparison with the control group. 
• ExtraExtra (ExEx) (Figure 5.4 E) expression levels remained consistent between 
the two groups of pupae, with no significant differences (p>0.05). Varroa 
exposure and DWV infection appeared to have no impact on the pattern on ExEx 
expression in these pupae. 
• For drop1 (Dr1) (Figure 5.4 F) the expression levels were not significantly 
different (p>0.05) in control bees when compared to DWV infected bees, with the 
exception of pupae sampled at 6 days post capping.  In these individuals, the 
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expression of Dr1 was detected as being significantly lower in the control group 
(t(11)=3.635, p=0.004).   
 
The results of this sampling experiment indicate that Varroa parasitism and/or DWV 
infection can influence the intricate expression patterns of developmental genes during 
honey bee pupation.  However, the disturbances measured in this set of sampled pupae 
were not as pronounced or as universal across large groups of Hox genes as those observed 
in the microarray experiment conducted previously.  There are two reasonable hypotheses 
for this inconsistency: Either the dissimilarities in expression pattern alterations are 
caused by the experimental method, as sampling of naturally infested pupae does not 
allow control of the viral dose, of the exact timing of the onset of Varroa feeding, the 
strain of DWV present within the colony or the environmental conditions experienced by 
the pupae prior to sampling.  Alternatively, it could be that the honey bee transcriptional 
response to Varroa feeding or DWV infection is influenced by the honey bee genotype, 
and the pupae sampled in the two separate experiments have differing responses due to 
their genetic dissimilarities.   
 
A number of further experiments were therefore conducted, firstly using direct injection 
of DWV to allow for closer control of the viral dose, followed by a comparison of the 
transcriptional response of honey bee pupae from a range of colonies using this more 
controllable technique.  
  
 
5.3.2 Analysis of developmental gene expression in experimentally DWV injected 
honey bee pupae 
 
Injection of DWV VP into ‘white eye’ pupae can be used to simulate DWV exposure 
through Varroa feeding, as described in Chapter 3 of this work. An experiment was done 
in which individual ‘white eye’ pupae from a single colony were given a single infectious 
dose of DWV (1x10-5ng viral RNA) by injection, and then samples taken at regular 
intervals to reveal more about how DWV infection affects developmental gene expression 
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in honey bee pupae. This experiment was done twice, using honey bees taken from a 
different colony each time.  
 
Experiment 1. 
This experiment was done on 19.7.2016 
 
  
Figure 5.5. Experiment 1 -  Comparative levels of DWV in honeybee pupae injected with DWV RNA (V+) or with a 
PBS control injection (Control) as shown by qPCR deltaCt.  Linear regression fitted, shown as dotted lines. Samples 
collected at 1,10, 24, 48, 72, 80 96 and 105 hours post injection. 
 
 
Once it had been established that the DWV injection had led to the expected DWV 
infection in V+ bees (Figure 5.5), qPCR was used to investigate the impact on this 
















Figure 5.6  qPCR results, revealing the pattern of gene expression in 6 Hox genes in experimentally DWV injected 
pupae: A. Distalless (Dll). B. Extradenticle (Ext). C. Buttonless (Btn). D. Abdominal A (AbdA). E. ExtraExtra (ExEx). 
F. Drop1 (Dr1).  Mean expression levels, normalized to actin (Delta Ct) are shown for DWV injected pupae (solid line) 

















































































The control lines in Figure 5.6 show the fluctuations in expression for the selected Hox 
gene during the pupal to adult transition in pupae that have been removed from the colony 
and given a control injection.  There are subtle but significant differences at certain 
sampling points between the control group and the DWV exposed, virus infected 
individuals; 
 
• There were no significant differences between the treatment groups in the 
expression of Dll.  The expression patterns were broadly similar in the virus 
injected and control injected pupae (Figure 5.6 A). 
• Expression levels of ExEx showed no significant differences between the 
treatment groups, until the 58 hour post injection (h.p.i) sampling point, when 
levels are significantly higher in DWV infected pupae (t(10)=2.241, p=0.049), and 
at the 96 h.p.i sampling point where the control pupae have higher ExEx 
expression (t(9)=3.72, p=0.007) (Figure 5.6 B). 
• Btn levels appear to be affected by the very early stages of DWV infection, with 
a significant difference between the levels in the two treatment groups at the first 
sampling point (t(9)=2.753, p=0.025) (Figure 5.6 C).   
• Similarly, expression of AbdA are perturbed immediately after DWV injection at 
the 1 h.p.i sampling point (t(8)=3.852, p=0.005).  However, unlike Btn, AbdA 
expression levels also appear to be disturbed by DWV infection at later time 
points, including the 72 h.p.i sampling point (t(9)=2.821, p=0.02) (Figure 5.6 D). 
• ExEx expression is different according to treatment group at 1 h.p.i (t(8)=4.457, 
p=0.002), but the expression levels then showed no significant difference (p>0.05) 
between the treatment groups for all subsequent sampling points (Figure 5.6 E). 
• In contrast, Dr1 expression levels are unaffected by DWV injection at the early 
sampling points, with no significant difference (p>0.05) between the treatment 
groups, but there appears to be a significant impact of DWV infection at the later 
sampling points – 96 h.p.i (t(7)=3.385, p=0.012).  
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Along with Hox genes, the ecdysone signalling pathway is known to play a crucial role 
in post embryonic development and caste determination in honey bees.  The transcription 
levels of the ecdysone receptors EcR-A and EcR-B have been shown to fluctuate during 
honey bee pupation and to be linked to the titre of 20-hydroxyecdysone (20E) (Mello, et 
al., 2014).  Here we have compared the expression levels of the two ecdysone receptors 
(EcR-A and B) and two members of the ecdysone signalling pathway crooked legs (Crol) 
and insulin like peptide receptor (InR) in honey bee pupae injected with either DWV RNA 
or a virus free control injection. 
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Figure 5.7. qPCR results, revealing the pattern of gene expression in 4 ecdysone signaling pathway genes in 
experimentally DWV injected pupae: A. Apis mellifera ecdysone receptor transcript variant A (EcR-A). B. Apis mellifera 
ecdysone receptor transcript variant B. C. Insulin like peptide receptor (InR), D. Crooked legs (Crol). Mean expression 
levels, normalized to actin (Delta Ct) are shown for DWV injected pupae (solid line) or control (control injection) 


























































As with the Hox genes, the tested genes from the ecdysone signalling pathway were found 
to have different expression patterns in DWV injected honey bee pupae, when compared 
to pupae given a control injection.  The main impacts of DWV infection are outlined 
below: 
 
• EcR-A expression is strongly impacted by early DWV infection, with a 
significantly lower expression level in injected pupae sampled at 1 h.p.i 
(t(7)=3.945, p=0.006), 10 h.p.i (t(6)=4.138, p=0.006) and 24 h.p.i (t(7)=3.997, 
p=0.005).  The expression pattern then appears to be similar in the infected and 
control groups, with the exception of a significant perturbation at 58 h.p.i 
(t(10)=5.080, p<0.001) (Figure 5.7 A).  
• EcR-B expression levels were observed to be significantly lower in DWV infected 
bees at 1 h.p.i (t(8)=5.777, p<0.001), with the expression pattern appearing to be 
largely unaffected by DWV at later sampling points (Figure 5.7 B). 
• InR follows a similar expression pattern in both DWV infected and control pupae 
until the 58 h.p.i sampling point, when the levels in infected bees are significantly 
higher than those found in the control individuals (t(9)=4.626, p=0.001).  There is 
also a difference in the expression of InR detected at the 80 h.p.i sampling point 
(t(9)=2.427, p=0.038)(Figure 5.7 C) 
• Crol expression appears to be affected by the early stages of DWV infection (1 
h.p.i (t(8)=3.919, p=0.004) but then the infected and control pupae show similar 
levels of expression until the 58 h.p.i sampling point, where they diverge 
(t(10)=3.197, p=0.010). 
 
This experiment has allowed greater control of viral dose, pupal conditions and sampling 
times and it has therefore allowed us a greater insight into the effect that DWV infection 
has on developmental gene expression.  However, all of the individuals used in the 
experiment  were worker pupae from a single colony at a single time point and can 
therefore be assumed to be closely genetically related (Blanchetot, 1991).  In order to 
determine how reproducible, the results are across genetically distant honey bees the 





 The honey bee pupae used for the repeat injection and sequential sampling experiment 
were susceptible to DWV infection, with the levels of DWV increasing rapidly in DWV 
injected pupae during the first 60 hours of the experiment (Figure 5.8).  The progression 
of the DWV infection appears to follow a similar pattern, in terms of virus levels per 
pupae at each sampling time point.   
 
  
Figure 5.8 Experiment 2 - Comparative levels of DWV in honeybee pupae injected with DWV RNA (V+) or with a 
PBS control injection (Control) as shown by qPCR deltaCt.  Linear regression fitted, shown as  dotted lines. Samples 


















Figure 5.9.  qPCR results, revealing the pattern of gene expression in Hox and ecdysone signalling pathway genes in 
experimentally DWV injected pupae:, A. Extradenticle, B Buttonless, C. AbdominalA, D. Apis mellifera ecdysone 
receptor transcript variant A (EcR-A). E. Apis mellifera ecdysone receptor transcript variant B. Mean expression levels, 
normalized to actin (Delta Ct) are shown for DWV injected pupae (solid line) or control (sham injection) pupae (dotted 























































The impacts of DWV infection on pupal developmental gene expression in the second 
experiment are outlined below: 
 
• Expression levels of ExEx remain similar in both treatment groups, with no 
significant impacts of DWV infection detected in this sample set (p>0.05) (Figure 
5.9 A).  
• In this sample set, Btn levels appear to be unaffected by DWV infection until the 
48 h.p.i sampling point, where the expression level appears to be significantly 
increased in the DWV infected individuals (t(9)=2.76, p=0.22).  At later sampling 
points the detected levels of Btn are similar in both treatment groups (Figure 5.9 
B).   
• AbdA expression does not appear to be affected by DWV infection in these pupae 
(Figure 5.9 C), with no significant difference between the expression in the two 
treatment groups (p>0.05). 
• Expression of Ecr-A is disturbed by early stage DWV infection in these pupae, 
however, unlike the pupae in the first experiment, in these bees the disturbance is 
at 10 h.p.i and here expression in the DWV infected pupae is significantly higher 
than the control group (t(10)=2.413, p=0.037). 
• EcR-B expression is unaffected by the early stages of DWV infection, but is 
significantly higher at 48 h.p.i in DWV infected individuals (t(9)=2.626, p=0.027). 
 
As described in the first injection experiment, the DWV infection does appear to disturb 
the pattern of expression of certain developmental genes, the timeframes and magnitude 
of the disturbances are not consistent between the two experiments.  This indicates that 
viral replication may be leading to gene expression deregulation rather than a controlled, 
directional alteration in the expression of these crucial developmental genes.  The genetic 
differences between the two sampled colonies may be the basis of the differing responses 
observed in the two sets of samples. 
 
When compared to the previous injection experiment, the magnitude and direction of the 
disturbances to developmental gene expression appear to be specific to each sampled 
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colony of bees rather than a universal, directional response to DWV infection.  There are 
also some differences between the ‘control’ expression patterns for the genes, but in 
general they are far more similar between the experiments than those observed in the 
infected pupae. 
 
5.3.3 Multi colony injection experiment  
 
The results of the previous experiment (5.3.2) indicate that, whilst developmental gene 
expression in honey bee worker pupae is perturbed by DWV infection, the actual 
magnitude and direction of the disturbance to each tested gene appears to be fairly 
consistent within a colony of genetically related individuals but to differ between colonies.  
In order to further explore this observation, a larger scale injection experiment was carried 














































































































Figure 5.10. Comparison of levels of DWV (A) and developmental genes in 
honey bee pupae injected with DWV RNA - sampling at 24h post injection. 
A. DWV levels, B. Extradenticle, C Buttonless, D. AbdominalA, E. Apis mellifera 
ecdysone receptor transcript variant A (EcR-A). F. Apis mellifera ecdysone 
receptor transcript variant B (EcR-B). Mean expression levels, normalized to 
actin (Delta Ct) are shown for DWV injected pupae (solid black bars) or control 
(control injection) pupae (grey hashed bars).  Error bars show the standard error 
of the mean. 
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5.3.3.1 Sampling at 24h Post Injection 
 
Honey bee pupae from 6 colonies, spread over 2 apiaries, were sampled and age matched, 
Varroa free pupae were injected with a single infectious dose of DWV or with a virus free 
control injection.  Half of the injected pupae were sampled after 24h and, following RNA 
extraction and processing, qPCR was used to compare the levels of DWV and selected 
developmental genes in the infected and control pupae. 
 
In Figure 5.10 A the DWV levels in pupae at the 24h sampling point are shown.  It 
appeared that some colonies (T1, R2, and RS1) are more susceptible to DWV, with the 
infection in the DWV injected pupae yielding increased levels of DWV than those found 
in the control pupae at the 24h sampling point.  The other colonies (T2, R1 and R3) did 
not appear to show elevated DWV levels following DWV injection at this 24h post 
injection sampling, however at the later (96h) time point (Fig 5.11 A) the DWV levels are 
significantly elevated in all colonies.  A two tailed ANOVA indicated that, 24 hours post 
DWV infection, there was a significant difference in viral outcome between the DWV 
injected and control pupae (F(1,59)=83.365, p<0.001).  There was also a statistically 
significant effect of parent colony on DWV levels (F(5,59)=16.366, p<0.001), and a 
significant interaction between the effects of treatment (DWV injection or control 
injection) and source colony on the DWV levels in the sampled pupae F (5,59) = 13.603, 
p<0.001).  This result reveals that the progression of DWV infection differs between 
colonies, even when the dose, time of injection, and strain of DWV are experimentally 
controlled. 
 
As we hypothesized following the previous results from two colonies, the expression of 
the selected developmental genes is altered by DWV infection, with clear variability 
between colonies.  The main results from the 24 h sampling point are outlined below: 
 
• Exd expression levels do not show a significant interaction between the effects of 
treatment and source colony (F (5,60) = 1.414, p=0.232).  There was also no 
significant effect of DWV injection compared to the sham injection (F 
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(1,60)=1.219, p=0..274) and no significant differences between the responses of 
the source colonies (F(5,60)=2.243,  p=0,061).   Post hoc testing showed that only 
samples from colony R3 showed a significant difference in Exd expression levels 
between treatment groups at this sampling point (t(10)=2.563, p=0.028).  
• The expression of Btn does differ significantly between the sample colonies at the 
24h sampling point (F(5,60)=14.452, p<0.001), but there was no difference 
between the two treatment groups (F(1,60)=2.343, p=0.131).  Btn expression 
levels do not show a significant interaction between the effects of treatment and 
source colony (F (5,60) = 1.660, p=0.158).  However, post hoc testing shows that 
one colony - T1 (t(10)=3.343, p=0.007 – does have a significant alteration in Btn 
expression in DWV injected pupae, when compared to sham injected. 
• AbdA expression differs significantly between the sample colonies at the 24h 
sampling point (F(5,60)=13.82, p<0.001).  However there was no a significant 
difference in expression caused by the treatment (F(1,60)=1.841, p=0.18).  The 
expression of AbdA does appear to show a significant interaction between effects 
of treatment and source colony (F (5,60) = 2.485, p=0.041).  Post hoc testing 
shows that in this case two colonies, R2 (t(10)=2.443, p=0.035) and R3 (t(10) = 
3.836, p=0.003) show significant alterations in AbdA expression following DWV 
inoculation, when compared to the expression in sham injected pupae from the 
same source colony. 
• EcrA expression differs significantly between the sample colonies at the 24h 
sampling point (F(5,60)=15.216, p<0.001).  However there was no a significant 
difference in expression caused by the treatment (F(1,60)=0.237, p=0.628).  EcrA 
expression also shows a significant interaction between effects of treatment and 
source colony (F (5,60) = 3.796, p=0.005), however, when considered alone, the 
differences in expression in the individual colonies are not consistent enough to 
be considered significant. 
• EcrB expression differs significantly between the sample colonies at the 24h 
sampling point (F(5,60)=6.541, p<0.001).  However there was no a significant 
difference in expression caused by the treatment (F(1,60)=1.186, p=0.281).  EcrB 
expression does not show a significant interaction between the effects of treatment 
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and of source colony (F (5,60) = 0.718, p=0.613) and the expression levels 
measured in both the treatment groups are not significantly different in any of the 
tested colonies. 
 
There is no clear distinction between the transcriptional responses shown by the rapidly 
susceptible to DWV colonies (T1, R2, and RS1) and the other colonies which had low 













































































































 Figure 5.11 Comparison of levels of DWV (A) and developmental genes in 
honey bee pupae injected with DWV RNA - sampling at 96h post injection. 
A. DWV levels, B. Extradenticle, C Buttonless, D. AbdominalA, E. Apis 
mellifera ecdysone receptor transcript variant A (EcR-A). F. Apis mellifera 
ecdysone receptor transcript variant B. Mean expression levels, normalized 
to actin (Delta Ct) are shown for DWV injected pupae (solid black bars) or 
control (control injection) pupae (grey hashed bars).  Error bars show the 
standard error of the mean. 
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5.3.3.2 Sampling at 96h Post Injection 
 
Figure 5.11 A shows the levels of DWV and the selected Hox and EcR genes in pupae 
samples 96h after injection.  In contrast to the earlier (24 h) sampling point, there is a 
significant DWV infection in pupae from all colonies by 96 h post injection with DWV.  
A two tailed ANOVA reveals that, 96 hours post DWV infection, there is a significant 
effect of both treatment (F(1,59=306.084, p<0.001) and source colony F(5,59)=92.255, 
p<0.001).  There is also a statistically significant interaction between the effects of 
treatment (DWV injection or control injection) and source colony on the DWV levels in 
the sampled pupae F (5,59) = 29.528, p<0.001.  From this we can conclude that, although 
the infections progress at different rates according to source colony, all of the colonies 
sampled were ultimately susceptible to experimental DWV infection. 
 
There was some disturbance to the expression of the developmental genes at this sampling 
point, although less than that observed at the 24h point.  Again, we do observe variability 
in the responses of pupae from different source colonies.   
 
• The expression of Exd was significantly influenced by the source colony of the 
pupae (F(5,58)=8.756, p<0.001) but not by the experimental treatment 
(F(1,59)<0.001, p=0.995).  Exd expression levels do not show a significant 
interaction between the effects of treatment and source colony (F (5,58) = 0.646, 
p=0.666).  Post hoc testing did not indicate any significant differences between 
the control and treatment groups in any of the sampled colonies. 
• The expression of Btn was significantly influenced by the source colony of the 
pupae (F(5,58)=26.741, p<0.001) but not by the experimental treatment 
(F(1,58)<1.241, p=0.270).  Btn expression levels do not show a significant 
interaction between the effects of treatment and source colony (F (5,58) = 0.522, 
p=0.759).  Again, post hoc testing did not indicate any significant differences 
between the control and treatment groups in any of the sampled colonies. 
• The expression of AbdA is significantly different between the sample colonies 
(F(5,58) = 26.038, p<0.001) but not between treatment groups (F(1,58)=0.001, 
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p=0.974).  AbdA expression does not appear to show a significant interaction 
between effects of treatment and source colony (F (5,58) = 1.028, p=0.410).  
Again, post hoc testing did not indicate any significant differences between the 
control and treatment groups in any of the sampled colonies. 
 
• EcrA expression also fails to show a significant difference in expression due to 
treatment group at 96 h (F(1,58) = 2.571, p=0.114) but there is a significant effect 
of source colony (F(5,58) = 35.244, p<0.001).  No interaction was found between 
effects of treatment and source colony (F (5,58) = 0.618, p=0.687), and any 
differences between the control and treatment groups were not significant. 
• EcrB expression is significantly affected by both source colony (F(5,58) = 9.211, 
p<0.001) and by the treatment group (F(1,58)= 8.312, p=0.006).  In contrast to 
the other genes analysed at this time point, EcrB expression does show a 
significant interaction between effects of treatment and source colony (F (5,58) = 
2.550, p=0.037), with expression of EcrB being significantly increased in DWV 



















The results of this chapter suggest that, whilst DWV infection may alter the expression 
patterns of key developmental genes in infected honey bee pupae as they undergo 
morphological development to the adult life stage, the outcome of the effect of DWV 
infection is complex and depends on a range of variables including bee colony and pupal 
age.  The experiments described in this chapter may begin to illuminate the interaction 
between DWV infection and honey bee developmental genes, but the outcomes of the 
experiments were too variable to allow us to draw firm conclusions. 
 
To our knowledge, this chapter represents the first published report of the effect of DWV 
infection on the expression of honeybee developmental genes.  This is surprising, given 
that the main effect of DWV infection is to cause developmental abnormalities in Varroa-
parasitized bees.  However, it may also reflect the technical challenges involved in this 
area of study.  
 
Little is known about the precise molecular mechanisms that underpin the normal 
developmental transition from honeybee larvae to the adult form, and the main focus of 
published work on gene expression during honey bee development has been queen-
worker dimorphism (Evans and Wheeler, 1999; Evans and Wheeler, 2001) and on 
perturbations to gene expression following Varroa parasitism (Navajas, et al., 2008; 
Kuster, et al., 2014).  As outlined in the introduction to this chapter, what we do know 
about the control of larval-to-adult insect metamorphosis indicates that the ecdysone 
signalling pathway, controlled by changes in the titre of the hormone 20-hydroxyecdysone 
(20-HE), detected by an ecdysone receptor protein complex (ECR-C) plays a crucial role 
in the control of honey bee metamorphosis and pupal development (Barchuk, et al., 2008; 
Gauhar, et al., 2009).  Insect morphological development is also known to be regulated 
by a suite of evolutionary conserved homeodomain proteins, regulating cell fate and cell-
type gene expression to determine insect segment morphology and the development of 
appendages, organs, the nervous system and the neuroendocrine systems (Hayashi and 
Scott, 1990; Ladam and Sagerstrom, 2014). 
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The research in this chapter was based on preliminary results from a honey bee microarray 
experiment done by our research group, in which gene expression was quantified for 
individual pupae of different ages sampled from a single bee colony and naturally 
parasitized with different numbers of Varroa mites (data not shown).  This data led us to 
hypothesise that DWV infection, alongside Varroa parasitism, resulted in a significant, 
directional perturbance to developmental gene expression.  However, the results from this 
chapter point to a more complex situation, in which experimental DWV infection has been 
shown to cause subtle up or down regulation of developmental gene expression, but these 
disturbances are transient, occurring only during certain sampling points, and appear to 
differ depending on the source colony of the experimental bees.  Both the direction and 
magnitude of the disturbance to gene expression appear to be dependent on the sampled 
colony.  This is best illustrated by looking at the expression of a single gene, EcrA, across 
the different injection experiments:  
 
EcrA is one of two ecdysone receptors found in honey bees, transcription of which is 
closely linked to honey bee developmental stage and caste, and to be inversely linked 
to the titres of the hormone 20-hydroxyecdysone (20-HE) (Mello, et al., 2014).  EcrA 
has been shown to be the predominantly expressed ecdysone receptor during 
postembryonic development, and to exhibit major differences in expression 
according to honey bee caste during the larval/pupal metamorphic molt (Mello, et al., 
2014). 
 
• In the initial, single colony injection time course experiment (Section 5.3.2, 
Figure 5.6 A) the expression of EcrA was significantly reduced in individuals 
injected with DWV when compared to the control pupa during the first 24 h post 
injection, but at the later sampling points (36 h.p.i onwards) the levels of EcrA 
detected in the control and infected pupae followed a similar expression pattern.  
This experiment was then done again, using pupae from a different source colony 
and injected with the same DWV virus preparation. In this second experiment, a 
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disturbance to the expression pattern of EcrA was observed shortly after DWV 
injection, but the disruption was restricted to the 10 h.p.i sampling point. 
• At the first (=24 h) sampling point of the multi colony injection experiment 
(Section 5.3.3.1) the expression of EcrA within pupae was affected by the 
presence of infecting DWV, with EcrA expression higher than the control pupae 
in some colonies (RS1) and lower in others (R2).  The results also indicate that a 
larger sample size would have allowed us to identify a significant up or down 
regulation in a number of the other colonies.  At the 96 h.p.i time point no colonies 
showed significant differences in EcrA expression between the control and 
experimental groups, this result is in line with the earlier experiments where the 
transcriptional response in infected bees was restricted to the earlier sampling 
points.   
 
These results effectively illustrate the between-colony variation in transcriptional 
response to DWV infection in honey bees.  All of the experiments described in the 
previous paragraph used the same strain of DWV for inoculation and the same 
experimental design in terms of age of bee pupa, dose of DWV, treatment of samples and 
processing of sampled insects.  Therefore, it is reasonable to suggest that the variation in 
response must be caused by between-colony variation in the bees sampled.  This variation 
could be due to the genetic differences between colonies of bees or it could be due to 
differences in environment (such as the nutritional status or forage abundance experienced 
by each colony, the climatic conditions or temperature experienced by the experimental 
individuals after laying but prior to their collection for injection or the predominant strain 
of DWV or other disease within each source colony).  The fact that the multi colony 
injection experiment involved sampling from bees within a small area on the same day 
(and therefore with very similar climatic and forage conditions) removed some of this 
variability, but we still cannot be sure of the real cause of this result without further 
experiments.  However, the results from this study have opened up the way forward for 
understanding the effects of DWV infection on honeybee development.  
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One testable hypothesis is that different honeybee genotypes show different responses in 
developmental gene expression to DWV infection.  Genotypic variation in transcriptional 
responses to parasite infection has been observed in other insects.  For example, it has 
been shown that different strains of the mosquito Aedes Aegypti have very distinctive 
transcriptional responses to infection with dengue virus, with only 5% of the differentially 
expressed genes in experimentally infected mosquitos being common to both strains of 
the insect used in the study (Behura, et al., 2014).  Meanwhile, bumblebee (Bombus 
terrestris) genotype has also been shown to determine  the host response to infection with 
the trypansome gut parasite Crithidia bombi, leading to some bumblebee genotypes being 
more susceptible to the parasite (Barribeau, et al., 2014). 
 
 
There have been a number of studies quantifying the honey bee transcriptional response 
to viral infection, notably (Ryabov, et al., 2014; Ryabov, et al., 2016; Brutscher, et al., 
2017; Doublet, et al., 2017) but none of these have gone on to compare these responses 
in bees with different genotypes.  For example, the Ryabov et al. (2014, 2016) papers 
focused on individual honey bees from a single colony, so no between-colony variation 
was taken into account.  The scope of the Ryabov et al. work did not allow genotyping of 
these individual honey bee samples, which would have been necessary to determine if the 
divergent transcriptional responses and susceptibility to DWV infection were due to 
differences in the genotypes of the bees in the study.  A meta-analysis study by Doublet 
et al. (2016) of many published and newly conducted honey bee transcriptome projects, 
allowed the identification of common molecular responses to major parasites and 
pathogens; this approach is useful for revealing responses conserved across 
geographically, temporally (and therefore presumably genetically) diverse bees, but as a 
consequence of this, discrepancies due to genetic variation are ignored or obscured.  The 
results described in this chapter highlight how subtle or inconsistent variability in 
transcriptional responses can be missed by widely used microarray techniques and by 
experimental designs involving pooled or closely genetically related individuals. 
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The results of these experiments allow us to conclude that DWV infection can subtly alter 
the expression patterns of key developmental genes in infected honey bee pupae, but could 
these subtle, variable alterations be responsible for the consistent, well characterised 
deformities that are known to be the result of DWV infection, and that have been shown 
to occur in pupae injected with DWV using the experimental system employed in this 
chapter (Chapter 3, Section 3.3.3.2.)?  It has been experimentally demonstrated that 
disruption to Hox gene expression can result in dramatic defects in the development of 
the nervous system or physical structure of the experimental animal.  In Drosophila, 
knocking out Hox genes causes homeotic transformations, for example the antennapedia 
mutants, where loss of function of the gene results in one leg pair being replaced by 
ectopic antennae.   Overexpression of antennapedia (gain of function) transforms the 
antenna into ectopic legs (Pearson, et al., 2005).  However, there is very little known about 
the effects of virus infection on Hox gene expression, and the consequences for the 
development of the infected individual.  The other developmental pathway indicated to 
be affected by DWV infection, the ecdysteroid signalling pathway, has previously been 
shown to be susceptible to manipulation by virus infection in insects.  As described in the 
introduction to this chapter, infection with the baculovirus Lymantria dispar nuclear 
polyhedrosis virus affects the development of its insect hosts Lymantria dispar (the gypsy 
moth) and Spodoptera frugiperda (the fall armyworm) by altering the levels of 
ecdysteroid, the insect moulting hormone, in the haemolymph of infected individuals 
(Burand and Park, 1992; Park, et al., 1993; Park, et al., 1996) 
 
Further experiments are required to establish if the novel results outlined in this chapter 
could provide an explanation for the characteristic deformities observed in DWV infected 
honey bees.  Experimental manipulation of the expression of Hox and ecdysone 
responsive genes in developing pupae would give a clearer indication of the impact that 
disturbances to these pathways has on honey bee development.  This could be achieved 
through RNAi-mediated gene knockdown.  This technique has been used to effectively 
supress developmental and regulatory gene expression in adult honey bees, where 
injection of targeted dsRNA reduced the expression of both vitellogenin (vg) which 
encodes a precursor of the egg yolk proteins and is crucial in the caste differentiation of 
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honey bee larvae, and ultraspiracle (usp) which encodes a juvenile hormone (JH) receptor 
and is thought to be a transcription factor, mediating responses to JH (Corona, et al., 2007; 
Ament, et al., 2012; Wang, et al., 2013).   
 
The experiments described in the chapter were restricted by the need for age matched, 
Varroa free pupae, from specific honey bee colonies.  There are always a limited number 
of suitable individuals within a colony at any one time.  The result of this restriction was 
that it was not possible to collect a pre injection sample (0 h p i) or a no injection control 
for our experiments.  Our results indicate that many of the perturbations to developmental 
gene expression occur within the first 48 h of DWV infection.  It would be useful to 




Chapter 6. Conclusions and future questions 
 
 
For the past two decades, reports on declines in honey bee health and increases in 
colony losses have concerned beekeepers, scientists and the wider public (Meixner and 
Le Conte, 2016).  There is a general consensus that both macro- and micro-parasites 
play a major role amongst the multifactorial catalogue of challenges faced by modern 
beekeepers (Potts, et al., 2010; Ratnieks and Carreck, 2010; Vanbergen, et al., 2013) 
and of particular concern is the invasive parasitic mite Varroa destructor and the 
microbial parasites that it vectors.  Varroa has spread to most beekeeping areas of the 




One of the Varroa-vectored pathogens which has emerged as a significant threat to 
honey bee health is deformed wing virus (DWV), an RNA virus that has been shown to 
be closely associated with colony losses (de Miranda and Genersch, 2010; Moeckel, et 
al., 2011).  Deformed wing virus (DWV) is widespread in honey bees and usually 
present as a low level, asymptomatic infection.  However, the transmission of DWV by 
Varroa to developing pupae causes markedly elevated levels of a near clonal virus 
population, leading to characteristic developmental abnormalities  (de Miranda and 
Genersch, 2010; Ryabov, et al., 2014).  DWV has been a focal point for research since 
this association was uncovered, but significant gaps remain in our understanding of 
pathology of Varroa-mediated DWV infections.  This thesis attempts to address some of 
those knowledge gaps. 
 
The aim of this project was to address three main research questions, revealing more 
about the interactions between honey bees, Varroa and DWV.  Firstly, I examined how 
the transmission route of DWV affects the virulence and tissue localisation of the virus, 
testing the hypothesis that DWV is more infectious when transmitted by Varroa because 
it is injected directly into the haemolymph, bypassing the host’s immune defences and 
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gaining unobstructed access to a wider range of tissues, as shown by RNA-FISH 
imaging of the timecourse of DWV infection.  Next, I focussed on a question that 
currently divides the scientific community, investigating how Varroa transmission of 
DWV affects the diversity and predominant strain of the virus within the honey bee 
hosts.  The published literature on the subject shows that Varroa parasitism leads to a 
narrowing in DWV diversity that accompanies the documented increase in viral load 
and the appearance of symptomatic honey bees (Martin, et al., 2012; Ryabov, et al., 
2014).  This points towards a single strain of the virus having a selective advantage 
when transmitted by Varroa, but there is currently no agreement over the sequence 
identity of that strain. Two repeated sampling experiments were conducted to try and 
resolve these inconsistencies, looking at the change in DWV population at the forefront 
of the Varroa invasion in the UK, and attempting to track any changes in the 
predominant strain of the virus over a single season in a heavily Varroa infested honey 
bee colony.  Finally, I have investigated the hypothesis that DWV infection during 
crucial stages of honey bee pupation and metamorphosis causes disturbances to the 
expression of developmental gene pathways, including ecdysone receptor signalling and 
homeobox developmental genes, leading to the characteristic DWV symptoms.   
 
As hypothesised, DWV is significantly more virulent when administered via injection 
rather than orally, as revealed by the infectious dose of the virus required to produce a 
symptomatic outcome in our two experimental systems (injection or oral exposure).  At 
a fundamental level, this finding explains why the spread of Varroa mites, the saliva of 
which contains DWV proteins (Zhang and Han, 2018) and is injected into the honey bee 
pupae to facilitate mite feeding (Kuster, et al., 2014), has led to the documented increase 
in DWV associated pathologies in honey bees (Martin, et al., 2013).  The results 
outlined in Chapter 3 of this work also reveal more about the intricacies of early stage 
DWV infection in developing honey bee pupae.  An infectious dose of DWV, when 
administered by injection, takes just 2 or 3 days to result in an infection that is 
detectable by qPCR or RNA-FISH, and this is the case whether the injection takes place 
at the white eye, purple eye or newly emerged adult stage of honey bee development.  
However, when an infectious dose is given orally, it takes longer for virus replication to 
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progress to a detectable level (6 or 7 days from oral exposure), while the infection itself 
does not progress until a specific stage in pupal development, the fifth moult transition 
from propupae to pupae (Stell, 2012), when the digestive system is broken down during 
metamorphosis.  This suggests that – in the absence of Varroa, when DWV infection 
occurs orally - the larval gut forms an effective barrier against DWV infection that 
confines infectious virus particles to the midgut or in the epithelial tissues of the gut 
lining at pupation.  The RNA-FISH imaging conducted also revealed some tissue 
specificity in early stage DWV infection, with the virus appearing to preferentially 
replicate in the developing compound eye and the layer of cells surrounding the brain 
tissue, the salivary glands and mouth parts and in the epithelial cells of the mid and hind 
gut.  DWV replication within the brain tissue may be linked to the cognitive and 
behavioural abnormalities in DWV infected honey bees described by (Wells, et al., 
2016; Benaets, et al., 2017).  The rapid rate of increase of DWV titre within bees that 
have been inoculated by injection indicates, a priori, that the bee immune system is 
unable to control the replication of the virus when this route of infection takes place. 
This most likely reflects the co-evolutionary history of honey bees and DWV, as prior to 
the invasion of Varroa, the bee gut would have been the first immune barrier to DWV.  
 
 
The results of the Ardnamurchan sampling experiment show a shift from a mixed 
population of viruses, predominantly VDV-like or VDV/DWV recombinants, towards a 
mainly DWV-like virus population.  This result needs to be examined in the context of 
the literature on DWV strain virulence.  Our previous research (Ryabov, et al., 2014) led 
us to predict that, as the recombinant strain that dominates local apiaries was present in 
the Varroa free Ardnamurchan bees, this strain would have a selective advantage when 
transmitted by the colonising Varroa mites and would become the most prevalent strain 
following the arrival of Varroa into the area.  However, this was not the case in the 
Ardnamurchan samples where, in apiaries where the Varroa became established, there 
was a significant shift towards DWV-like virus strains.  This result is more in line with 
the shift in the DWV-like virus population in Hawaii following the introduction of 
Varroa (Martin, et al., 2012; Brettell, et al., 2017).  Another study that needs to be 
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considered when interpreting our results is (McMahon, et al., 2016a),  where it was 
established that VDV-like viruses caused significantly faster mortality in injected honey 
bees than DWV-like viruses, and that VDV-like and VDV/DWV recombinant strains of 
the virus dominate in apiaries in the south of the UK, where Varroa mites have been 
established for longer.  In light of these results, we can conclude that Varroa mediated 
transmission does exert a selection pressure upon the diverse DWV viruses within honey 
bee colonies, and that DWV-like strains appear to have a selective advantage in the 
early stages of Varroa infestation.  However, it appears that sampling within the first 
few years of Varroa becoming established may not tell the full story, and the virus 
population dynamics are influenced by more factors than are taken into account by this 
early shift towards DWV-like strains.  Tracking the DWV-like viruses present in 
Ardnamurchan in a longer-term study would allow us to see if the early increase in 
DWV-like viruses has created a stable population, or if the levels of VDV-like and 
recombinant strains increase after more years of Varroa parasitism, as appears to have 
occurred in southern areas of the UK.   
 
The results of our Warwickshire single apiary sampling experiment show that, over the 
course of a single season, the composition of the DWV-like virus population within a 
single heavily Varroa infected colony, with a well-established mite population, appears 
to be stable, irrespective of Varroa levels or virus load.  If we also take into 
consideration the results of a previous experiment conducted in the same apiary 
(Ryabov, et al., 2014) where the most prevalent strain of DWV was revealed by qPCR 
and Illumina sequencing, it would appear that the predominant strain in Varroa exposed 
bees, a VDV/DWV recombinant, has remained stable across a number of years.  One 
possible explanation is that  this strain has a  selective advantage in this system, 
preventing random drift or diversification of DWV-like viruses back towards the mixed 
population found in Varroa naïve bees.  The next step towards determining why certain 
strains of the virus dominate following Varroa mediated transmission, would be to 
sequence the DWV-like virus populations within apiaries in different countries, 
including areas where Varroa is present and absent, with the aim of identifying a section 
of the viral genome that confers this selective advantage.  This approach has been 
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instrumental in uncovering the molecular drivers behind emerging human viral diseases, 
such as the Zika virus (Zhu, et al., 2016). 
 
The techniques used to quantify and visualise the dynamics of early stage DWV 
infections outlined in Chapter 3 of this work could also be used to further investigate 
this question of virulent DWV strains, particularly if used in combination with a novel 
reverse genetic system (Lamp, et al., 2016).  Full length infectious clones of the 
published genomes of DWV, VDV and the VDV/DWV recombinant strain could be 
used for dose response and time course injection experiments to reveal more about how 
infectious each strain is when injected to mimic Varroa feeding.  Competition 
experiments involving the injection of exact mixtures of the infectious clones, followed 
by strain specific qPCR, would show how the strains compete whist replicating within 
honey bee tissue.  If fluorescently tagged infectious clones were produced, as 
(Kummerer, et al., 2012) successfully accomplished with the Chikungunya virus (a 
positive sense RNA virus, vectored by mosquitos), then the early stage infection 
dynamics of the different viral genomes could be visualised and compared. 
 
The work described in Chapter 5 supports our hypothesis that DWV infection during 
crucial stages of honey bee pupation and metamorphosis causes disturbances to the 
expression of developmental gene pathways, including ecdysone receptor signalling and 
homeobox developmental genes.  The precise nature of this relationship is complex and 
it appears to depend on a number of variables, including the parent colony of the bee, 
the age (or developmental stage) of the bee and the amount of DWV present (or stage of 
DWV infection).  The literature indicates that the expression of these developmental 
genes is highly dynamic, even in bees unchallenged by Varroa or disease (Walldorf, et 
al., 2000; Bomtorin, et al., 2012; Mello, et al., 2014),  which makes the testing and 
interpretation of how DWV infection affects the programmed development in honey 
bees very challenging.  However, this study suggests that the effect of DWV on bee 
development could be understood provided that key variables are identified and taken 
into account when designing experiments.  In order to reveal how DWV infection is 
subtly affecting developmental gene expression in honey bees it is crucial to avoid 
	 174	
pooling bee samples, to closely control the developmental stage of the sampled bees, to 
factor in the bee genotype or genetic pool, and to closely control the dose of DWV.   
 
Having designed experiments to closely control for the above factors, it is clear that 
DWV infection can alter the expression patterns of key developmental genes in infected 
honey bee pupae as they undergo morphological development to the adult life stage.  
This experimental system could be combined with the knowledge acquired in the 
previous two results chapters of this work to reveal more about this previously unknown 
association.  For example, as well as being temporally determined, the expression of 
ecdysone-regulated genomic networks (Li and White, 2003) and Hox gene expression 
(Mallo and Alonso, 2013) is known to be tissue specific in insects.  With our knowledge 
of the tissues most affected by DWV infection, both in terms of viral load and of 
developmental abnormalities in infected bees, it would be possible to dissect out 
particular organs or tissues (for example the brain, salivary glands, midgut epithelium or 
developing wing buds) and analyse developmental gene expression in these alone.  This 
would further reduce any ‘background noise’ that is caused by testing the whole bee, 
including any organs or tissues less affected by DWV infection.  It is also possible to 
study the transient expression of Hox gene expression using RNA-FISH (Bantignies and 
Cavalli, 2014), so it would be interesting to attempt to visualise and co-localise 
developmental gene expression and virus replication in honey bee tissue using our 
RNA-FISH and confocal microscopy techniques. This has potential to provide a 
mechanistic understanding of how DWV causes developmental abnormalities in virus 
infected bees.  
 
 
When taken as a whole, the work described in this thesis addresses key gaps in the 
knowledge about Varroa/DWV interactions in honey bees, from the population level, 
down to the individual.  The dynamics of early stage DWV infection in individual bees 
have been explored, both in terms of infectious doses and time coursed of infection for 
contrasting modes of transmission, and in terms of the effect on the developmental 
transcriptome of infected bees.  The link between DWV infection and developmental 
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and cognitive abnormalities has been clear for some time (de Miranda and Genersch, 
2010; Moeckel, et al., 2011) but the results described in Chapter 5 represent, to our 
knowledge, the first published account of a possible mechanism for this pathology.  
 
On a larger whole colony and population scale, this work addresses the conflicts in the 
published literature concerning the impact of Varroa mediated transmission of DWV on 
the viral diversity and potential selection of a virulent strain.  As well as showing that 
DWV-like viruses dominate in recently Varroa colonised apiaries in an isolated area of 
Western Scotland, we have shown that there is likely to be a stable ‘climax population’ 
of a recombinant strain of the virus in our experimental Warwickshire apiary.  These 
results, when considered alongside the results published by other research groups 
(Martin, et al., 2012; Ryabov, et al., 2014; McMahon, et al., 2016b; Mordecai, et al., 
2016; Brettell, et al., 2017), suggest a potential model for DWV strain selection, with 
early Varroa infestation appearing to select for DWV-like viral strains, with the 
possibility of further selection pressures causing a shift towards more VDV-like or 
recombinant strains as the Varroa mites become more established within an area.  
Further work is required, including continued environmental sampling and molecular 
analysis of DWV strains, and experimental manipulation of a reverse genetic system, in 
order to test this theory and reveal the possible mechanism behind this strain selection. 
 
 
There are a number of original questions raised by the findings described in this thesis, 
and these have been briefly mentioned above.  Here I will expand upon two of them and 
propose potential experiments to build upon the knowledge we have already acquired: 
 
The potential role played by developmental gene expression perturbation during DWV 
infection in honey bees is an interesting and novel area of research.  The results of my 
experiments indicate that virus replication may result in subtle alterations in the 
developmental gene transcriptome but further investigation is required before we could 
confidently conclude that these transient, variable disturbances are the previously 
unknown mechanism behind the pathology of DWV.  In order to reveal more about this 
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delicate system, we must firstly find out more about the variability in the observed 
transcriptional responses of honey bees, and how this is linked to the bee genome and to 
the susceptibility to DWV infection.   
 
I propose a larger scale multi colony injection experiment, injecting geographically (and 
therefore genetically) distant bees with a controlled dose of DWV.  The results of this 
experiment could be linked to a DWV dose response or susceptibility experiment, to 
establish whether bees exhibiting certain perturbations to developmental genes are more 
likely to go on to develop symptomatic DWV infections.  It would also be interesting to 
learn more about the genotypes of the experimental colonies, perhaps using a single 
nucleotide polymorphism (SNP) based assay, as described by (Muñoz, et al., 2015; 
Henriques, et al., 2018) to establish if the between colony variation in response is 
determined by honey bee genotype.   
 
Experimental manipulation of the expression of Hox and ecdysone responsive genes in 
developing pupae would give a clearer indication of the impact that disturbances to these 
pathways has on honey bee physiological or cognative development.  Sub lethal effects 
on behavioural reflexes could be measured by a proboscis extention response assay (Iqbal 
and Mueller, 2007; Smith and Burden, 2014).  This manipulation could be achieved 
through RNAi-mediated gene knockdown, a technique which has been shown to be 
effective in suppression of developmental and regulatory gene expression in adult honey 
bees (Corona, et al., 2007; Ament, et al., 2012; Wang, et al., 2013).  Experimental 
manipulation of developmental gene expression could be usefully combined with the 
RNA-FISH techniques developed in Chapter 3 of this work, to reveal more about the 
tissue specificity and association with DWV infected tissues of the candidate genes. 
 
There is also further work to be done in determining why Varroa mediated transmission 
of DWV selects for certain strains of the virus, and why these strains appear to differ 
according to the geographical location or stage of Varroa colonisation of the sampled 
bees.  I propose a longer-term sampling experiment in Ardnamurchan, to establish if the 
shift towards DWV-like strains is stable or if the predominant strain changes after further 
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years of Varroa parasitism.  I also think that next generation sequencing of global samples 
should be conducted to ascertain the dominant strain of DWV in all the areas where 
Varroa mites have become established.  Alignment of these global full length DWV 
sequences would allow identification of any conserved elements of the genome, potential 
candidates for conferring this selective advantage.   
 
A reverse genetic system, which is now possible following the identification and 
publication of an infectious full length DWV clone (Lamp, et al., 2016), would allow 
testing of viral clones containing any candidate sequences identified in the global 
sequencing programme.  Identification of the virulent strains of DWV, or of the element 
of the DWV genome that confers a selective advantage during Varroa transmission, 
would shed more light on why the DWV/Varroa combination has proved so deleterious 
to honey bee health worldwide.  It may also provide potential targets for developing anti-
viral treatments. 
 
The results of this work have implications, not only in informing future research and 
resolving key gaps in the knowledge about Varroa/DWV interactions in honey bees, but 
also on a practical level for beekeepers.  DWV is an extremely harmful pathogen of honey 
bees, replicating freely within many tissue types and quickly causing symptomatic 
infections in Varroa exposed individuals, and strategies to prevent its accumulation within 
colonies would be beneficial for honey bee health worldwide. 
 
Traditionally beekeepers in Varroa afflicted areas treat their colonies to remove the mites 
at the end of the season, after honey harvesting in September, to remove the mites before 
the over winter worker bees are produced and the winter break in brood production and 
foraging occurs.  However, the results of this work indicate that, by September, unchecked 
Varroa levels and DWV load are likely to have already risen to harmful levels, as seen in 
our single apiary experiment (Chapter 4 – section 4.3.2).  We have also shown how 
quickly DWV infections can progress in infected bees and how the transition to Varroa 
mediated transmission can alter the prevalent strain of DWV within a colony, potentially 
shifting towards more pathogenic strains.  In a late season colony where the majority of 
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bees are exposed to DWV, either via Varroa parasitism or in high does orally through 
hygienic behaviour (cannibalism of DWV infected brood), there are likely to be serious 
negative consequences for the crucial over winter workers, including perturbations to the 
expression of developmental genes.  The results of this thesis serve to highlight the 
importance of early and consistent Varroa control strategies.  The National Bee Unit 
(BeeBase, Fera) publish an excellent guide to Varroa management 
(http://www.nationalbeeunit.com/downloadDocument.cfm?id=16) which includes 
strategies on integrated pest management for Varroa control.  These focus on biotechnical 
methods early in the season (such as drone brood removal) and varroacides (such as 
thymol or oxalic acid) later in the season after the honey has been collected or the brood 
rearing season has finished.  The results of this thesis may inform future advice for bee 
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Appendix 1 – Table of oligonucleotide primers 
 
Primer ID Primer sequence (5' to 3') Description 
DWV-like-366 CTGTAGTTAAGCGGTTATTAGAA qPCR-VDV-Struc-For 
DWV-like-367 GGTGCTTCTGGAACAGCGGAA qPCR-VDV-Struct-Rev 
DWV-like-368 CTGTAGTCAAGCGGTTACTTGAG qPCR-DWV-Struct-For 
DWV-like-369 GGAGCTTCTGGAACGGCAGGT qPCR-DWV-Struct-Rev 
DWV-like-370 TTCATTAAAACCGCCAGGCTCT qPCR-VDV-Pol-For 
DWV-like-371 CAAGTTCAGGTCTCATCCCTCT qPCR-VDV-pol-Rev 
DWV-like-372 TTCATTAAAGCCACCTGGAACA qPCR-DWV-pol-For 
DWV-like-373 CAAGTTCGGGACGCATTCCACG qPCR-DWV-pol-Rev 
Bee-actin -374 AGGAATGGAAGCTTGCGGTA qPCR-Bee-actin-For 
Bee-actin -375 AATTTTCATGGTGGATGGTGC qPCR-Bee-actin-Rev 
Varroa-actin-132 TGAAGGTAGTCTCATGGATAC qPCR-Varroa-actin-For 
Varroa-actin-130 TGAAGGTAGTCTCATGGATAC qPCR-Varroa-actin-Rev 
DWV-like -163 GTTTGTATGAGGTTATACTTCAAGGAG qPCR-Universal-DWV-like-pol-R 
DWV-like -164 GCCATGCAATCCTTCAGTACCAGC qPCR-Universal-DWV-like-pol-R 
DWV-like-155 CAGTAGCTTGGGCGATTGTTTCG Nested-outer-Uni-DWV-4700-For 
DWV-like-156 CGCGCTTAACACACGCAAATTATC Nested-outer-Uni-DWV-6700-Rev 
DWV-like-151 CTGTAGTCAAGCGGTTACTTGAG Nested-Inner-DWV-4900-For 
DWV-like-152 CTGTAGTTAAGCGGTTATTAGAA Nested-Inner-VDV-4900-For 
DWV-like-153 CTTGGAGCTTGAGGCTCTACA Nested-Inner-DWV-6500-Rev 
 210 
DWV-like-154 CTGAAGTACTAATCTCTGAG Nested-Inner-VDV-6300-Rev 
Dll S1 F ACGCCTACGGATATCACCTG Distal-less qPCR For 
Dll S1 R CCCTTTACCGTTCCTCAAG Distal-less qPCR Rev 
Btnless S1 F TGCCGAATATACAGAAGATGGCA Buttonless qPCR For 
Btnless S1 R CGATGGAATCTCCCAAGCGT Buttonless qPCR Rev 
AbdA F ACAACCACTACCTGACGCG Abdominal A qPCR For 
AbdA R ACTCCTTCTTCAATTTCATC Abdominal A qPCR Rev 
ExEx S1 F TAAGGTGGAGGATGGTGGG ExtraExtra qPCR For 
ExEx S1 R CGGTCGTGTTTCTTTGCGTG ExtraExtra qPCR Rev 
Drop1 S2 F GCACCCTGAGGAAGCACAAG Drop1 qPCR For 
Drop1 S2 F GGCGATGGTTAGGTACTGCT Drop1 qPCR Rev 
EcrA F CCAACAGCAACAACGGCTAC  Ecdysone Receptor variant A For 
EcrA R AAAGAGCCAGGCTGCGACAA   Ecdysone Receptor variant A Rev 
EcrB F ACAGTGTTGCCAACGGTCAC  Ecdysone Receptor variant B For 
EcrB R AAAGAGCCAGGCTGCGACAA  Ecdysone Receptor variant B Rev 
InR S2 F CCACTGTCCTGCCGGTTATT Insulin-like peptide receptor For 
InR S2 R ACGAATATAGATGGGCGGGG Insulin-like peptide receptor Rev 
Crol S2 F ACGAAGCGAGATGCCAGAAC Crooked legs For 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































Predominantly VDV like virus in sample 
Mixed population
Predominantly DWV like virus in sample 
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Blue colony – Varroa infestation. 
Blue 1 (start of season) Blue 13 (end of season)
VDV Clone Control
DWV clone Control
Predominantly VDV like 
virus in sample 
Mixed population
Predominantly DWV like 






VDV like virus in sample 
Mixed population
Mixed population
White Colony – Very low levels of Varroa
White 1 (start of season) White 13 (end of season)
